id	sid	tid	token	lemma	pos
aiua-2211	1	1	stesura	stesura	PROPN
aiua-2211	1	2	seveso	seveso	PROPN
aiua-2211	1	3	archivio	archivio	PROPN
aiua-2211	1	4	italiano	italiano	X
aiua-2211	1	5	di	di	X
aiua-2211	1	6	urologia	urologia	PROPN
aiua-2211	1	7	e	e	PROPN
aiua-2211	1	8	andrologia	andrologia	NOUN
aiua-2211	1	9	2013	2013	NUM
aiua-2211	1	10	;	;	PUNCT
aiua-2211	1	11	85	85	NUM
aiua-2211	1	12	,	,	PUNCT
aiua-2211	1	13	4164	4164	NUM
aiua-2211	1	14	introduction	introduction	NOUN
aiua-2211	1	15	prostate	prostate	NOUN
aiua-2211	1	16	cancer	cancer	NOUN
aiua-2211	1	17	(	(	PUNCT
aiua-2211	1	18	pca	pca	PROPN
aiua-2211	1	19	)	)	PUNCT
aiua-2211	1	20	represents	represent	VERB
aiua-2211	1	21	the	the	DET
aiua-2211	1	22	second	second	ADJ
aiua-2211	1	23	major	major	ADJ
aiua-2211	1	24	cause	cause	NOUN
aiua-2211	1	25	of	of	ADP
aiua-2211	1	26	cancer	cancer	NOUN
aiua-2211	1	27	death	death	NOUN
aiua-2211	1	28	in	in	ADP
aiua-2211	1	29	men	man	NOUN
aiua-2211	1	30	(	(	PUNCT
aiua-2211	1	31	1	1	NUM
aiua-2211	1	32	)	)	PUNCT
aiua-2211	1	33	.	.	PUNCT
aiua-2211	2	1	radical	radical	ADJ
aiua-2211	2	2	prostatectomy	prostatectomy	NOUN
aiua-2211	2	3	(	(	PUNCT
aiua-2211	2	4	rp	rp	NOUN
aiua-2211	2	5	)	)	PUNCT
aiua-2211	2	6	and	and	CCONJ
aiua-2211	2	7	radiotherapy	radiotherapy	NOUN
aiua-2211	2	8	(	(	PUNCT
aiua-2211	2	9	rt	rt	PROPN
aiua-2211	2	10	)	)	PUNCT
aiua-2211	2	11	are	be	AUX
aiua-2211	2	12	well	well	ADV
aiua-2211	2	13	-	-	PUNCT
aiua-2211	2	14	established	establish	VERB
aiua-2211	2	15	primary	primary	ADJ
aiua-2211	2	16	therapeutic	therapeutic	ADJ
aiua-2211	2	17	options	option	NOUN
aiua-2211	2	18	for	for	ADP
aiua-2211	2	19	management	management	NOUN
aiua-2211	2	20	of	of	ADP
aiua-2211	2	21	localized	localized	ADJ
aiua-2211	2	22	pca	pca	NOUN
aiua-2211	2	23	,	,	PUNCT
aiua-2211	2	24	although	although	SCONJ
aiua-2211	2	25	cancer	cancer	NOUN
aiua-2211	2	26	recurrence	recurrence	NOUN
aiua-2211	2	27	still	still	ADV
aiua-2211	2	28	remains	remain	VERB
aiua-2211	2	29	a	a	DET
aiua-2211	2	30	significant	significant	ADJ
aiua-2211	2	31	concern	concern	NOUN
aiua-2211	2	32	for	for	ADP
aiua-2211	2	33	patients	patient	NOUN
aiua-2211	2	34	.	.	PUNCT
aiua-2211	3	1	in	in	ADP
aiua-2211	3	2	fact	fact	NOUN
aiua-2211	3	3	,	,	PUNCT
aiua-2211	3	4	about	about	ADV
aiua-2211	3	5	27	27	NUM
aiua-2211	3	6	-	-	SYM
aiua-2211	3	7	53	53	NUM
aiua-2211	3	8	%	%	NOUN
aiua-2211	3	9	of	of	ADP
aiua-2211	3	10	patients	patient	NOUN
aiua-2211	3	11	original	original	ADJ
aiua-2211	3	12	paper	paper	NOUN
aiua-2211	3	13	potential	potential	NOUN
aiua-2211	3	14	usefulness	usefulness	NOUN
aiua-2211	3	15	of	of	ADP
aiua-2211	3	16	ctc	ctc	NOUN
aiua-2211	3	17	detection	detection	NOUN
aiua-2211	3	18	in	in	ADP
aiua-2211	3	19	follow	follow	NOUN
aiua-2211	3	20	up	up	ADP
aiua-2211	3	21	of	of	ADP
aiua-2211	3	22	prostate	prostate	NOUN
aiua-2211	3	23	cancer	cancer	NOUN
aiua-2211	3	24	patients	patient	NOUN
aiua-2211	3	25	.	.	PUNCT
aiua-2211	4	1	a	a	DET
aiua-2211	4	2	preliminary	preliminary	ADJ
aiua-2211	4	3	report	report	NOUN
aiua-2211	4	4	obtained	obtain	VERB
aiua-2211	4	5	by	by	ADP
aiua-2211	4	6	using	use	VERB
aiua-2211	4	7	adnagene	adnagene	ADJ
aiua-2211	4	8	platform	platform	NOUN
aiua-2211	4	9	giuseppe	giuseppe	PROPN
aiua-2211	4	10	albino	albino	PROPN
aiua-2211	4	11	1	1	NUM
aiua-2211	4	12	,	,	PUNCT
aiua-2211	4	13	2	2	NUM
aiua-2211	4	14	,	,	PUNCT
aiua-2211	4	15	francesca	francesca	PROPN
aiua-2211	4	16	vendittelli	vendittelli	PROPN
aiua-2211	4	17	1	1	NUM
aiua-2211	4	18	,	,	PUNCT
aiua-2211	4	19	carmela	carmela	PROPN
aiua-2211	4	20	paolillo	paolillo	PROPN
aiua-2211	4	21	1	1	NUM
aiua-2211	4	22	,	,	PUNCT
aiua-2211	4	23	cecilia	cecilia	X
aiua-2211	4	24	zuppi	zuppi	PROPN
aiua-2211	4	25	1	1	NUM
aiua-2211	4	26	,	,	PUNCT
aiua-2211	4	27	ettore	ettore	NOUN
aiua-2211	4	28	capoluongo	capoluongo	NOUN
aiua-2211	4	29	1	1	NUM
aiua-2211	4	30	1	1	NUM
aiua-2211	4	31	laboratory	laboratory	NOUN
aiua-2211	4	32	of	of	ADP
aiua-2211	4	33	molecular	molecular	ADJ
aiua-2211	4	34	diagnostics	diagnostic	NOUN
aiua-2211	4	35	,	,	PUNCT
aiua-2211	4	36	institute	institute	NOUN
aiua-2211	4	37	of	of	ADP
aiua-2211	4	38	biochemistry	biochemistry	NOUN
aiua-2211	4	39	and	and	CCONJ
aiua-2211	4	40	clinical	clinical	ADJ
aiua-2211	4	41	biochemistry	biochemistry	NOUN
aiua-2211	4	42	,	,	PUNCT
aiua-2211	4	43	catholic	catholic	PROPN
aiua-2211	4	44	university	university	PROPN
aiua-2211	4	45	,	,	PUNCT
aiua-2211	4	46	rome	rome	PROPN
aiua-2211	4	47	,	,	PUNCT
aiua-2211	4	48	italy	italy	PROPN
aiua-2211	4	49	;	;	PUNCT
aiua-2211	4	50	2	2	NUM
aiua-2211	4	51	unit	unit	NOUN
aiua-2211	4	52	of	of	ADP
aiua-2211	4	53	urology	urology	NOUN
aiua-2211	4	54	,	,	PUNCT
aiua-2211	4	55	ospedale	ospedale	PROPN
aiua-2211	4	56	di	di	PROPN
aiua-2211	4	57	andria	andria	PROPN
aiua-2211	4	58	,	,	PUNCT
aiua-2211	4	59	asl	asl	PROPN
aiua-2211	4	60	bat	bat	NOUN
aiua-2211	4	61	,	,	PUNCT
aiua-2211	4	62	italy	italy	PROPN
aiua-2211	4	63	.	.	PUNCT
aiua-2211	5	1	objective	objective	NOUN
aiua-2211	5	2	:	:	PUNCT
aiua-2211	5	3	prostate	prostate	NOUN
aiua-2211	5	4	cancer	cancer	NOUN
aiua-2211	5	5	(	(	PUNCT
aiua-2211	5	6	pca	pca	PROPN
aiua-2211	5	7	)	)	PUNCT
aiua-2211	5	8	represents	represent	VERB
aiua-2211	5	9	one	one	NUM
aiua-2211	5	10	of	of	ADP
aiua-2211	5	11	the	the	DET
aiua-2211	5	12	most	most	ADV
aiua-2211	5	13	important	important	ADJ
aiua-2211	5	14	medical	medical	ADJ
aiua-2211	5	15	problems	problem	NOUN
aiua-2211	5	16	for	for	ADP
aiua-2211	5	17	males	male	NOUN
aiua-2211	5	18	,	,	PUNCT
aiua-2211	5	19	being	be	AUX
aiua-2211	5	20	the	the	DET
aiua-2211	5	21	second	second	ADJ
aiua-2211	5	22	major	major	ADJ
aiua-2211	5	23	cause	cause	NOUN
aiua-2211	5	24	of	of	ADP
aiua-2211	5	25	cancer	cancer	NOUN
aiua-2211	5	26	death	death	NOUN
aiua-2211	5	27	.	.	PUNCT
aiua-2211	6	1	routinely	routinely	ADV
aiua-2211	6	2	,	,	PUNCT
aiua-2211	6	3	pca	pca	NOUN
aiua-2211	6	4	patients	patient	NOUN
aiua-2211	6	5	are	be	AUX
aiua-2211	6	6	followed	follow	VERB
aiua-2211	6	7	up	up	ADP
aiua-2211	6	8	with	with	ADP
aiua-2211	6	9	both	both	CCONJ
aiua-2211	6	10	periodic	periodic	ADJ
aiua-2211	6	11	evaluation	evaluation	NOUN
aiua-2211	6	12	of	of	ADP
aiua-2211	6	13	serum	serum	NOUN
aiua-2211	6	14	psa	psa	NOUN
aiua-2211	6	15	levels	level	NOUN
aiua-2211	6	16	and	and	CCONJ
aiua-2211	6	17	imaging	imaging	NOUN
aiua-2211	6	18	.	.	PUNCT
aiua-2211	7	1	recently	recently	ADV
aiua-2211	7	2	,	,	PUNCT
aiua-2211	7	3	alternative	alternative	ADJ
aiua-2211	7	4	laboratory	laboratory	NOUN
aiua-2211	7	5	methods	method	NOUN
aiua-2211	7	6	were	be	AUX
aiua-2211	7	7	proposed	propose	VERB
aiua-2211	7	8	for	for	ADP
aiua-2211	7	9	pca	pca	NOUN
aiua-2211	7	10	patients	patient	NOUN
aiua-2211	7	11	’	'	PUNCT
aiua-2211	7	12	monitoring	monitoring	NOUN
aiua-2211	7	13	,	,	PUNCT
aiua-2211	7	14	with	with	ADP
aiua-2211	7	15	contrasting	contrast	VERB
aiua-2211	7	16	results	result	NOUN
aiua-2211	7	17	.	.	PUNCT
aiua-2211	8	1	aim	aim	NOUN
aiua-2211	8	2	of	of	ADP
aiua-2211	8	3	the	the	DET
aiua-2211	8	4	present	present	ADJ
aiua-2211	8	5	study	study	NOUN
aiua-2211	8	6	was	be	AUX
aiua-2211	8	7	to	to	PART
aiua-2211	8	8	evaluate	evaluate	VERB
aiua-2211	8	9	the	the	DET
aiua-2211	8	10	usefulness	usefulness	NOUN
aiua-2211	8	11	of	of	ADP
aiua-2211	8	12	a	a	DET
aiua-2211	8	13	new	new	ADJ
aiua-2211	8	14	commercially	commercially	ADV
aiua-2211	8	15	ce	ce	PROPN
aiua-2211	8	16	-	-	PUNCT
aiua-2211	8	17	ivd	ivd	PROPN
aiua-2211	8	18	kit	kit	NOUN
aiua-2211	8	19	for	for	ADP
aiua-2211	8	20	detection	detection	NOUN
aiua-2211	8	21	of	of	ADP
aiua-2211	8	22	prostate	prostate	NOUN
aiua-2211	8	23	circulating	circulate	VERB
aiua-2211	8	24	tumour	tumour	NOUN
aiua-2211	8	25	cells	cell	NOUN
aiua-2211	8	26	.	.	PUNCT
aiua-2211	9	1	our	our	PRON
aiua-2211	9	2	intention	intention	NOUN
aiua-2211	9	3	was	be	AUX
aiua-2211	9	4	to	to	PART
aiua-2211	9	5	verify	verify	VERB
aiua-2211	9	6	the	the	DET
aiua-2211	9	7	adnagene	adnagene	ADJ
aiua-2211	9	8	platform	platform	NOUN
aiua-2211	9	9	usefulness	usefulness	NOUN
aiua-2211	9	10	to	to	PART
aiua-2211	9	11	identify	identify	VERB
aiua-2211	9	12	patients	patient	NOUN
aiua-2211	9	13	with	with	ADP
aiua-2211	9	14	disease	disease	NOUN
aiua-2211	9	15	progression	progression	NOUN
aiua-2211	9	16	,	,	PUNCT
aiua-2211	9	17	whatever	whatever	DET
aiua-2211	9	18	treatment	treatment	NOUN
aiua-2211	9	19	ongoing	ongoing	ADJ
aiua-2211	9	20	,	,	PUNCT
aiua-2211	9	21	in	in	ADP
aiua-2211	9	22	order	order	NOUN
aiua-2211	9	23	to	to	PART
aiua-2211	9	24	modify	modify	VERB
aiua-2211	9	25	the	the	DET
aiua-2211	9	26	therapeutic	therapeutic	ADJ
aiua-2211	9	27	process	process	NOUN
aiua-2211	9	28	even	even	ADV
aiua-2211	9	29	before	before	SCONJ
aiua-2211	9	30	treatment	treatment	NOUN
aiua-2211	9	31	failure	failure	NOUN
aiua-2211	9	32	is	be	AUX
aiua-2211	9	33	evident	evident	ADJ
aiua-2211	9	34	with	with	ADP
aiua-2211	9	35	imaging	imaging	NOUN
aiua-2211	9	36	methods	method	NOUN
aiua-2211	9	37	.	.	PUNCT
aiua-2211	10	1	materials	material	NOUN
aiua-2211	10	2	and	and	CCONJ
aiua-2211	10	3	methods	method	NOUN
aiua-2211	10	4	:	:	PUNCT
aiua-2211	10	5	twenty	twenty	NUM
aiua-2211	10	6	-	-	PUNCT
aiua-2211	10	7	one	one	NUM
aiua-2211	10	8	patients	patient	NOUN
aiua-2211	10	9	were	be	AUX
aiua-2211	10	10	enrolled	enrol	VERB
aiua-2211	10	11	and	and	CCONJ
aiua-2211	10	12	subdivided	subdivide	VERB
aiua-2211	10	13	into	into	ADP
aiua-2211	10	14	three	three	NUM
aiua-2211	10	15	groups	group	NOUN
aiua-2211	10	16	:	:	PUNCT
aiua-2211	10	17	n	n	NOUN
aiua-2211	10	18	=	=	SYM
aiua-2211	10	19	10	10	NUM
aiua-2211	10	20	high	high	ADJ
aiua-2211	10	21	risk	risk	NOUN
aiua-2211	10	22	tumor	tumor	NOUN
aiua-2211	10	23	pca	pca	NOUN
aiua-2211	10	24	patients	patient	NOUN
aiua-2211	10	25	;	;	PUNCT
aiua-2211	10	26	n	n	NOUN
aiua-2211	10	27	=	=	SYM
aiua-2211	10	28	6	6	NUM
aiua-2211	10	29	low	low	ADJ
aiua-2211	10	30	risk	risk	NOUN
aiua-2211	10	31	pca	pca	NOUN
aiua-2211	10	32	patients	patient	NOUN
aiua-2211	10	33	;	;	PUNCT
aiua-2211	10	34	n	n	NOUN
aiua-2211	10	35	=	=	SYM
aiua-2211	10	36	5	5	NUM
aiua-2211	10	37	sbjects	sbject	NOUN
aiua-2211	10	38	without	without	ADP
aiua-2211	10	39	any	any	DET
aiua-2211	10	40	signs	sign	NOUN
aiua-2211	10	41	of	of	ADP
aiua-2211	10	42	pca	pca	PROPN
aiua-2211	10	43	.	.	PUNCT
aiua-2211	11	1	adnatest	adnate	ADJ
aiua-2211	11	2	prostate	prostate	NOUN
aiua-2211	11	3	cancer	cancer	NOUN
aiua-2211	11	4	kit	kit	NOUN
aiua-2211	11	5	was	be	AUX
aiua-2211	11	6	used	use	VERB
aiua-2211	11	7	for	for	ADP
aiua-2211	11	8	enrichment	enrichment	NOUN
aiua-2211	11	9	and	and	CCONJ
aiua-2211	11	10	molecular	molecular	ADJ
aiua-2211	11	11	characterization	characterization	NOUN
aiua-2211	11	12	of	of	ADP
aiua-2211	11	13	prostate	prostate	NOUN
aiua-2211	11	14	circulating	circulate	VERB
aiua-2211	11	15	tumour	tumour	NOUN
aiua-2211	11	16	cells	cell	NOUN
aiua-2211	11	17	.	.	PUNCT
aiua-2211	12	1	results	result	NOUN
aiua-2211	12	2	:	:	PUNCT
aiua-2211	12	3	healthy	healthy	ADJ
aiua-2211	12	4	subjects	subject	NOUN
aiua-2211	12	5	(	(	PUNCT
aiua-2211	12	6	with	with	ADP
aiua-2211	12	7	bph	bph	NOUN
aiua-2211	12	8	)	)	PUNCT
aiua-2211	12	9	and	and	CCONJ
aiua-2211	12	10	patients	patient	NOUN
aiua-2211	12	11	without	without	ADP
aiua-2211	12	12	metastases	metastasis	NOUN
aiua-2211	12	13	resulted	result	VERB
aiua-2211	12	14	as	as	ADP
aiua-2211	12	15	negative	negative	ADJ
aiua-2211	12	16	,	,	PUNCT
aiua-2211	12	17	while	while	SCONJ
aiua-2211	12	18	3	3	NUM
aiua-2211	12	19	out	out	ADP
aiua-2211	12	20	of	of	ADP
aiua-2211	12	21	10	10	NUM
aiua-2211	12	22	high	high	ADJ
aiua-2211	12	23	risk	risk	NOUN
aiua-2211	12	24	pca	pca	NOUN
aiua-2211	12	25	patients	patient	NOUN
aiua-2211	12	26	were	be	AUX
aiua-2211	12	27	positive	positive	ADJ
aiua-2211	12	28	at	at	ADP
aiua-2211	12	29	least	least	ADJ
aiua-2211	12	30	for	for	ADP
aiua-2211	12	31	one	one	NUM
aiua-2211	12	32	molecular	molecular	ADJ
aiua-2211	12	33	marker	marker	NOUN
aiua-2211	12	34	like	like	ADP
aiua-2211	12	35	psa	psa	NOUN
aiua-2211	12	36	,	,	PUNCT
aiua-2211	12	37	while	while	SCONJ
aiua-2211	12	38	only	only	ADV
aiua-2211	12	39	two	two	NUM
aiua-2211	12	40	showed	show	VERB
aiua-2211	12	41	positivity	positivity	NOUN
aiua-2211	12	42	for	for	ADP
aiua-2211	12	43	psma	psma	PROPN
aiua-2211	12	44	mrna	mrna	PROPN
aiua-2211	12	45	.	.	PUNCT
aiua-2211	13	1	our	our	PRON
aiua-2211	13	2	results	result	NOUN
aiua-2211	13	3	indicate	indicate	VERB
aiua-2211	13	4	that	that	SCONJ
aiua-2211	13	5	the	the	DET
aiua-2211	13	6	test	test	NOUN
aiua-2211	13	7	specificity	specificity	NOUN
aiua-2211	13	8	is	be	AUX
aiua-2211	13	9	100	100	NUM
aiua-2211	13	10	%	%	NOUN
aiua-2211	13	11	and	and	CCONJ
aiua-2211	13	12	the	the	DET
aiua-2211	13	13	sensitivity	sensitivity	NOUN
aiua-2211	13	14	is	be	AUX
aiua-2211	13	15	100	100	NUM
aiua-2211	13	16	%	%	NOUN
aiua-2211	13	17	;	;	PUNCT
aiua-2211	13	18	of	of	ADP
aiua-2211	13	19	course	course	NOUN
aiua-2211	13	20	the	the	DET
aiua-2211	13	21	sample	sample	NOUN
aiua-2211	13	22	is	be	AUX
aiua-2211	13	23	too	too	ADV
aiua-2211	13	24	small	small	ADJ
aiua-2211	13	25	to	to	PART
aiua-2211	13	26	give	give	VERB
aiua-2211	13	27	it	it	PRON
aiua-2211	13	28	statistical	statistical	ADJ
aiua-2211	13	29	validity	validity	NOUN
aiua-2211	13	30	.	.	PUNCT
aiua-2211	14	1	in	in	ADP
aiua-2211	14	2	detail	detail	NOUN
aiua-2211	14	3	we	we	PRON
aiua-2211	14	4	verified	verify	VERB
aiua-2211	14	5	that	that	SCONJ
aiua-2211	14	6	only	only	ADV
aiua-2211	14	7	the	the	DET
aiua-2211	14	8	“	"	PUNCT
aiua-2211	14	9	not	not	PART
aiua-2211	14	10	responder	responder	NOUN
aiua-2211	14	11	”	"	PUNCT
aiua-2211	14	12	patients	patient	NOUN
aiua-2211	14	13	resulted	result	VERB
aiua-2211	14	14	positive	positive	ADJ
aiua-2211	14	15	for	for	ADP
aiua-2211	14	16	adnatest	adnate	ADJ
aiua-2211	14	17	.	.	PUNCT
aiua-2211	15	1	conclusions	conclusion	NOUN
aiua-2211	15	2	:	:	PUNCT
aiua-2211	15	3	the	the	DET
aiua-2211	15	4	present	present	ADJ
aiua-2211	15	5	preliminary	preliminary	ADJ
aiua-2211	15	6	report	report	NOUN
aiua-2211	15	7	provides	provide	VERB
aiua-2211	15	8	evidence	evidence	NOUN
aiua-2211	15	9	that	that	SCONJ
aiua-2211	15	10	isolation	isolation	NOUN
aiua-2211	15	11	and	and	CCONJ
aiua-2211	15	12	detection	detection	NOUN
aiua-2211	15	13	of	of	ADP
aiua-2211	15	14	circulating	circulate	VERB
aiua-2211	15	15	tumour	tumour	NOUN
aiua-2211	15	16	cells	cell	NOUN
aiua-2211	15	17	(	(	PUNCT
aiua-2211	15	18	ctcs	ctcs	NOUN
aiua-2211	15	19	)	)	PUNCT
aiua-2211	15	20	is	be	AUX
aiua-2211	15	21	feasible	feasible	ADJ
aiua-2211	15	22	and	and	CCONJ
aiua-2211	15	23	it	it	PRON
aiua-2211	15	24	may	may	AUX
aiua-2211	15	25	be	be	AUX
aiua-2211	15	26	useful	useful	ADJ
aiua-2211	15	27	in	in	ADP
aiua-2211	15	28	the	the	DET
aiua-2211	15	29	follow	follow	NOUN
aiua-2211	15	30	-	-	PUNCT
aiua-2211	15	31	up	up	NOUN
aiua-2211	15	32	of	of	ADP
aiua-2211	15	33	patients	patient	NOUN
aiua-2211	15	34	with	with	ADP
aiua-2211	15	35	advanced	advanced	ADJ
aiua-2211	15	36	prostate	prostate	NOUN
aiua-2211	15	37	cancer	cancer	NOUN
aiua-2211	15	38	.	.	PUNCT
aiua-2211	16	1	if	if	SCONJ
aiua-2211	16	2	the	the	DET
aiua-2211	16	3	results	result	NOUN
aiua-2211	16	4	of	of	ADP
aiua-2211	16	5	this	this	DET
aiua-2211	16	6	preliminary	preliminary	ADJ
aiua-2211	16	7	study	study	NOUN
aiua-2211	16	8	would	would	AUX
aiua-2211	16	9	be	be	AUX
aiua-2211	16	10	confirmed	confirm	VERB
aiua-2211	16	11	by	by	ADP
aiua-2211	16	12	a	a	DET
aiua-2211	16	13	large	large	ADJ
aiua-2211	16	14	prospective	prospective	ADJ
aiua-2211	16	15	cohort	cohort	NOUN
aiua-2211	16	16	study	study	NOUN
aiua-2211	16	17	,	,	PUNCT
aiua-2211	16	18	it	it	PRON
aiua-2211	16	19	could	could	AUX
aiua-2211	16	20	be	be	AUX
aiua-2211	16	21	demonstrated	demonstrate	VERB
aiua-2211	16	22	that	that	SCONJ
aiua-2211	16	23	this	this	DET
aiua-2211	16	24	test	test	NOUN
aiua-2211	16	25	is	be	AUX
aiua-2211	16	26	a	a	DET
aiua-2211	16	27	rapid	rapid	ADJ
aiua-2211	16	28	diagnostic	diagnostic	ADJ
aiua-2211	16	29	method	method	NOUN
aiua-2211	16	30	,	,	PUNCT
aiua-2211	16	31	based	base	VERB
aiua-2211	16	32	on	on	ADP
aiua-2211	16	33	the	the	DET
aiua-2211	16	34	analysis	analysis	NOUN
aiua-2211	16	35	of	of	ADP
aiua-2211	16	36	a	a	DET
aiua-2211	16	37	blood	blood	NOUN
aiua-2211	16	38	sample	sample	NOUN
aiua-2211	16	39	and	and	CCONJ
aiua-2211	16	40	useful	useful	ADJ
aiua-2211	16	41	to	to	ADP
aiua-2211	16	42	the	the	DET
aiua-2211	16	43	clinician	clinician	NOUN
aiua-2211	16	44	to	to	PART
aiua-2211	16	45	decide	decide	VERB
aiua-2211	16	46	when	when	SCONJ
aiua-2211	16	47	to	to	PART
aiua-2211	16	48	change	change	VERB
aiua-2211	16	49	therapy	therapy	NOUN
aiua-2211	16	50	for	for	ADP
aiua-2211	16	51	patients	patient	NOUN
aiua-2211	16	52	resistant	resistant	ADJ
aiua-2211	16	53	to	to	ADP
aiua-2211	16	54	castration	castration	NOUN
aiua-2211	16	55	or	or	CCONJ
aiua-2211	16	56	able	able	ADJ
aiua-2211	16	57	to	to	PART
aiua-2211	16	58	confirm	confirm	VERB
aiua-2211	16	59	that	that	PRON
aiua-2211	16	60	,	,	PUNCT
aiua-2211	16	61	at	at	ADP
aiua-2211	16	62	that	that	DET
aiua-2211	16	63	time	time	NOUN
aiua-2211	16	64	,	,	PUNCT
aiua-2211	16	65	the	the	DET
aiua-2211	16	66	therapy	therapy	NOUN
aiua-2211	16	67	is	be	AUX
aiua-2211	16	68	effective	effective	ADJ
aiua-2211	16	69	.	.	PUNCT
aiua-2211	17	1	key	key	ADJ
aiua-2211	17	2	words	word	NOUN
aiua-2211	17	3	:	:	PUNCT
aiua-2211	17	4	prostate	prostate	NOUN
aiua-2211	17	5	cancer	cancer	NOUN
aiua-2211	17	6	;	;	PUNCT
aiua-2211	17	7	circulating	circulate	VERB
aiua-2211	17	8	prostate	prostate	NOUN
aiua-2211	17	9	tumor	tumor	NOUN
aiua-2211	17	10	cells	cell	NOUN
aiua-2211	17	11	;	;	PUNCT
aiua-2211	17	12	adnatest	adnate	ADJ
aiua-2211	17	13	.	.	PUNCT
aiua-2211	18	1	submitted	submit	VERB
aiua-2211	18	2	12	12	NUM
aiua-2211	18	3	july	july	PROPN
aiua-2211	18	4	2013	2013	NUM
aiua-2211	18	5	;	;	PUNCT
aiua-2211	18	6	accepted	accept	VERB
aiua-2211	18	7	31	31	NUM
aiua-2211	18	8	july	july	PROPN
aiua-2211	18	9	2013	2013	NUM
aiua-2211	18	10	no	no	DET
aiua-2211	18	11	conflict	conflict	NOUN
aiua-2211	18	12	of	of	ADP
aiua-2211	18	13	interest	interest	NOUN
aiua-2211	18	14	declared	declare	VERB
aiua-2211	18	15	summary	summary	NOUN
aiua-2211	18	16	undergoing	undergo	VERB
aiua-2211	18	17	rt	rt	PROPN
aiua-2211	18	18	or	or	CCONJ
aiua-2211	18	19	rp	rp	NOUN
aiua-2211	18	20	will	will	AUX
aiua-2211	18	21	develop	develop	VERB
aiua-2211	18	22	local	local	ADJ
aiua-2211	18	23	or	or	CCONJ
aiua-2211	18	24	at	at	ADP
aiua-2211	18	25	distance	distance	NOUN
aiua-2211	18	26	metastases	metastasis	NOUN
aiua-2211	18	27	within	within	ADP
aiua-2211	18	28	10	10	NUM
aiua-2211	18	29	years	year	NOUN
aiua-2211	18	30	from	from	ADP
aiua-2211	18	31	initial	initial	ADJ
aiua-2211	18	32	treatment	treatment	NOUN
aiua-2211	18	33	and	and	CCONJ
aiua-2211	18	34	1635	1635	NUM
aiua-2211	18	35	%	%	NOUN
aiua-2211	18	36	of	of	ADP
aiua-2211	18	37	pca	pca	NOUN
aiua-2211	18	38	patients	patient	NOUN
aiua-2211	18	39	will	will	AUX
aiua-2211	18	40	receive	receive	VERB
aiua-2211	18	41	second	second	ADJ
aiua-2211	18	42	-	-	PUNCT
aiua-2211	18	43	line	line	NOUN
aiua-2211	18	44	treatment	treatment	NOUN
aiua-2211	18	45	within	within	ADP
aiua-2211	18	46	5	5	NUM
aiua-2211	18	47	years	year	NOUN
aiua-2211	18	48	of	of	ADP
aiua-2211	18	49	initial	initial	ADJ
aiua-2211	18	50	therapy	therapy	NOUN
aiua-2211	18	51	(	(	PUNCT
aiua-2211	18	52	2	2	NUM
aiua-2211	18	53	,	,	PUNCT
aiua-2211	18	54	3	3	NUM
aiua-2211	18	55	)	)	PUNCT
aiua-2211	18	56	.	.	PUNCT
aiua-2211	19	1	routinely	routinely	ADV
aiua-2211	19	2	,	,	PUNCT
aiua-2211	19	3	pca	pca	NOUN
aiua-2211	19	4	patients	patient	NOUN
aiua-2211	19	5	are	be	AUX
aiua-2211	19	6	followed	follow	VERB
aiua-2211	19	7	up	up	ADP
aiua-2211	19	8	with	with	ADP
aiua-2211	19	9	periodic	periodic	ADJ
aiua-2211	19	10	evaluation	evaluation	NOUN
aiua-2211	19	11	of	of	ADP
aiua-2211	19	12	serum	serum	NOUN
aiua-2211	19	13	prostate	prostate	NOUN
aiua-2211	19	14	-	-	PUNCT
aiua-2211	19	15	specific	specific	ADJ
aiua-2211	19	16	antigen	antigen	NOUN
aiua-2211	19	17	(	(	PUNCT
aiua-2211	19	18	psa	psa	NOUN
aiua-2211	19	19	)	)	PUNCT
aiua-2211	19	20	levels	level	NOUN
aiua-2211	19	21	and	and	CCONJ
aiua-2211	19	22	imaging	imaging	NOUN
aiua-2211	19	23	doi	doi	NOUN
aiua-2211	19	24	:	:	PUNCT
aiua-2211	19	25	10.4081	10.4081	NUM
aiua-2211	19	26	/	/	SYM
aiua-2211	19	27	aiua.2013.4.164	aiua.2013.4.164	NOUN
aiua-2211	19	28	165archivio	165archivio	PROPN
aiua-2211	19	29	italiano	italiano	NOUN
aiua-2211	19	30	di	di	X
aiua-2211	19	31	urologia	urologia	PROPN
aiua-2211	19	32	e	e	PROPN
aiua-2211	19	33	andrologia	andrologia	NOUN
aiua-2211	19	34	2013	2013	NUM
aiua-2211	19	35	;	;	PUNCT
aiua-2211	19	36	85	85	NUM
aiua-2211	19	37	,	,	PUNCT
aiua-2211	19	38	4	4	NUM
aiua-2211	19	39	potential	potential	ADJ
aiua-2211	19	40	usefulness	usefulness	NOUN
aiua-2211	19	41	of	of	ADP
aiua-2211	19	42	ctc	ctc	NOUN
aiua-2211	19	43	detection	detection	NOUN
aiua-2211	19	44	in	in	ADP
aiua-2211	19	45	follow	follow	NOUN
aiua-2211	19	46	up	up	ADP
aiua-2211	19	47	of	of	ADP
aiua-2211	19	48	prostate	prostate	NOUN
aiua-2211	19	49	cancer	cancer	NOUN
aiua-2211	19	50	patients	patient	NOUN
aiua-2211	19	51	.	.	PUNCT
aiua-2211	20	1	a	a	DET
aiua-2211	20	2	preliminary	preliminary	ADJ
aiua-2211	20	3	report	report	NOUN
aiua-2211	20	4	obtained	obtain	VERB
aiua-2211	20	5	by	by	ADP
aiua-2211	20	6	using	use	VERB
aiua-2211	20	7	adnagene	adnagene	ADJ
aiua-2211	20	8	platform	platform	NOUN
aiua-2211	20	9	(	(	PUNCT
aiua-2211	20	10	tc	tc	NOUN
aiua-2211	20	11	,	,	PUNCT
aiua-2211	20	12	rmn	rmn	NOUN
aiua-2211	20	13	,	,	PUNCT
aiua-2211	20	14	bone	bone	NOUN
aiua-2211	20	15	scintigraphy	scintigraphy	NOUN
aiua-2211	20	16	,	,	PUNCT
aiua-2211	20	17	18	18	NUM
aiua-2211	20	18	-	-	PUNCT
aiua-2211	20	19	f	f	PROPN
aiua-2211	20	20	choline	choline	NOUN
aiua-2211	20	21	pet	pet	NOUN
aiua-2211	20	22	)	)	PUNCT
aiua-2211	20	23	(	(	PUNCT
aiua-2211	20	24	4	4	NUM
aiua-2211	20	25	)	)	PUNCT
aiua-2211	20	26	,	,	PUNCT
aiua-2211	20	27	although	although	SCONJ
aiua-2211	20	28	undetectable	undetectable	ADJ
aiua-2211	20	29	serum	serum	NOUN
aiua-2211	20	30	psa	psa	NOUN
aiua-2211	20	31	does	do	AUX
aiua-2211	20	32	not	not	PART
aiua-2211	20	33	necessarily	necessarily	ADV
aiua-2211	20	34	indicate	indicate	VERB
aiua-2211	20	35	the	the	DET
aiua-2211	20	36	absence	absence	NOUN
aiua-2211	20	37	of	of	ADP
aiua-2211	20	38	any	any	DET
aiua-2211	20	39	potential	potential	ADJ
aiua-2211	20	40	metastatic	metastatic	ADJ
aiua-2211	20	41	risk	risk	NOUN
aiua-2211	20	42	.	.	PUNCT
aiua-2211	21	1	in	in	ADP
aiua-2211	21	2	this	this	DET
aiua-2211	21	3	way	way	NOUN
aiua-2211	21	4	,	,	PUNCT
aiua-2211	21	5	the	the	DET
aiua-2211	21	6	release	release	NOUN
aiua-2211	21	7	of	of	ADP
aiua-2211	21	8	tumor	tumor	NOUN
aiua-2211	21	9	cells	cell	NOUN
aiua-2211	21	10	into	into	ADP
aiua-2211	21	11	bloodstream	bloodstream	NOUN
aiua-2211	21	12	could	could	AUX
aiua-2211	21	13	represent	represent	VERB
aiua-2211	21	14	a	a	DET
aiua-2211	21	15	peculiar	peculiar	ADJ
aiua-2211	21	16	sign	sign	NOUN
aiua-2211	21	17	of	of	ADP
aiua-2211	21	18	cancer	cancer	NOUN
aiua-2211	21	19	aggressiveness	aggressiveness	NOUN
aiua-2211	21	20	both	both	CCONJ
aiua-2211	21	21	before	before	ADP
aiua-2211	21	22	and	and	CCONJ
aiua-2211	21	23	after	after	ADP
aiua-2211	21	24	therapy	therapy	NOUN
aiua-2211	21	25	(	(	PUNCT
aiua-2211	21	26	5	5	NUM
aiua-2211	21	27	,	,	PUNCT
aiua-2211	21	28	6	6	NUM
aiua-2211	21	29	):	):	PUNCT
aiua-2211	21	30	therefore	therefore	ADV
aiua-2211	21	31	,	,	PUNCT
aiua-2211	21	32	circulating	circulate	VERB
aiua-2211	21	33	tumour	tumour	ADJ
aiua-2211	21	34	cells	cell	NOUN
aiua-2211	21	35	(	(	PUNCT
aiua-2211	21	36	ctcs	ctcs	ADJ
aiua-2211	21	37	)	)	PUNCT
aiua-2211	21	38	detection	detection	NOUN
aiua-2211	21	39	could	could	AUX
aiua-2211	21	40	provide	provide	VERB
aiua-2211	21	41	precious	precious	ADJ
aiua-2211	21	42	informations	information	NOUN
aiua-2211	21	43	to	to	ADP
aiua-2211	21	44	the	the	DET
aiua-2211	21	45	clinician	clinician	NOUN
aiua-2211	21	46	regarding	regard	VERB
aiua-2211	21	47	disease	disease	NOUN
aiua-2211	21	48	status	status	NOUN
aiua-2211	21	49	.	.	PUNCT
aiua-2211	22	1	in	in	ADP
aiua-2211	22	2	this	this	DET
aiua-2211	22	3	context	context	NOUN
aiua-2211	22	4	,	,	PUNCT
aiua-2211	22	5	due	due	ADP
aiua-2211	22	6	to	to	ADP
aiua-2211	22	7	the	the	DET
aiua-2211	22	8	lack	lack	NOUN
aiua-2211	22	9	of	of	ADP
aiua-2211	22	10	additional	additional	ADJ
aiua-2211	22	11	markers	marker	NOUN
aiua-2211	22	12	able	able	ADJ
aiua-2211	22	13	to	to	PART
aiua-2211	22	14	early	early	ADV
aiua-2211	22	15	detect	detect	VERB
aiua-2211	22	16	pca	pca	PROPN
aiua-2211	22	17	relapse	relapse	NOUN
aiua-2211	22	18	,	,	PUNCT
aiua-2211	22	19	use	use	NOUN
aiua-2211	22	20	of	of	ADP
aiua-2211	22	21	reliable	reliable	ADJ
aiua-2211	22	22	test	test	NOUN
aiua-2211	22	23	for	for	ADP
aiua-2211	22	24	prostate	prostate	NOUN
aiua-2211	22	25	ctcs	ctcs	NOUN
aiua-2211	22	26	detection	detection	NOUN
aiua-2211	22	27	could	could	AUX
aiua-2211	22	28	provide	provide	VERB
aiua-2211	22	29	novel	novel	ADJ
aiua-2211	22	30	opportunities	opportunity	NOUN
aiua-2211	22	31	for	for	ADP
aiua-2211	22	32	alternative	alternative	ADJ
aiua-2211	22	33	therapeutic	therapeutic	ADJ
aiua-2211	22	34	approaches	approach	NOUN
aiua-2211	22	35	(	(	PUNCT
aiua-2211	22	36	7	7	NUM
aiua-2211	22	37	,	,	PUNCT
aiua-2211	22	38	8)	8)	NUM
aiua-2211	22	39	.	.	PUNCT
aiua-2211	23	1	recent	recent	ADJ
aiua-2211	23	2	studies	study	NOUN
aiua-2211	23	3	employed	employ	VERB
aiua-2211	23	4	rt	rt	ADJ
aiua-2211	23	5	-	-	PUNCT
aiua-2211	23	6	pcr	pcr	ADJ
aiua-2211	23	7	methods	method	NOUN
aiua-2211	23	8	for	for	ADP
aiua-2211	23	9	detection	detection	NOUN
aiua-2211	23	10	of	of	ADP
aiua-2211	23	11	prostate	prostate	NOUN
aiua-2211	23	12	-	-	PUNCT
aiua-2211	23	13	specific	specific	ADJ
aiua-2211	23	14	mrnas	mrna	NOUN
aiua-2211	23	15	in	in	ADP
aiua-2211	23	16	whole	whole	ADJ
aiua-2211	23	17	blood	blood	NOUN
aiua-2211	23	18	without	without	ADP
aiua-2211	23	19	any	any	DET
aiua-2211	23	20	pre	pre	NOUN
aiua-2211	23	21	-	-	NOUN
aiua-2211	23	22	selection	selection	NOUN
aiua-2211	23	23	of	of	ADP
aiua-2211	23	24	ctcs	ctcs	NOUN
aiua-2211	23	25	(	(	PUNCT
aiua-2211	23	26	9	9	NUM
aiua-2211	23	27	,	,	PUNCT
aiua-2211	23	28	10	10	NUM
aiua-2211	23	29	)	)	PUNCT
aiua-2211	23	30	.	.	PUNCT
aiua-2211	24	1	prostate	prostate	NOUN
aiua-2211	24	2	-	-	PUNCT
aiua-2211	24	3	specific	specific	ADJ
aiua-2211	24	4	mrnas	mrna	NOUN
aiua-2211	24	5	are	be	AUX
aiua-2211	24	6	considered	consider	VERB
aiua-2211	24	7	as	as	ADP
aiua-2211	24	8	surrogate	surrogate	ADJ
aiua-2211	24	9	markers	marker	NOUN
aiua-2211	24	10	of	of	ADP
aiua-2211	24	11	ctc	ctc	PROPN
aiua-2211	24	12	presence	presence	NOUN
aiua-2211	24	13	,	,	PUNCT
aiua-2211	24	14	although	although	SCONJ
aiua-2211	24	15	with	with	ADP
aiua-2211	24	16	conflicting	conflicting	ADJ
aiua-2211	24	17	results	result	NOUN
aiua-2211	24	18	(	(	PUNCT
aiua-2211	24	19	11	11	NUM
aiua-2211	24	20	,	,	PUNCT
aiua-2211	24	21	12	12	NUM
aiua-2211	24	22	)	)	PUNCT
aiua-2211	24	23	.	.	PUNCT
aiua-2211	25	1	however	however	ADV
aiua-2211	25	2	,	,	PUNCT
aiua-2211	25	3	recent	recent	ADJ
aiua-2211	25	4	studies	study	NOUN
aiua-2211	25	5	on	on	ADP
aiua-2211	25	6	individuals	individual	NOUN
aiua-2211	25	7	with	with	ADP
aiua-2211	25	8	prostate	prostate	NOUN
aiua-2211	25	9	cancer	cancer	NOUN
aiua-2211	25	10	at	at	ADP
aiua-2211	25	11	advanced	advanced	ADJ
aiua-2211	25	12	stages	stage	NOUN
aiua-2211	25	13	,	,	PUNCT
aiua-2211	25	14	performed	perform	VERB
aiua-2211	25	15	using	use	VERB
aiua-2211	25	16	the	the	DET
aiua-2211	25	17	cellsearch	cellsearch	ADJ
aiua-2211	25	18	platform	platform	NOUN
aiua-2211	25	19	(	(	PUNCT
aiua-2211	25	20	13	13	NUM
aiua-2211	25	21	-	-	SYM
aiua-2211	25	22	15	15	NUM
aiua-2211	25	23	)	)	PUNCT
aiua-2211	25	24	,	,	PUNCT
aiua-2211	25	25	found	find	VERB
aiua-2211	25	26	that	that	SCONJ
aiua-2211	25	27	high	high	ADJ
aiua-2211	25	28	ctc	ctc	NOUN
aiua-2211	25	29	counts	count	NOUN
aiua-2211	25	30	correlated	correlate	VERB
aiua-2211	25	31	with	with	ADP
aiua-2211	25	32	poor	poor	ADJ
aiua-2211	25	33	prognosis	prognosis	NOUN
aiua-2211	25	34	(	(	PUNCT
aiua-2211	25	35	13	13	NUM
aiua-2211	25	36	-	-	SYM
aiua-2211	25	37	18	18	NUM
aiua-2211	25	38	)	)	PUNCT
aiua-2211	25	39	.	.	PUNCT
aiua-2211	26	1	ctc	ctc	NOUN
aiua-2211	26	2	detection	detection	NOUN
aiua-2211	26	3	rates	rate	NOUN
aiua-2211	26	4	are	be	AUX
aiua-2211	26	5	really	really	ADV
aiua-2211	26	6	variable	variable	ADJ
aiua-2211	26	7	among	among	ADP
aiua-2211	26	8	studies	study	NOUN
aiua-2211	26	9	,	,	PUNCT
aiua-2211	26	10	ranging	range	VERB
aiua-2211	26	11	from	from	ADP
aiua-2211	26	12	54	54	NUM
aiua-2211	26	13	%	%	NOUN
aiua-2211	26	14	to	to	PART
aiua-2211	26	15	62	62	NUM
aiua-2211	26	16	%	%	NOUN
aiua-2211	26	17	,	,	PUNCT
aiua-2211	26	18	mainly	mainly	ADV
aiua-2211	26	19	depending	depend	VERB
aiua-2211	26	20	on	on	ADP
aiua-2211	26	21	the	the	DET
aiua-2211	26	22	characteristics	characteristic	NOUN
aiua-2211	26	23	of	of	ADP
aiua-2211	26	24	the	the	DET
aiua-2211	26	25	patients	patient	NOUN
aiua-2211	26	26	studied	study	VERB
aiua-2211	26	27	(	(	PUNCT
aiua-2211	26	28	19	19	NUM
aiua-2211	26	29	-	-	SYM
aiua-2211	26	30	20	20	NUM
aiua-2211	26	31	)	)	PUNCT
aiua-2211	26	32	.	.	PUNCT
aiua-2211	27	1	some	some	DET
aiua-2211	27	2	methods	method	NOUN
aiua-2211	27	3	for	for	ADP
aiua-2211	27	4	ctc	ctc	NOUN
aiua-2211	27	5	characterization	characterization	NOUN
aiua-2211	27	6	in	in	ADP
aiua-2211	27	7	pca	pca	NOUN
aiua-2211	27	8	patients	patient	NOUN
aiua-2211	27	9	are	be	AUX
aiua-2211	27	10	in	in	ADP
aiua-2211	27	11	developing	develop	VERB
aiua-2211	27	12	or	or	CCONJ
aiua-2211	27	13	under	under	ADP
aiua-2211	27	14	clinical	clinical	ADJ
aiua-2211	27	15	laboratory	laboratory	NOUN
aiua-2211	27	16	evaluation	evaluation	NOUN
aiua-2211	27	17	(	(	PUNCT
aiua-2211	27	18	20	20	NUM
aiua-2211	27	19	,	,	PUNCT
aiua-2211	27	20	21	21	NUM
aiua-2211	27	21	)	)	PUNCT
aiua-2211	27	22	.	.	PUNCT
aiua-2211	28	1	a	a	DET
aiua-2211	28	2	recent	recent	ADJ
aiua-2211	28	3	ce	ce	PROPN
aiua-2211	28	4	-	-	PUNCT
aiua-2211	28	5	ivd	ivd	PROPN
aiua-2211	28	6	method	method	NOUN
aiua-2211	28	7	,	,	PUNCT
aiua-2211	28	8	namely	namely	ADV
aiua-2211	28	9	adnatest	adnate	ADJ
aiua-2211	28	10	prostate	prostate	NOUN
aiua-2211	28	11	cancer	cancer	NOUN
aiua-2211	28	12	select	select	NOUN
aiua-2211	28	13	plus	plus	CCONJ
aiua-2211	28	14	adnatest	adnate	ADJ
aiua-2211	28	15	prostate	prostate	NOUN
aiua-2211	28	16	cancer	cancer	NOUN
aiua-2211	28	17	detect	detect	NOUN
aiua-2211	28	18	(	(	PUNCT
aiua-2211	28	19	adnagen	adnagen	PROPN
aiua-2211	28	20	ag	ag	PROPN
aiua-2211	28	21	,	,	PUNCT
aiua-2211	28	22	langenhagen	langenhagen	PROPN
aiua-2211	28	23	,	,	PUNCT
aiua-2211	28	24	germany	germany	PROPN
aiua-2211	28	25	)	)	PUNCT
aiua-2211	28	26	,	,	PUNCT
aiua-2211	28	27	has	have	AUX
aiua-2211	28	28	been	be	AUX
aiua-2211	28	29	commercialized	commercialize	VERB
aiua-2211	28	30	for	for	ADP
aiua-2211	28	31	laboratory	laboratory	NOUN
aiua-2211	28	32	ctcs	ctcs	NOUN
aiua-2211	28	33	detection	detection	NOUN
aiua-2211	28	34	through	through	ADP
aiua-2211	28	35	multiple	multiple	ADJ
aiua-2211	28	36	amplification	amplification	NOUN
aiua-2211	28	37	for	for	ADP
aiua-2211	28	38	pca	pca	NOUN
aiua-2211	28	39	-	-	PUNCT
aiua-2211	28	40	associated	associate	VERB
aiua-2211	28	41	transcripts	transcript	NOUN
aiua-2211	28	42	(	(	PUNCT
aiua-2211	28	43	reviewed	review	VERB
aiua-2211	28	44	as	as	ADP
aiua-2211	28	45	possible	possible	ADJ
aiua-2211	28	46	useful	useful	ADJ
aiua-2211	28	47	markers	marker	NOUN
aiua-2211	28	48	for	for	ADP
aiua-2211	28	49	monitoring	monitoring	NOUN
aiua-2211	28	50	of	of	ADP
aiua-2211	28	51	pca	pca	NOUN
aiua-2211	28	52	patients	patient	NOUN
aiua-2211	28	53	)	)	PUNCT
aiua-2211	28	54	(	(	PUNCT
aiua-2211	28	55	22	22	NUM
aiua-2211	28	56	-	-	SYM
aiua-2211	28	57	24	24	NUM
aiua-2211	28	58	)	)	PUNCT
aiua-2211	28	59	.	.	PUNCT
aiua-2211	29	1	in	in	ADP
aiua-2211	29	2	the	the	DET
aiua-2211	29	3	present	present	ADJ
aiua-2211	29	4	work	work	NOUN
aiua-2211	29	5	,	,	PUNCT
aiua-2211	29	6	we	we	PRON
aiua-2211	29	7	evaluated	evaluate	VERB
aiua-2211	29	8	adnagene	adnagene	ADJ
aiua-2211	29	9	method	method	NOUN
aiua-2211	29	10	for	for	ADP
aiua-2211	29	11	discriminating	discriminate	VERB
aiua-2211	29	12	pca	pca	NOUN
aiua-2211	29	13	patients	patient	NOUN
aiua-2211	29	14	at	at	ADP
aiua-2211	29	15	risk	risk	NOUN
aiua-2211	29	16	for	for	ADP
aiua-2211	29	17	metastasis	metastasis	NOUN
aiua-2211	29	18	from	from	ADP
aiua-2211	29	19	those	those	PRON
aiua-2211	29	20	with	with	ADP
aiua-2211	29	21	remission	remission	NOUN
aiua-2211	29	22	or	or	CCONJ
aiua-2211	29	23	stable	stable	ADJ
aiua-2211	29	24	disease	disease	NOUN
aiua-2211	29	25	,	,	PUNCT
aiua-2211	29	26	in	in	ADP
aiua-2211	29	27	order	order	NOUN
aiua-2211	29	28	to	to	PART
aiua-2211	29	29	establish	establish	VERB
aiua-2211	29	30	if	if	SCONJ
aiua-2211	29	31	this	this	DET
aiua-2211	29	32	method	method	NOUN
aiua-2211	29	33	may	may	AUX
aiua-2211	29	34	be	be	AUX
aiua-2211	29	35	predictive	predictive	ADJ
aiua-2211	29	36	or	or	CCONJ
aiua-2211	29	37	not	not	PART
aiua-2211	29	38	of	of	ADP
aiua-2211	29	39	disease	disease	NOUN
aiua-2211	29	40	recurrence	recurrence	NOUN
aiua-2211	29	41	,	,	PUNCT
aiua-2211	29	42	with	with	ADP
aiua-2211	29	43	any	any	DET
aiua-2211	29	44	ongoing	ongoing	ADJ
aiua-2211	29	45	therapy	therapy	NOUN
aiua-2211	29	46	.	.	PUNCT
aiua-2211	30	1	we	we	PRON
aiua-2211	30	2	describe	describe	VERB
aiua-2211	30	3	preliminary	preliminary	ADJ
aiua-2211	30	4	data	datum	NOUN
aiua-2211	30	5	that	that	PRON
aiua-2211	30	6	might	might	AUX
aiua-2211	30	7	suggest	suggest	VERB
aiua-2211	30	8	the	the	DET
aiua-2211	30	9	use	use	NOUN
aiua-2211	30	10	of	of	ADP
aiua-2211	30	11	this	this	DET
aiua-2211	30	12	method	method	NOUN
aiua-2211	30	13	for	for	ADP
aiua-2211	30	14	management	management	NOUN
aiua-2211	30	15	of	of	ADP
aiua-2211	30	16	pca	pca	NOUN
aiua-2211	30	17	patients	patient	NOUN
aiua-2211	30	18	and	and	CCONJ
aiua-2211	30	19	support	support	VERB
aiua-2211	30	20	the	the	DET
aiua-2211	30	21	clinical	clinical	ADJ
aiua-2211	30	22	utility	utility	NOUN
aiua-2211	30	23	of	of	ADP
aiua-2211	30	24	the	the	DET
aiua-2211	30	25	assay	assay	NOUN
aiua-2211	30	26	here	here	ADV
aiua-2211	30	27	described	describe	VERB
aiua-2211	30	28	.	.	PUNCT
aiua-2211	31	1	materials	material	NOUN
aiua-2211	31	2	and	and	CCONJ
aiua-2211	31	3	methods	method	NOUN
aiua-2211	31	4	patients	patient	NOUN
aiua-2211	31	5	selection	selection	NOUN
aiua-2211	31	6	and	and	CCONJ
aiua-2211	31	7	blood	blood	NOUN
aiua-2211	31	8	sampling	sampling	NOUN
aiua-2211	31	9	(	(	PUNCT
aiua-2211	31	10	more	more	ADJ
aiua-2211	31	11	details	detail	NOUN
aiua-2211	31	12	reported	report	VERB
aiua-2211	31	13	in	in	ADP
aiua-2211	31	14	supplemental	supplemental	ADJ
aiua-2211	31	15	files	file	NOUN
aiua-2211	31	16	)	)	PUNCT
aiua-2211	32	1	we	we	PRON
aiua-2211	32	2	selected	select	VERB
aiua-2211	32	3	21	21	NUM
aiua-2211	32	4	patients	patient	NOUN
aiua-2211	32	5	who	who	PRON
aiua-2211	32	6	were	be	AUX
aiua-2211	32	7	subdivided	subdivide	VERB
aiua-2211	32	8	into	into	ADP
aiua-2211	32	9	three	three	NUM
aiua-2211	32	10	groups	group	NOUN
aiua-2211	32	11	(	(	PUNCT
aiua-2211	32	12	table	table	NOUN
aiua-2211	32	13	1	1	NUM
aiua-2211	32	14	)	)	PUNCT
aiua-2211	32	15	,	,	PUNCT
aiua-2211	32	16	according	accord	VERB
aiua-2211	32	17	to	to	ADP
aiua-2211	32	18	d’amico	d’amico	PROPN
aiua-2211	32	19	(	(	PUNCT
aiua-2211	32	20	25	25	NUM
aiua-2211	32	21	)	)	PUNCT
aiua-2211	32	22	classification	classification	NOUN
aiua-2211	32	23	:	:	PUNCT
aiua-2211	32	24	n	n	PROPN
aiua-2211	32	25	=	=	SYM
aiua-2211	32	26	10	10	NUM
aiua-2211	32	27	pca	pca	NOUN
aiua-2211	32	28	patients	patient	NOUN
aiua-2211	32	29	belonging	belong	VERB
aiua-2211	32	30	to	to	ADP
aiua-2211	32	31	group	group	NOUN
aiua-2211	32	32	i	i	PRON
aiua-2211	32	33	(	(	PUNCT
aiua-2211	32	34	conventionally	conventionally	ADV
aiua-2211	32	35	defined	define	VERB
aiua-2211	32	36	as	as	ADP
aiua-2211	32	37	prognostic	prognostic	ADJ
aiua-2211	32	38	grouping	grouping	NOUN
aiua-2211	32	39	stage	stage	NOUN
aiua-2211	32	40	iv	iv	NOUN
aiua-2211	32	41	)	)	PUNCT
aiua-2211	32	42	,	,	PUNCT
aiua-2211	32	43	because	because	SCONJ
aiua-2211	32	44	of	of	ADP
aiua-2211	32	45	the	the	DET
aiua-2211	32	46	high	high	ADJ
aiua-2211	32	47	risk	risk	NOUN
aiua-2211	32	48	tumor	tumor	NOUN
aiua-2211	32	49	class	class	NOUN
aiua-2211	32	50	(	(	PUNCT
aiua-2211	32	51	gleason	gleason	PROPN
aiua-2211	32	52	score	score	NOUN
aiua-2211	32	53	(	(	PUNCT
aiua-2211	32	54	gs	gs	NOUN
aiua-2211	32	55	)	)	PUNCT
aiua-2211	32	56	=	=	NOUN
aiua-2211	32	57	8	8	NUM
aiua-2211	32	58	-	-	SYM
aiua-2211	32	59	10	10	NUM
aiua-2211	32	60	or	or	CCONJ
aiua-2211	32	61	tnm	tnm	PROPN
aiua-2211	32	62	>	>	X
aiua-2211	32	63	t2b	t2b	PROPN
aiua-2211	32	64	n0	n0	PROPN
aiua-2211	32	65	m0	m0	PROPN
aiua-2211	32	66	or	or	CCONJ
aiua-2211	32	67	psa	psa	VERB
aiua-2211	32	68	>	>	PUNCT
aiua-2211	32	69	20	20	NUM
aiua-2211	32	70	)	)	PUNCT
aiua-2211	32	71	;	;	PUNCT
aiua-2211	32	72	n	n	PROPN
aiua-2211	32	73	=	=	SYM
aiua-2211	32	74	6	6	NUM
aiua-2211	32	75	pca	pca	NOUN
aiua-2211	32	76	patients	patient	NOUN
aiua-2211	32	77	included	include	VERB
aiua-2211	32	78	into	into	ADP
aiua-2211	32	79	group	group	PROPN
aiua-2211	32	80	ii	ii	PROPN
aiua-2211	32	81	(	(	PUNCT
aiua-2211	32	82	conventionally	conventionally	ADV
aiua-2211	32	83	defined	define	VERB
aiua-2211	32	84	as	as	ADP
aiua-2211	32	85	prognostic	prognostic	ADJ
aiua-2211	32	86	grouping	grouping	NOUN
aiua-2211	32	87	stage	stage	NOUN
aiua-2211	32	88	i	i	PROPN
aiua-2211	32	89	)	)	PUNCT
aiua-2211	32	90	,	,	PUNCT
aiua-2211	32	91	who	who	PRON
aiua-2211	32	92	were	be	AUX
aiua-2211	32	93	defined	define	VERB
aiua-2211	32	94	as	as	ADP
aiua-2211	32	95	at	at	ADP
aiua-2211	32	96	low	low	ADJ
aiua-2211	32	97	risk	risk	NOUN
aiua-2211	32	98	tumor	tumor	NOUN
aiua-2211	32	99	class	class	NOUN
aiua-2211	32	100	(	(	PUNCT
aiua-2211	32	101	gs	gs	NOUN
aiua-2211	32	102	=	=	SYM
aiua-2211	32	103	2	2	NUM
aiua-2211	32	104	-	-	SYM
aiua-2211	32	105	6	6	NUM
aiua-2211	32	106	and	and	CCONJ
aiua-2211	32	107	tnm	tnm	PROPN
aiua-2211	32	108	=	=	PUNCT
aiua-2211	32	109	t1	t1	PROPN
aiua-2211	32	110	-	-	PUNCT
aiua-2211	32	111	t2a	t2a	ADV
aiua-2211	32	112	and	and	CCONJ
aiua-2211	32	113	psa	psa	VERB
aiua-2211	32	114	<	<	X
aiua-2211	32	115	10	10	NUM
aiua-2211	32	116	)	)	PUNCT
aiua-2211	32	117	;	;	PUNCT
aiua-2211	32	118	n	n	PROPN
aiua-2211	32	119	=	=	SYM
aiua-2211	32	120	5	5	NUM
aiua-2211	32	121	patients	patient	NOUN
aiua-2211	32	122	with	with	ADP
aiua-2211	32	123	benign	benign	ADJ
aiua-2211	32	124	prostate	prostate	NOUN
aiua-2211	32	125	hypertrophy	hypertrophy	NOUN
aiua-2211	32	126	,	,	PUNCT
aiua-2211	32	127	without	without	ADP
aiua-2211	32	128	any	any	DET
aiua-2211	32	129	clinical	clinical	ADJ
aiua-2211	32	130	and	and	CCONJ
aiua-2211	32	131	biochemical	biochemical	ADJ
aiua-2211	32	132	signs	sign	NOUN
aiua-2211	32	133	of	of	ADP
aiua-2211	32	134	pca	pca	NOUN
aiua-2211	32	135	,	,	PUNCT
aiua-2211	32	136	used	use	VERB
aiua-2211	32	137	as	as	ADP
aiua-2211	32	138	negative	negative	ADJ
aiua-2211	32	139	controls	control	NOUN
aiua-2211	32	140	(	(	PUNCT
aiua-2211	32	141	defined	define	VERB
aiua-2211	32	142	as	as	ADP
aiua-2211	32	143	group	group	NOUN
aiua-2211	32	144	iii	iii	PROPN
aiua-2211	32	145	;	;	PUNCT
aiua-2211	32	146	(	(	PUNCT
aiua-2211	32	147	psa	psa	VERB
aiua-2211	32	148	<	<	X
aiua-2211	32	149	2	2	NUM
aiua-2211	32	150	and	and	CCONJ
aiua-2211	32	151	negative	negative	ADJ
aiua-2211	32	152	digital	digital	ADJ
aiua-2211	32	153	rectal	rectal	ADJ
aiua-2211	32	154	exploration	exploration	NOUN
aiua-2211	32	155	or	or	CCONJ
aiua-2211	32	156	trus	trus	NOUN
aiua-2211	32	157	)	)	PUNCT
aiua-2211	32	158	.	.	PUNCT
aiua-2211	33	1	group	group	NOUN
aiua-2211	33	2	iii	iii	NUM
aiua-2211	33	3	cases	case	NOUN
aiua-2211	33	4	were	be	AUX
aiua-2211	33	5	well	well	ADV
aiua-2211	33	6	known	know	VERB
aiua-2211	33	7	patients	patient	NOUN
aiua-2211	33	8	,	,	PUNCT
aiua-2211	33	9	with	with	SCONJ
aiua-2211	33	10	psa	psa	VERB
aiua-2211	33	11	<	<	X
aiua-2211	33	12	2	2	NUM
aiua-2211	33	13	for	for	ADP
aiua-2211	33	14	at	at	ADV
aiua-2211	33	15	least	least	ADV
aiua-2211	33	16	5	5	NUM
aiua-2211	33	17	years	year	NOUN
aiua-2211	33	18	,	,	PUNCT
aiua-2211	33	19	taken	take	VERB
aiua-2211	33	20	from	from	ADP
aiua-2211	33	21	the	the	DET
aiua-2211	33	22	database	database	NOUN
aiua-2211	33	23	of	of	ADP
aiua-2211	33	24	our	our	PRON
aiua-2211	33	25	“	"	PUNCT
aiua-2211	33	26	stone	stone	NOUN
aiua-2211	33	27	center	center	NOUN
aiua-2211	33	28	”	"	PUNCT
aiua-2211	33	29	.	.	PUNCT
aiua-2211	34	1	group	group	PROPN
aiua-2211	34	2	ii	ii	PROPN
aiua-2211	34	3	and	and	CCONJ
aiua-2211	34	4	group	group	PROPN
aiua-2211	34	5	iii	iii	PROPN
aiua-2211	34	6	were	be	AUX
aiua-2211	34	7	assayed	assayed	ADJ
aiua-2211	34	8	as	as	ADP
aiua-2211	34	9	negative	negative	ADJ
aiua-2211	34	10	control	control	NOUN
aiua-2211	34	11	groups	group	NOUN
aiua-2211	34	12	.	.	PUNCT
aiua-2211	35	1	pca	pca	NOUN
aiua-2211	35	2	patients	patient	NOUN
aiua-2211	35	3	belonging	belong	VERB
aiua-2211	35	4	to	to	ADP
aiua-2211	35	5	intermediate	intermediate	ADJ
aiua-2211	35	6	risk	risk	NOUN
aiua-2211	35	7	class	class	NOUN
aiua-2211	35	8	(	(	PUNCT
aiua-2211	35	9	gs	gs	NOUN
aiua-2211	35	10	=	=	SYM
aiua-2211	35	11	7	7	NUM
aiua-2211	35	12	and	and	CCONJ
aiua-2211	35	13	tnm	tnm	NUM
aiua-2211	35	14	=	=	SYM
aiua-2211	35	15	2b	2b	NOUN
aiua-2211	35	16	-	-	PUNCT
aiua-2211	35	17	t2c	t2c	NOUN
aiua-2211	35	18	)	)	PUNCT
aiua-2211	35	19	were	be	AUX
aiua-2211	35	20	excluded	exclude	VERB
aiua-2211	35	21	.	.	PUNCT
aiua-2211	36	1	the	the	DET
aiua-2211	36	2	intermediate	intermediate	ADJ
aiua-2211	36	3	-	-	PUNCT
aiua-2211	36	4	risk	risk	NOUN
aiua-2211	36	5	patients	patient	NOUN
aiua-2211	36	6	were	be	AUX
aiua-2211	36	7	excluded	exclude	VERB
aiua-2211	36	8	due	due	ADP
aiua-2211	36	9	to	to	ADP
aiua-2211	36	10	their	their	PRON
aiua-2211	36	11	intermediate	intermediate	ADJ
aiua-2211	36	12	characteristics	characteristic	NOUN
aiua-2211	36	13	,	,	PUNCT
aiua-2211	36	14	concerning	concern	VERB
aiua-2211	36	15	the	the	DET
aiua-2211	36	16	risk	risk	NOUN
aiua-2211	36	17	of	of	ADP
aiua-2211	36	18	progression	progression	NOUN
aiua-2211	36	19	and	and	CCONJ
aiua-2211	36	20	recurrence	recurrence	NOUN
aiua-2211	36	21	of	of	ADP
aiua-2211	36	22	the	the	DET
aiua-2211	36	23	disease	disease	NOUN
aiua-2211	36	24	.	.	PUNCT
aiua-2211	37	1	the	the	DET
aiua-2211	37	2	design	design	NOUN
aiua-2211	37	3	of	of	ADP
aiua-2211	37	4	the	the	DET
aiua-2211	37	5	study	study	NOUN
aiua-2211	37	6	aims	aim	VERB
aiua-2211	37	7	to	to	PART
aiua-2211	37	8	verify	verify	VERB
aiua-2211	37	9	,	,	PUNCT
aiua-2211	37	10	without	without	ADP
aiua-2211	37	11	any	any	DET
aiua-2211	37	12	doubt	doubt	NOUN
aiua-2211	37	13	,	,	PUNCT
aiua-2211	37	14	that	that	SCONJ
aiua-2211	37	15	patients	patient	NOUN
aiua-2211	37	16	with	with	ADP
aiua-2211	37	17	localized	localized	ADJ
aiua-2211	37	18	disease	disease	NOUN
aiua-2211	37	19	or	or	CCONJ
aiua-2211	37	20	without	without	ADP
aiua-2211	37	21	prostatic	prostatic	ADJ
aiua-2211	37	22	cancer	cancer	NOUN
aiua-2211	37	23	may	may	AUX
aiua-2211	37	24	never	never	ADV
aiua-2211	37	25	have	have	VERB
aiua-2211	37	26	circulating	circulate	VERB
aiua-2211	37	27	tumor	tumor	NOUN
aiua-2211	37	28	cells	cell	NOUN
aiua-2211	37	29	detectable	detectable	ADJ
aiua-2211	37	30	by	by	ADP
aiua-2211	37	31	this	this	DET
aiua-2211	37	32	method	method	NOUN
aiua-2211	37	33	(	(	PUNCT
aiua-2211	37	34	group	group	NOUN
aiua-2211	37	35	ii	ii	PROPN
aiua-2211	37	36	and	and	CCONJ
aiua-2211	37	37	group	group	PROPN
aiua-2211	37	38	iii	iii	PROPN
aiua-2211	37	39	)	)	PUNCT
aiua-2211	37	40	.	.	PUNCT
aiua-2211	38	1	for	for	ADP
aiua-2211	38	2	logical	logical	ADJ
aiua-2211	38	3	reasoning	reasoning	NOUN
aiua-2211	38	4	,	,	PUNCT
aiua-2211	38	5	the	the	DET
aiua-2211	38	6	only	only	ADJ
aiua-2211	38	7	patients	patient	NOUN
aiua-2211	38	8	who	who	PRON
aiua-2211	38	9	might	might	AUX
aiua-2211	38	10	have	have	VERB
aiua-2211	38	11	ctcs	ctcs	PROPN
aiua-2211	38	12	are	be	AUX
aiua-2211	38	13	those	those	PRON
aiua-2211	38	14	belonging	belong	VERB
aiua-2211	38	15	at	at	ADP
aiua-2211	38	16	high	high	ADJ
aiua-2211	38	17	risk	risk	NOUN
aiua-2211	38	18	group	group	NOUN
aiua-2211	38	19	(	(	PUNCT
aiua-2211	38	20	group	group	NOUN
aiua-2211	38	21	i	i	PROPN
aiua-2211	38	22	)	)	PUNCT
aiua-2211	38	23	.	.	PUNCT
aiua-2211	39	1	in	in	ADP
aiua-2211	39	2	the	the	DET
aiua-2211	39	3	design	design	NOUN
aiua-2211	39	4	of	of	ADP
aiua-2211	39	5	the	the	DET
aiua-2211	39	6	“	"	PUNCT
aiua-2211	39	7	case	case	NOUN
aiua-2211	39	8	-	-	PUNCT
aiua-2211	39	9	control	control	NOUN
aiua-2211	39	10	”	"	PUNCT
aiua-2211	39	11	study	study	NOUN
aiua-2211	39	12	,	,	PUNCT
aiua-2211	39	13	the	the	DET
aiua-2211	39	14	group	group	NOUN
aiua-2211	39	15	to	to	PART
aiua-2211	39	16	be	be	AUX
aiua-2211	39	17	studied	study	VERB
aiua-2211	39	18	is	be	AUX
aiua-2211	39	19	the	the	DET
aiua-2211	39	20	“	"	PUNCT
aiua-2211	39	21	group	group	NOUN
aiua-2211	39	22	i	i	NOUN
aiua-2211	39	23	”	"	PUNCT
aiua-2211	39	24	.	.	PUNCT
aiua-2211	40	1	groups	group	NOUN
aiua-2211	40	2	ii	ii	PROPN
aiua-2211	40	3	and	and	CCONJ
aiua-2211	40	4	iii	iii	NUM
aiua-2211	40	5	are	be	AUX
aiua-2211	40	6	control	control	NOUN
aiua-2211	40	7	groups	group	NOUN
aiua-2211	40	8	.	.	PUNCT
aiua-2211	41	1	we	we	PRON
aiua-2211	41	2	felt	feel	VERB
aiua-2211	41	3	it	it	PRON
aiua-2211	41	4	was	be	AUX
aiua-2211	41	5	a	a	DET
aiua-2211	41	6	waste	waste	NOUN
aiua-2211	41	7	of	of	ADP
aiua-2211	41	8	resources	resource	NOUN
aiua-2211	41	9	the	the	DET
aiua-2211	41	10	introduction	introduction	NOUN
aiua-2211	41	11	of	of	ADP
aiua-2211	41	12	a	a	DET
aiua-2211	41	13	further	further	ADJ
aiua-2211	41	14	control	control	NOUN
aiua-2211	41	15	group	group	NOUN
aiua-2211	41	16	consisted	consist	VERB
aiua-2211	41	17	of	of	ADP
aiua-2211	41	18	intermediate	intermediate	ADJ
aiua-2211	41	19	risk	risk	NOUN
aiua-2211	41	20	patients	patient	NOUN
aiua-2211	41	21	.	.	PUNCT
aiua-2211	42	1	overall	overall	ADJ
aiua-2211	42	2	pca	pca	PROPN
aiua-2211	42	3	patients	patient	NOUN
aiua-2211	42	4	(	(	PUNCT
aiua-2211	42	5	groups	group	NOUN
aiua-2211	42	6	i	i	PRON
aiua-2211	42	7	and	and	CCONJ
aiua-2211	42	8	ii	ii	PROPN
aiua-2211	42	9	)	)	PUNCT
aiua-2211	42	10	were	be	AUX
aiua-2211	42	11	treated	treat	VERB
aiua-2211	42	12	with	with	ADP
aiua-2211	42	13	single	single	ADJ
aiua-2211	42	14	or	or	CCONJ
aiua-2211	42	15	combined	combined	ADJ
aiua-2211	42	16	therapy	therapy	NOUN
aiua-2211	42	17	:	:	PUNCT
aiua-2211	42	18	radical	radical	ADJ
aiua-2211	42	19	prostatectomy	prostatectomy	NOUN
aiua-2211	42	20	,	,	PUNCT
aiua-2211	42	21	external	external	ADJ
aiua-2211	42	22	beam	beam	NOUN
aiua-2211	42	23	radiotherapy	radiotherapy	NOUN
aiua-2211	42	24	,	,	PUNCT
aiua-2211	42	25	total	total	ADJ
aiua-2211	42	26	androgen	androgen	NOUN
aiua-2211	42	27	blockade	blockade	NOUN
aiua-2211	42	28	;	;	PUNCT
aiua-2211	42	29	two	two	NUM
aiua-2211	42	30	patients	patient	NOUN
aiua-2211	42	31	of	of	ADP
aiua-2211	42	32	group	group	NOUN
aiua-2211	42	33	i	i	PRON
aiua-2211	42	34	started	start	VERB
aiua-2211	42	35	chemotherapy	chemotherapy	VERB
aiua-2211	42	36	,	,	PUNCT
aiua-2211	42	37	because	because	SCONJ
aiua-2211	42	38	of	of	ADP
aiua-2211	42	39	their	their	PRON
aiua-2211	42	40	castration	castration	NOUN
aiua-2211	42	41	resistance	resistance	NOUN
aiua-2211	42	42	.	.	PUNCT
aiua-2211	43	1	in	in	ADP
aiua-2211	43	2	order	order	NOUN
aiua-2211	43	3	to	to	PART
aiua-2211	43	4	reduce	reduce	VERB
aiua-2211	43	5	the	the	DET
aiua-2211	43	6	biases	bias	NOUN
aiua-2211	43	7	due	due	ADP
aiua-2211	43	8	to	to	ADP
aiua-2211	43	9	the	the	DET
aiua-2211	43	10	selection	selection	NOUN
aiua-2211	43	11	during	during	ADP
aiua-2211	43	12	the	the	DET
aiua-2211	43	13	enrolment	enrolment	NOUN
aiua-2211	43	14	,	,	PUNCT
aiua-2211	43	15	we	we	PRON
aiua-2211	43	16	choose	choose	VERB
aiua-2211	43	17	consecutively	consecutively	ADV
aiua-2211	43	18	only	only	ADV
aiua-2211	43	19	patients	patient	NOUN
aiua-2211	43	20	who	who	PRON
aiua-2211	43	21	received	receive	VERB
aiua-2211	43	22	a	a	DET
aiua-2211	43	23	diagnosis	diagnosis	NOUN
aiua-2211	43	24	of	of	ADP
aiua-2211	43	25	pca	pca	NOUN
aiua-2211	43	26	within	within	ADP
aiua-2211	43	27	previous	previous	ADJ
aiua-2211	43	28	36	36	NUM
aiua-2211	43	29	±	±	NUM
aiua-2211	43	30	4	4	NUM
aiua-2211	43	31	months	month	NOUN
aiua-2211	43	32	,	,	PUNCT
aiua-2211	43	33	while	while	SCONJ
aiua-2211	43	34	the	the	DET
aiua-2211	43	35	period	period	NOUN
aiua-2211	43	36	of	of	ADP
aiua-2211	43	37	observation	observation	NOUN
aiua-2211	43	38	was	be	AUX
aiua-2211	43	39	12	12	NUM
aiua-2211	43	40	month	month	NOUN
aiua-2211	43	41	from	from	ADP
aiua-2211	43	42	first	first	ADJ
aiua-2211	43	43	blood	blood	NOUN
aiua-2211	43	44	sample	sample	NOUN
aiua-2211	43	45	collection	collection	NOUN
aiua-2211	43	46	for	for	ADP
aiua-2211	43	47	testing	test	VERB
aiua-2211	43	48	adnatest	adnate	ADJ
aiua-2211	43	49	prostate	prostate	NOUN
aiua-2211	43	50	cancer	cancer	NOUN
aiua-2211	43	51	kit	kit	NOUN
aiua-2211	43	52	.	.	PUNCT
aiua-2211	44	1	in	in	ADP
aiua-2211	44	2	fact	fact	NOUN
aiua-2211	44	3	,	,	PUNCT
aiua-2211	44	4	for	for	SCONJ
aiua-2211	44	5	each	each	DET
aiua-2211	44	6	patient	patient	NOUN
aiua-2211	44	7	enrolled	enrol	VERB
aiua-2211	44	8	we	we	PRON
aiua-2211	44	9	collected	collect	VERB
aiua-2211	44	10	both	both	DET
aiua-2211	44	11	7	7	NUM
aiua-2211	44	12	ml	ml	NOUN
aiua-2211	44	13	of	of	ADP
aiua-2211	44	14	whole	whole	ADJ
aiua-2211	44	15	blood	blood	NOUN
aiua-2211	44	16	using	use	VERB
aiua-2211	44	17	specific	specific	ADJ
aiua-2211	44	18	preservative	preservative	ADJ
aiua-2211	44	19	tubes	tube	NOUN
aiua-2211	44	20	for	for	ADP
aiua-2211	44	21	ctcs	ctcs	PROPN
aiua-2211	44	22	capture	capture	NOUN
aiua-2211	44	23	(	(	PUNCT
aiua-2211	44	24	adnagen	adnagen	NOUN
aiua-2211	44	25	,	,	PUNCT
aiua-2211	44	26	langenhagen	langenhagen	PROPN
aiua-2211	44	27	,	,	PUNCT
aiua-2211	44	28	germany	germany	PROPN
aiua-2211	44	29	)	)	PUNCT
aiua-2211	44	30	and	and	CCONJ
aiua-2211	44	31	3.5	3.5	NUM
aiua-2211	44	32	ml	ml	NOUN
aiua-2211	44	33	of	of	ADP
aiua-2211	44	34	vacutainer	vacutainer	ADJ
aiua-2211	44	35	tubes	tube	NOUN
aiua-2211	44	36	for	for	ADP
aiua-2211	44	37	psa	psa	NOUN
aiua-2211	44	38	measurement	measurement	NOUN
aiua-2211	44	39	at	at	ADP
aiua-2211	44	40	diagnosis	diagnosis	NOUN
aiua-2211	44	41	(	(	PUNCT
aiua-2211	44	42	psa	psa	VERB
aiua-2211	44	43	time	time	NOUN
aiua-2211	44	44	=	=	SYM
aiua-2211	44	45	0	0	NUM
aiua-2211	44	46	)	)	PUNCT
aiua-2211	44	47	.	.	PUNCT
aiua-2211	45	1	additional	additional	ADJ
aiua-2211	45	2	psa	psa	NOUN
aiua-2211	45	3	assays	assay	NOUN
aiua-2211	45	4	were	be	AUX
aiua-2211	45	5	done	do	VERB
aiua-2211	45	6	during	during	ADP
aiua-2211	45	7	the	the	DET
aiua-2211	45	8	follow	follow	NOUN
aiua-2211	45	9	up	up	ADP
aiua-2211	45	10	period	period	NOUN
aiua-2211	45	11	study	study	NOUN
aiua-2211	45	12	(	(	PUNCT
aiua-2211	45	13	2	2	NUM
aiua-2211	45	14	per	per	ADP
aiua-2211	45	15	year	year	NOUN
aiua-2211	45	16	)	)	PUNCT
aiua-2211	45	17	.	.	PUNCT
aiua-2211	46	1	therapeutic	therapeutic	ADJ
aiua-2211	46	2	information	information	NOUN
aiua-2211	46	3	and	and	CCONJ
aiua-2211	46	4	clinical	clinical	ADJ
aiua-2211	46	5	characteristics	characteristic	NOUN
aiua-2211	46	6	of	of	ADP
aiua-2211	46	7	patients	patient	NOUN
aiua-2211	46	8	were	be	AUX
aiua-2211	46	9	collected	collect	VERB
aiua-2211	46	10	by	by	ADP
aiua-2211	46	11	a	a	DET
aiua-2211	46	12	trained	train	VERB
aiua-2211	46	13	urologist	urologist	NOUN
aiua-2211	46	14	(	(	PUNCT
aiua-2211	46	15	table	table	NOUN
aiua-2211	46	16	i	i	NOUN
aiua-2211	46	17	)	)	PUNCT
aiua-2211	46	18	.	.	PUNCT
aiua-2211	47	1	all	all	DET
aiua-2211	47	2	subjects	subject	NOUN
aiua-2211	47	3	enrolled	enrol	VERB
aiua-2211	47	4	in	in	ADP
aiua-2211	47	5	this	this	DET
aiua-2211	47	6	preliminary	preliminary	ADJ
aiua-2211	47	7	investigation	investigation	NOUN
aiua-2211	47	8	gave	give	VERB
aiua-2211	47	9	their	their	PRON
aiua-2211	47	10	informed	informed	ADJ
aiua-2211	47	11	consent	consent	NOUN
aiua-2211	47	12	.	.	PUNCT
aiua-2211	48	1	all	all	DET
aiua-2211	48	2	procedures	procedure	NOUN
aiua-2211	48	3	were	be	AUX
aiua-2211	48	4	made	make	VERB
aiua-2211	48	5	following	follow	VERB
aiua-2211	48	6	the	the	DET
aiua-2211	48	7	helsinki	helsinki	PROPN
aiua-2211	48	8	criteria	criterion	NOUN
aiua-2211	48	9	for	for	ADP
aiua-2211	48	10	research	research	NOUN
aiua-2211	48	11	studies	study	NOUN
aiua-2211	48	12	.	.	PUNCT
aiua-2211	49	1	adnatest	adnate	ADJ
aiua-2211	49	2	prostate	prostate	NOUN
aiua-2211	49	3	cancer	cancer	NOUN
aiua-2211	49	4	select	select	NOUN
aiua-2211	49	5	/	/	SYM
aiua-2211	49	6	detect	detect	NOUN
aiua-2211	49	7	blood	blood	NOUN
aiua-2211	49	8	(	(	PUNCT
aiua-2211	49	9	5	5	NUM
aiua-2211	49	10	ml	ml	NOUN
aiua-2211	49	11	)	)	PUNCT
aiua-2211	49	12	samples	sample	NOUN
aiua-2211	49	13	were	be	AUX
aiua-2211	49	14	taken	take	VERB
aiua-2211	49	15	using	use	VERB
aiua-2211	49	16	adnacollect	adnacollect	ADJ
aiua-2211	49	17	blood	blood	NOUN
aiua-2211	49	18	collection	collection	NOUN
aiua-2211	49	19	tubes	tube	NOUN
aiua-2211	49	20	(	(	PUNCT
aiua-2211	49	21	adnagen	adnagen	PROPN
aiua-2211	49	22	,	,	PUNCT
aiua-2211	49	23	langenhagen	langenhagen	PROPN
aiua-2211	49	24	,	,	PUNCT
aiua-2211	49	25	germany	germany	PROPN
aiua-2211	49	26	)	)	PUNCT
aiua-2211	49	27	and	and	CCONJ
aiua-2211	49	28	immediately	immediately	ADV
aiua-2211	49	29	processed	process	VERB
aiua-2211	49	30	not	not	PART
aiua-2211	49	31	later	later	ADV
aiua-2211	49	32	than	than	ADP
aiua-2211	49	33	24	24	NUM
aiua-2211	49	34	hours	hour	NOUN
aiua-2211	49	35	after	after	ADP
aiua-2211	49	36	blood	blood	NOUN
aiua-2211	49	37	withdrawal	withdrawal	NOUN
aiua-2211	49	38	,	,	PUNCT
aiua-2211	49	39	since	since	SCONJ
aiua-2211	49	40	it	it	PRON
aiua-2211	49	41	has	have	AUX
aiua-2211	49	42	been	be	AUX
aiua-2211	49	43	reported	report	VERB
aiua-2211	49	44	the	the	DET
aiua-2211	49	45	possible	possible	ADJ
aiua-2211	49	46	lack	lack	NOUN
aiua-2211	49	47	of	of	ADP
aiua-2211	49	48	stability	stability	NOUN
aiua-2211	49	49	of	of	ADP
aiua-2211	49	50	cancer	cancer	NOUN
aiua-2211	49	51	cell	cell	NOUN
aiua-2211	49	52	transcripts	transcript	NOUN
aiua-2211	49	53	(	(	PUNCT
aiua-2211	49	54	26	26	NUM
aiua-2211	49	55	)	)	PUNCT
aiua-2211	49	56	.	.	PUNCT
aiua-2211	50	1	the	the	DET
aiua-2211	50	2	immunomagnetic	immunomagnetic	ADJ
aiua-2211	50	3	enrichment	enrichment	NOUN
aiua-2211	50	4	of	of	ADP
aiua-2211	50	5	ctcs	ctcs	NOUN
aiua-2211	50	6	was	be	AUX
aiua-2211	50	7	performed	perform	VERB
aiua-2211	50	8	by	by	ADP
aiua-2211	50	9	using	use	VERB
aiua-2211	50	10	adnatest	adnate	ADJ
aiua-2211	50	11	prostate	prostate	NOUN
aiua-2211	50	12	cancer	cancer	NOUN
aiua-2211	50	13	select	select	NOUN
aiua-2211	50	14	and	and	CCONJ
aiua-2211	50	15	total	total	ADJ
aiua-2211	50	16	mrna	mrna	PROPN
aiua-2211	50	17	/	/	SYM
aiua-2211	50	18	bead	bead	NOUN
aiua-2211	50	19	mixture	mixture	NOUN
aiua-2211	50	20	was	be	AUX
aiua-2211	50	21	retro	retro	NOUN
aiua-2211	50	22	-	-	PUNCT
aiua-2211	50	23	transcribed	transcribe	VERB
aiua-2211	50	24	by	by	ADP
aiua-2211	50	25	sensiscript	sensiscript	ADJ
aiua-2211	50	26	reverse	reverse	ADJ
aiua-2211	50	27	transcriptase	transcriptase	NOUN
aiua-2211	50	28	(	(	PUNCT
aiua-2211	50	29	qiagen	qiagen	PROPN
aiua-2211	50	30	,	,	PUNCT
aiua-2211	50	31	valencia	valencia	PROPN
aiua-2211	50	32	,	,	PUNCT
aiua-2211	50	33	ca	ca	PROPN
aiua-2211	50	34	,	,	PUNCT
aiua-2211	50	35	usa	usa	PROPN
aiua-2211	50	36	)	)	PUNCT
aiua-2211	50	37	according	accord	VERB
aiua-2211	50	38	to	to	ADP
aiua-2211	50	39	the	the	DET
aiua-2211	50	40	manufacturer	manufacturer	NOUN
aiua-2211	50	41	’s	’s	PART
aiua-2211	50	42	instructions	instruction	NOUN
aiua-2211	50	43	.	.	PUNCT
aiua-2211	51	1	analysis	analysis	NOUN
aiua-2211	51	2	of	of	ADP
aiua-2211	51	3	tumor	tumor	NOUN
aiua-2211	51	4	-	-	PUNCT
aiua-2211	51	5	associated	associate	VERB
aiua-2211	51	6	mrnas	mrna	NOUN
aiua-2211	51	7	,	,	PUNCT
aiua-2211	51	8	a	a	DET
aiua-2211	51	9	multiplex	multiplex	PROPN
aiua-2211	51	10	pcr	pcr	NOUN
aiua-2211	51	11	was	be	AUX
aiua-2211	51	12	carried	carry	VERB
aiua-2211	51	13	out	out	ADP
aiua-2211	51	14	using	use	VERB
aiua-2211	51	15	adnatest	adnate	ADJ
aiua-2211	51	16	prostate	prostate	NOUN
aiua-2211	51	17	cancer	cancer	NOUN
aiua-2211	51	18	detect	detect	NOUN
aiua-2211	51	19	according	accord	VERB
aiua-2211	51	20	to	to	ADP
aiua-2211	51	21	the	the	DET
aiua-2211	51	22	manufacturer	manufacturer	NOUN
aiua-2211	51	23	’s	’s	PART
aiua-2211	51	24	instructions	instruction	NOUN
aiua-2211	51	25	.	.	PUNCT
aiua-2211	52	1	the	the	DET
aiua-2211	52	2	primer	primer	NOUN
aiua-2211	52	3	mixture	mixture	NOUN
aiua-2211	52	4	consisted	consist	VERB
aiua-2211	52	5	of	of	ADP
aiua-2211	52	6	amplified	amplify	VERB
aiua-2211	52	7	three	three	NUM
aiua-2211	52	8	tumour	tumour	ADJ
aiua-2211	52	9	markers	marker	NOUN
aiua-2211	52	10	(	(	PUNCT
aiua-2211	52	11	psma	psma	PROPN
aiua-2211	52	12	,	,	PUNCT
aiua-2211	52	13	psa	psa	VERB
aiua-2211	52	14	,	,	PUNCT
aiua-2211	52	15	egfr	egfr	NOUN
aiua-2211	52	16	)	)	PUNCT
aiua-2211	52	17	and	and	CCONJ
aiua-2211	52	18	one	one	NUM
aiua-2211	52	19	housekeeping	housekeeping	NOUN
aiua-2211	52	20	gene	gene	NOUN
aiua-2211	52	21	(	(	PUNCT
aiua-2211	52	22	actin	actin	NOUN
aiua-2211	52	23	)	)	PUNCT
aiua-2211	52	24	.	.	PUNCT
aiua-2211	53	1	evaluations	evaluation	NOUN
aiua-2211	53	2	of	of	ADP
aiua-2211	53	3	cdna	cdna	PROPN
aiua-2211	53	4	run	run	NOUN
aiua-2211	53	5	were	be	AUX
aiua-2211	53	6	carried	carry	VERB
aiua-2211	53	7	out	out	ADP
aiua-2211	53	8	using	use	VERB
aiua-2211	53	9	experion	experion	NOUN
aiua-2211	53	10	1k	1k	NUM
aiua-2211	53	11	analysis	analysis	NOUN
aiua-2211	53	12	dna	dna	PROPN
aiua-2211	53	13	chip	chip	NOUN
aiua-2211	53	14	(	(	PUNCT
aiua-2211	53	15	bio	bio	NOUN
aiua-2211	53	16	-	-	ADJ
aiua-2211	53	17	rad	rad	PROPN
aiua-2211	53	18	hercules	hercules	PROPN
aiua-2211	53	19	,	,	PUNCT
aiua-2211	53	20	ca	ca	NOUN
aiua-2211	53	21	)	)	PUNCT
aiua-2211	53	22	and	and	CCONJ
aiua-2211	53	23	4	4	NUM
aiua-2211	53	24	%	%	NOUN
aiua-2211	53	25	agarose	agarose	X
aiua-2211	53	26	gel	gel	NOUN
aiua-2211	53	27	.	.	PUNCT
aiua-2211	54	1	results	result	VERB
aiua-2211	54	2	for	for	ADP
aiua-2211	54	3	the	the	DET
aiua-2211	54	4	correct	correct	ADJ
aiua-2211	54	5	interpretation	interpretation	NOUN
aiua-2211	54	6	of	of	ADP
aiua-2211	54	7	adnagene	adnagene	ADJ
aiua-2211	54	8	test	test	NOUN
aiua-2211	54	9	results	result	NOUN
aiua-2211	54	10	,	,	PUNCT
aiua-2211	54	11	actin	actin	NOUN
aiua-2211	54	12	amplicons	amplicon	NOUN
aiua-2211	54	13	must	must	AUX
aiua-2211	54	14	be	be	AUX
aiua-2211	54	15	present	present	ADJ
aiua-2211	54	16	in	in	ADP
aiua-2211	54	17	all	all	DET
aiua-2211	54	18	patient	patient	NOUN
aiua-2211	54	19	’s	’s	PART
aiua-2211	54	20	runs	run	NOUN
aiua-2211	54	21	(	(	PUNCT
aiua-2211	54	22	internal	internal	ADJ
aiua-2211	54	23	pcr	pcr	ADJ
aiua-2211	54	24	control	control	NOUN
aiua-2211	54	25	):	):	PUNCT
aiua-2211	54	26	actin	actin	NOUN
aiua-2211	54	27	signal	signal	NOUN
aiua-2211	54	28	represents	represent	VERB
aiua-2211	54	29	,	,	PUNCT
aiua-2211	54	30	in	in	ADP
aiua-2211	54	31	fact	fact	NOUN
aiua-2211	54	32	,	,	PUNCT
aiua-2211	54	33	the	the	DET
aiua-2211	54	34	positive	positive	ADJ
aiua-2211	54	35	control	control	NOUN
aiua-2211	54	36	for	for	ADP
aiua-2211	54	37	cell	cell	NOUN
aiua-2211	54	38	separation	separation	NOUN
aiua-2211	54	39	,	,	PUNCT
aiua-2211	54	40	reverse	reverse	VERB
aiua-2211	54	41	transcriparchivio	transcriparchivio	NOUN
aiua-2211	54	42	italiano	italiano	NOUN
aiua-2211	54	43	di	di	X
aiua-2211	54	44	urologia	urologia	PROPN
aiua-2211	54	45	e	e	PROPN
aiua-2211	54	46	andrologia	andrologia	NOUN
aiua-2211	54	47	2013	2013	NUM
aiua-2211	54	48	;	;	PUNCT
aiua-2211	54	49	85	85	NUM
aiua-2211	54	50	,	,	PUNCT
aiua-2211	54	51	4	4	NUM
aiua-2211	54	52	g.	g.	NOUN
aiua-2211	54	53	albino	albino	PROPN
aiua-2211	54	54	,	,	PUNCT
aiua-2211	54	55	f.	f.	PROPN
aiua-2211	54	56	vendittelli	vendittelli	PROPN
aiua-2211	54	57	,	,	PUNCT
aiua-2211	54	58	c.	c.	PROPN
aiua-2211	54	59	paolillo	paolillo	PROPN
aiua-2211	54	60	,	,	PUNCT
aiua-2211	54	61	c.	c.	PROPN
aiua-2211	54	62	zuppi	zuppi	PROPN
aiua-2211	54	63	,	,	PUNCT
aiua-2211	54	64	e.	e.	PROPN
aiua-2211	54	65	capoluongo	capoluongo	PROPN
aiua-2211	54	66	166	166	NUM
aiua-2211	54	67	tion	tion	NOUN
aiua-2211	54	68	and	and	CCONJ
aiua-2211	54	69	multiplex	multiplex	PROPN
aiua-2211	54	70	pcr	pcr	PROPN
aiua-2211	54	71	.	.	PUNCT
aiua-2211	55	1	adnatest	adnate	ADJ
aiua-2211	55	2	was	be	AUX
aiua-2211	55	3	considered	consider	VERB
aiua-2211	55	4	positive	positive	ADJ
aiua-2211	55	5	for	for	ADP
aiua-2211	55	6	ctc	ctc	NOUN
aiua-2211	55	7	presence	presence	NOUN
aiua-2211	55	8	if	if	SCONJ
aiua-2211	55	9	a	a	DET
aiua-2211	55	10	pcr	pcr	ADJ
aiua-2211	55	11	fragment	fragment	NOUN
aiua-2211	55	12	of	of	ADP
aiua-2211	55	13	at	at	ADV
aiua-2211	55	14	least	least	ADV
aiua-2211	55	15	one	one	NUM
aiua-2211	55	16	tumor	tumor	NOUN
aiua-2211	55	17	-	-	PUNCT
aiua-2211	55	18	associated	associate	VERB
aiua-2211	55	19	transcript	transcript	NOUN
aiua-2211	55	20	was	be	AUX
aiua-2211	55	21	clearly	clearly	ADV
aiua-2211	55	22	detectable	detectable	ADJ
aiua-2211	55	23	and	and	CCONJ
aiua-2211	55	24	visible	visible	ADJ
aiua-2211	55	25	(	(	PUNCT
aiua-2211	55	26	peak	peak	NOUN
aiua-2211	55	27	concentration	concentration	NOUN
aiua-2211	55	28	!	!	PUNCT
aiua-2211	56	1	10	10	NUM
aiua-2211	56	2	ng/µl	ng/µl	PRON
aiua-2211	56	3	was	be	AUX
aiua-2211	56	4	fixed	fix	VERB
aiua-2211	56	5	as	as	ADP
aiua-2211	56	6	the	the	DET
aiua-2211	56	7	cut	cut	NOUN
aiua-2211	56	8	-	-	PUNCT
aiua-2211	56	9	off	off	NOUN
aiua-2211	56	10	)	)	PUNCT
aiua-2211	56	11	.	.	PUNCT
aiua-2211	57	1	peaks	peak	NOUN
aiua-2211	57	2	outside	outside	ADP
aiua-2211	57	3	the	the	DET
aiua-2211	57	4	above	above	ADV
aiua-2211	57	5	described	describe	VERB
aiua-2211	57	6	criteria	criterion	NOUN
aiua-2211	57	7	were	be	AUX
aiua-2211	57	8	defined	define	VERB
aiua-2211	57	9	as	as	ADP
aiua-2211	57	10	inconclusive	inconclusive	ADJ
aiua-2211	57	11	.	.	PUNCT
aiua-2211	58	1	all	all	DET
aiua-2211	58	2	assays	assay	NOUN
aiua-2211	58	3	run	run	VERB
aiua-2211	58	4	on	on	ADP
aiua-2211	58	5	our	our	PRON
aiua-2211	58	6	samples	sample	NOUN
aiua-2211	58	7	passed	pass	VERB
aiua-2211	58	8	the	the	DET
aiua-2211	58	9	quality	quality	NOUN
aiua-2211	58	10	control	control	NOUN
aiua-2211	58	11	criteria	criterion	NOUN
aiua-2211	58	12	.	.	PUNCT
aiua-2211	59	1	results	result	NOUN
aiua-2211	59	2	are	be	AUX
aiua-2211	59	3	briefly	briefly	ADV
aiua-2211	59	4	summarized	summarize	VERB
aiua-2211	59	5	in	in	ADP
aiua-2211	59	6	table	table	NOUN
aiua-2211	59	7	1	1	NUM
aiua-2211	59	8	.	.	PUNCT
aiua-2211	60	1	as	as	SCONJ
aiua-2211	60	2	expected	expect	VERB
aiua-2211	60	3	,	,	PUNCT
aiua-2211	60	4	all	all	DET
aiua-2211	60	5	healthy	healthy	ADJ
aiua-2211	60	6	individuals	individual	NOUN
aiua-2211	60	7	,	,	PUNCT
aiua-2211	60	8	control	control	PROPN
aiua-2211	60	9	group	group	PROPN
aiua-2211	60	10	iii	iii	NUM
aiua-2211	60	11	bph	bph	NOUN
aiua-2211	60	12	patients	patient	NOUN
aiua-2211	60	13	,	,	PUNCT
aiua-2211	60	14	as	as	ADV
aiua-2211	60	15	well	well	ADV
aiua-2211	60	16	as	as	ADP
aiua-2211	60	17	those	those	PRON
aiua-2211	60	18	belonging	belong	VERB
aiua-2211	60	19	to	to	ADP
aiua-2211	60	20	group	group	PROPN
aiua-2211	60	21	ii	ii	PROPN
aiua-2211	60	22	(	(	PUNCT
aiua-2211	60	23	who	who	PRON
aiua-2211	60	24	presented	present	VERB
aiua-2211	60	25	with	with	ADP
aiua-2211	60	26	disease	disease	NOUN
aiua-2211	60	27	properly	properly	ADV
aiua-2211	60	28	controlled	control	VERB
aiua-2211	60	29	by	by	ADP
aiua-2211	60	30	therapy	therapy	NOUN
aiua-2211	60	31	)	)	PUNCT
aiua-2211	60	32	resulted	result	VERB
aiua-2211	60	33	as	as	ADP
aiua-2211	60	34	negative	negative	ADJ
aiua-2211	60	35	for	for	ADP
aiua-2211	60	36	adnatest	adnate	ADJ
aiua-2211	60	37	.	.	PUNCT
aiua-2211	61	1	contrastingly	contrastingly	ADV
aiua-2211	61	2	,	,	PUNCT
aiua-2211	61	3	among	among	ADP
aiua-2211	61	4	patients	patient	NOUN
aiua-2211	61	5	belonging	belong	VERB
aiua-2211	61	6	to	to	ADP
aiua-2211	61	7	group	group	NOUN
aiua-2211	61	8	i	i	PRON
aiua-2211	61	9	(	(	PUNCT
aiua-2211	61	10	staging	stage	VERB
aiua-2211	61	11	class	class	NOUN
aiua-2211	61	12	iv	iv	NUM
aiua-2211	61	13	)	)	PUNCT
aiua-2211	61	14	,	,	PUNCT
aiua-2211	61	15	adnatest	adnate	ADJ
aiua-2211	61	16	identified	identify	VERB
aiua-2211	61	17	as	as	ADP
aiua-2211	61	18	positive	positive	ADJ
aiua-2211	61	19	only	only	ADV
aiua-2211	61	20	those	those	PRON
aiua-2211	61	21	who	who	PRON
aiua-2211	61	22	were	be	AUX
aiua-2211	61	23	no	no	ADV
aiua-2211	61	24	more	more	ADV
aiua-2211	61	25	responsive	responsive	ADJ
aiua-2211	61	26	to	to	ADP
aiua-2211	61	27	firstor	firstor	NOUN
aiua-2211	61	28	second	second	ADJ
aiua-2211	61	29	-	-	PUNCT
aiua-2211	61	30	line	line	NOUN
aiua-2211	61	31	therapy	therapy	NOUN
aiua-2211	61	32	,	,	PUNCT
aiua-2211	61	33	while	while	SCONJ
aiua-2211	61	34	as	as	SCONJ
aiua-2211	61	35	negative	negative	ADJ
aiua-2211	61	36	those	those	PRON
aiua-2211	61	37	responsive	responsive	ADJ
aiua-2211	61	38	to	to	ADP
aiua-2211	61	39	firstor	firstor	NOUN
aiua-2211	61	40	second	second	ADJ
aiua-2211	61	41	-	-	PUNCT
aiua-2211	61	42	line	line	NOUN
aiua-2211	61	43	chemotherapy	chemotherapy	NOUN
aiua-2211	61	44	,	,	PUNCT
aiua-2211	61	45	although	although	SCONJ
aiua-2211	61	46	being	be	AUX
aiua-2211	61	47	escaped	escape	VERB
aiua-2211	61	48	by	by	ADP
aiua-2211	61	49	hormone	hormone	NOUN
aiua-2211	61	50	therapy	therapy	NOUN
aiua-2211	61	51	.	.	PUNCT
aiua-2211	62	1	three	three	NUM
aiua-2211	62	2	out	out	ADP
aiua-2211	62	3	of	of	ADP
aiua-2211	62	4	ten	ten	NUM
aiua-2211	62	5	pca	pca	NOUN
aiua-2211	62	6	group	group	NOUN
aiua-2211	62	7	i	i	PRON
aiua-2211	62	8	patients	patient	NOUN
aiua-2211	62	9	resulted	result	VERB
aiua-2211	62	10	as	as	ADP
aiua-2211	62	11	positive	positive	ADJ
aiua-2211	62	12	for	for	ADP
aiua-2211	62	13	at	at	ADV
aiua-2211	62	14	least	least	ADV
aiua-2211	62	15	one	one	NUM
aiua-2211	62	16	tumor	tumor	NOUN
aiua-2211	62	17	-	-	PUNCT
aiua-2211	62	18	associated	associate	VERB
aiua-2211	62	19	marker	marker	NOUN
aiua-2211	62	20	like	like	ADP
aiua-2211	62	21	psa	psa	NOUN
aiua-2211	62	22	,	,	PUNCT
aiua-2211	62	23	while	while	SCONJ
aiua-2211	62	24	only	only	ADV
aiua-2211	62	25	two	two	NUM
aiua-2211	62	26	showed	show	VERB
aiua-2211	62	27	positivity	positivity	NOUN
aiua-2211	62	28	also	also	ADV
aiua-2211	62	29	for	for	ADP
aiua-2211	62	30	psma	psma	PROPN
aiua-2211	62	31	mrna	mrna	PROPN
aiua-2211	62	32	.	.	PUNCT
aiua-2211	63	1	it	it	PRON
aiua-2211	63	2	is	be	AUX
aiua-2211	63	3	important	important	ADJ
aiua-2211	63	4	to	to	PART
aiua-2211	63	5	underline	underline	VERB
aiua-2211	63	6	that	that	SCONJ
aiua-2211	63	7	the	the	DET
aiua-2211	63	8	group	group	NOUN
aiua-2211	63	9	i	i	PRON
aiua-2211	63	10	patient	patient	VERB
aiua-2211	63	11	(	(	PUNCT
aiua-2211	63	12	listed	list	VERB
aiua-2211	63	13	as	as	ADP
aiua-2211	63	14	number	number	NOUN
aiua-2211	63	15	2	2	NUM
aiua-2211	63	16	in	in	ADP
aiua-2211	63	17	table	table	NOUN
aiua-2211	63	18	1	1	NUM
aiua-2211	63	19	)	)	PUNCT
aiua-2211	63	20	,	,	PUNCT
aiua-2211	63	21	who	who	PRON
aiua-2211	63	22	was	be	AUX
aiua-2211	63	23	negative	negative	ADJ
aiua-2211	63	24	for	for	ADP
aiua-2211	63	25	adnatest	adnate	ADJ
aiua-2211	63	26	during	during	ADP
aiua-2211	63	27	the	the	DET
aiua-2211	63	28	first	first	ADJ
aiua-2211	63	29	-	-	PUNCT
aiua-2211	63	30	line	line	NOUN
aiua-2211	63	31	of	of	ADP
aiua-2211	63	32	chemotherapy	chemotherapy	NOUN
aiua-2211	63	33	,	,	PUNCT
aiua-2211	63	34	became	become	VERB
aiua-2211	63	35	positive	positive	ADJ
aiua-2211	63	36	for	for	ADP
aiua-2211	63	37	psa	psa	NOUN
aiua-2211	63	38	marker	marker	NOUN
aiua-2211	63	39	five	five	NUM
aiua-2211	63	40	months	month	NOUN
aiua-2211	63	41	later	later	ADV
aiua-2211	63	42	(	(	PUNCT
aiua-2211	63	43	as	as	SCONJ
aiua-2211	63	44	shown	show	VERB
aiua-2211	63	45	in	in	ADP
aiua-2211	63	46	the	the	DET
aiua-2211	63	47	comparison	comparison	NOUN
aiua-2211	63	48	between	between	ADP
aiua-2211	63	49	figures	figure	NOUN
aiua-2211	63	50	1a	1a	NOUN
aiua-2211	63	51	and1b	and1b	NOUN
aiua-2211	63	52	)	)	PUNCT
aiua-2211	63	53	.	.	PUNCT
aiua-2211	64	1	surprisingly	surprisingly	ADV
aiua-2211	64	2	,	,	PUNCT
aiua-2211	64	3	egfr	egfr	PROPN
aiua-2211	64	4	mrna	mrna	PROPN
aiua-2211	64	5	resulted	result	VERB
aiua-2211	64	6	always	always	ADV
aiua-2211	64	7	negative	negative	ADJ
aiua-2211	64	8	in	in	ADP
aiua-2211	64	9	our	our	PRON
aiua-2211	64	10	patients	patient	NOUN
aiua-2211	64	11	:	:	PUNCT
aiua-2211	64	12	in	in	ADP
aiua-2211	64	13	order	order	NOUN
aiua-2211	64	14	to	to	PART
aiua-2211	64	15	establish	establish	VERB
aiua-2211	64	16	if	if	SCONJ
aiua-2211	64	17	the	the	DET
aiua-2211	64	18	negative	negative	ADJ
aiua-2211	64	19	results	result	NOUN
aiua-2211	64	20	were	be	AUX
aiua-2211	64	21	dependent	dependent	ADJ
aiua-2211	64	22	on	on	ADP
aiua-2211	64	23	limits	limit	NOUN
aiua-2211	64	24	of	of	ADP
aiua-2211	64	25	adna	adna	NOUN
aiua-2211	64	26	-	-	PUNCT
aiua-2211	64	27	kit	kit	NOUN
aiua-2211	64	28	,	,	PUNCT
aiua-2211	64	29	we	we	PRON
aiua-2211	64	30	spiked	spike	VERB
aiua-2211	64	31	mrna	mrna	PROPN
aiua-2211	64	32	extracted	extract	VERB
aiua-2211	64	33	from	from	ADP
aiua-2211	64	34	prostate	prostate	NOUN
aiua-2211	64	35	cancer	cancer	NOUN
aiua-2211	64	36	slices	slice	NOUN
aiua-2211	64	37	positive	positive	ADJ
aiua-2211	64	38	at	at	ADP
aiua-2211	64	39	immunehistochemical	immunehistochemical	ADJ
aiua-2211	64	40	analysis	analysis	NOUN
aiua-2211	64	41	,	,	PUNCT
aiua-2211	64	42	and	and	CCONJ
aiua-2211	64	43	we	we	PRON
aiua-2211	64	44	found	find	VERB
aiua-2211	64	45	a	a	DET
aiua-2211	64	46	perfect	perfect	ADJ
aiua-2211	64	47	amplification	amplification	NOUN
aiua-2211	64	48	of	of	ADP
aiua-2211	64	49	egfr	egfr	ADJ
aiua-2211	64	50	target	target	NOUN
aiua-2211	64	51	(	(	PUNCT
aiua-2211	64	52	data	datum	NOUN
aiua-2211	64	53	not	not	PART
aiua-2211	64	54	shown	show	VERB
aiua-2211	64	55	)	)	PUNCT
aiua-2211	64	56	.	.	PUNCT
aiua-2211	65	1	our	our	PRON
aiua-2211	65	2	results	result	NOUN
aiua-2211	65	3	indicate	indicate	VERB
aiua-2211	65	4	that	that	SCONJ
aiua-2211	65	5	specificity	specificity	NOUN
aiua-2211	65	6	of	of	ADP
aiua-2211	65	7	test	test	NOUN
aiua-2211	65	8	is	be	AUX
aiua-2211	65	9	100	100	NUM
aiua-2211	65	10	%	%	NOUN
aiua-2211	65	11	and	and	CCONJ
aiua-2211	65	12	sensitivity	sensitivity	NOUN
aiua-2211	65	13	was	be	AUX
aiua-2211	65	14	100	100	NUM
aiua-2211	65	15	%	%	NOUN
aiua-2211	65	16	(	(	PUNCT
aiua-2211	65	17	table	table	NOUN
aiua-2211	65	18	2	2	NUM
aiua-2211	65	19	)	)	PUNCT
aiua-2211	65	20	.	.	PUNCT
aiua-2211	66	1	in	in	ADP
aiua-2211	66	2	detail	detail	NOUN
aiua-2211	66	3	,	,	PUNCT
aiua-2211	66	4	individuals	individual	NOUN
aiua-2211	66	5	with	with	ADP
aiua-2211	66	6	bph	bph	NOUN
aiua-2211	66	7	(	(	PUNCT
aiua-2211	66	8	group	group	NOUN
aiua-2211	66	9	iii	iii	PROPN
aiua-2211	66	10	)	)	PUNCT
aiua-2211	66	11	and	and	CCONJ
aiua-2211	66	12	those	those	PRON
aiua-2211	66	13	defined	define	VERB
aiua-2211	66	14	as	as	ADP
aiua-2211	66	15	“	"	PUNCT
aiua-2211	66	16	stage	stage	NOUN
aiua-2211	66	17	i	i	PRON
aiua-2211	66	18	”	"	PUNCT
aiua-2211	66	19	(	(	PUNCT
aiua-2211	66	20	group	group	NOUN
aiua-2211	66	21	ii	ii	PROPN
aiua-2211	66	22	)	)	PUNCT
aiua-2211	66	23	resulted	result	VERB
aiua-2211	66	24	as	as	ADP
aiua-2211	66	25	negative	negative	ADJ
aiua-2211	66	26	,	,	PUNCT
aiua-2211	66	27	while	while	SCONJ
aiua-2211	66	28	all	all	DET
aiua-2211	66	29	patients	patient	NOUN
aiua-2211	66	30	belonging	belong	VERB
aiua-2211	66	31	to	to	ADP
aiua-2211	66	32	group	group	NOUN
aiua-2211	66	33	i	i	PRON
aiua-2211	66	34	(	(	PUNCT
aiua-2211	66	35	defined	define	VERB
aiua-2211	66	36	as	as	ADP
aiua-2211	66	37	stage	stage	NOUN
aiua-2211	66	38	iv	iv	NUM
aiua-2211	66	39	)	)	PUNCT
aiua-2211	66	40	and	and	CCONJ
aiua-2211	66	41	responsive	responsive	ADJ
aiua-2211	66	42	to	to	ADP
aiua-2211	66	43	therapy	therapy	NOUN
aiua-2211	66	44	did	do	AUX
aiua-2211	66	45	not	not	PART
aiua-2211	66	46	show	show	VERB
aiua-2211	66	47	any	any	DET
aiua-2211	66	48	positivity	positivity	NOUN
aiua-2211	66	49	for	for	ADP
aiua-2211	66	50	adnatest	adnate	ADJ
aiua-2211	66	51	markers	marker	NOUN
aiua-2211	66	52	,	,	PUNCT
aiua-2211	66	53	while	while	SCONJ
aiua-2211	66	54	all	all	DET
aiua-2211	66	55	“	"	PUNCT
aiua-2211	66	56	not	not	PART
aiua-2211	66	57	responder	responder	NOUN
aiua-2211	66	58	”	"	PUNCT
aiua-2211	66	59	patients	patient	NOUN
aiua-2211	66	60	resulted	result	VERB
aiua-2211	66	61	positive	positive	ADJ
aiua-2211	66	62	for	for	ADP
aiua-2211	66	63	adnatest	adnate	ADJ
aiua-2211	66	64	.	.	PUNCT
aiua-2211	67	1	the	the	DET
aiua-2211	67	2	number	number	NOUN
aiua-2211	67	3	of	of	ADP
aiua-2211	67	4	patients	patient	NOUN
aiua-2211	67	5	is	be	AUX
aiua-2211	67	6	too	too	ADV
aiua-2211	67	7	small	small	ADJ
aiua-2211	67	8	to	to	PART
aiua-2211	67	9	apply	apply	VERB
aiua-2211	67	10	the	the	DET
aiua-2211	67	11	tests	test	NOUN
aiua-2211	67	12	of	of	ADP
aiua-2211	67	13	analysis	analysis	NOUN
aiua-2211	67	14	of	of	ADP
aiua-2211	67	15	variance	variance	NOUN
aiua-2211	67	16	.	.	PUNCT
aiua-2211	68	1	furthermore	furthermore	ADV
aiua-2211	68	2	,	,	PUNCT
aiua-2211	68	3	figure	figure	NOUN
aiua-2211	68	4	1a	1a	PROPN
aiua-2211	68	5	is	be	AUX
aiua-2211	68	6	representative	representative	NOUN
aiua-2211	68	7	of	of	ADP
aiua-2211	68	8	a	a	DET
aiua-2211	68	9	group	group	NOUN
aiua-2211	68	10	of	of	ADP
aiua-2211	68	11	patients	patient	NOUN
aiua-2211	68	12	’	'	PUNCT
aiua-2211	68	13	amplicons	amplicon	NOUN
aiua-2211	68	14	analyzed	analyze	VERB
aiua-2211	68	15	with	with	ADP
aiua-2211	68	16	experion	experion	NOUN
aiua-2211	68	17	instrumentation	instrumentation	NOUN
aiua-2211	68	18	.	.	PUNCT
aiua-2211	69	1	clinical	clinical	ADJ
aiua-2211	69	2	characteristics	characteristic	NOUN
aiua-2211	69	3	and	and	CCONJ
aiua-2211	69	4	main	main	ADJ
aiua-2211	69	5	results	result	NOUN
aiua-2211	69	6	of	of	ADP
aiua-2211	69	7	adnatest	adnate	ADJ
aiua-2211	69	8	are	be	AUX
aiua-2211	69	9	synthetically	synthetically	ADV
aiua-2211	69	10	reported	report	VERB
aiua-2211	69	11	below	below	ADV
aiua-2211	69	12	for	for	ADP
aiua-2211	69	13	each	each	DET
aiua-2211	69	14	patient	patient	NOUN
aiua-2211	69	15	.	.	PUNCT
aiua-2211	70	1	details	detail	NOUN
aiua-2211	70	2	of	of	ADP
aiua-2211	70	3	clinical	clinical	ADJ
aiua-2211	70	4	features	feature	NOUN
aiua-2211	70	5	of	of	ADP
aiua-2211	70	6	15	15	NUM
aiua-2211	70	7	pca	pca	NOUN
aiua-2211	70	8	patients	patient	NOUN
aiua-2211	70	9	studied	study	VERB
aiua-2211	70	10	patient	patient	ADJ
aiua-2211	70	11	n.	n.	NOUN
aiua-2211	70	12	1	1	NUM
aiua-2211	70	13	:	:	PUNCT
aiua-2211	70	14	showed	show	VERB
aiua-2211	70	15	a	a	DET
aiua-2211	70	16	psa	psa	NOUN
aiua-2211	70	17	relapse	relapse	NOUN
aiua-2211	70	18	perhaps	perhaps	ADV
aiua-2211	70	19	only	only	ADV
aiua-2211	70	20	for	for	ADP
aiua-2211	70	21	the	the	DET
aiua-2211	70	22	infiltration	infiltration	NOUN
aiua-2211	70	23	of	of	ADP
aiua-2211	70	24	the	the	DET
aiua-2211	70	25	bladder	bladder	NOUN
aiua-2211	70	26	neck	neck	NOUN
aiua-2211	70	27	,	,	PUNCT
aiua-2211	70	28	but	but	CCONJ
aiua-2211	70	29	the	the	DET
aiua-2211	70	30	bone	bone	NOUN
aiua-2211	70	31	and	and	CCONJ
aiua-2211	70	32	lymph	lymph	NOUN
aiua-2211	70	33	node	node	NOUN
aiua-2211	70	34	metastases	metastasis	NOUN
aiua-2211	70	35	were	be	AUX
aiua-2211	70	36	not	not	PART
aiua-2211	70	37	metabolically	metabolically	ADV
aiua-2211	70	38	active	active	ADJ
aiua-2211	70	39	at	at	ADP
aiua-2211	70	40	scintigraphy	scintigraphy	NOUN
aiua-2211	70	41	examination	examination	NOUN
aiua-2211	70	42	:	:	PUNCT
aiua-2211	70	43	this	this	DET
aiua-2211	70	44	test	test	NOUN
aiua-2211	70	45	did	do	AUX
aiua-2211	70	46	not	not	PART
aiua-2211	70	47	indicate	indicate	VERB
aiua-2211	70	48	the	the	DET
aiua-2211	70	49	need	need	NOUN
aiua-2211	70	50	of	of	ADP
aiua-2211	70	51	radiotherapy	radiotherapy	NOUN
aiua-2211	70	52	on	on	ADP
aiua-2211	70	53	the	the	DET
aiua-2211	70	54	primitive	primitive	ADJ
aiua-2211	70	55	mass	mass	NOUN
aiua-2211	70	56	;	;	PUNCT
aiua-2211	70	57	patient	patient	ADJ
aiua-2211	70	58	n.	n.	NOUN
aiua-2211	70	59	2	2	NUM
aiua-2211	70	60	:	:	PUNCT
aiua-2211	70	61	was	be	AUX
aiua-2211	70	62	resistant	resistant	ADJ
aiua-2211	70	63	to	to	ADP
aiua-2211	70	64	hormonal	hormonal	ADJ
aiua-2211	70	65	treatment	treatment	NOUN
aiua-2211	70	66	.	.	PUNCT
aiua-2211	71	1	he	he	PRON
aiua-2211	71	2	initially	initially	ADV
aiua-2211	71	3	responded	respond	VERB
aiua-2211	71	4	to	to	ADP
aiua-2211	71	5	the	the	DET
aiua-2211	71	6	first	first	ADJ
aiua-2211	71	7	level	level	NOUN
aiua-2211	71	8	chemotherapy	chemotherapy	NOUN
aiua-2211	71	9	,	,	PUNCT
aiua-2211	71	10	but	but	CCONJ
aiua-2211	71	11	subsequently	subsequently	ADV
aiua-2211	71	12	his	his	PRON
aiua-2211	71	13	clinical	clinical	ADJ
aiua-2211	71	14	conditions	condition	NOUN
aiua-2211	71	15	worsened	worsen	VERB
aiua-2211	71	16	.	.	PUNCT
aiua-2211	72	1	the	the	DET
aiua-2211	72	2	adnatest	adnate	ADJ
aiua-2211	72	3	prognostic	prognostic	ADJ
aiua-2211	72	4	patients	patient	NOUN
aiua-2211	72	5	psa	psa	VERB
aiua-2211	72	6	t0	t0	PROPN
aiua-2211	72	7	grouping	grouping	NOUN
aiua-2211	72	8	(	(	PUNCT
aiua-2211	72	9	stage	stage	NOUN
aiua-2211	72	10	)	)	PUNCT
aiua-2211	72	11	gs	gs	PROPN
aiua-2211	72	12	tnm	tnm	PROPN
aiua-2211	72	13	therapy	therapy	PROPN
aiua-2211	72	14	current	current	ADJ
aiua-2211	72	15	psa	psa	PROPN
aiua-2211	72	16	adna	adna	PROPN
aiua-2211	72	17	markers	markers	PROPN
aiua-2211	72	18	group	group	PROPN
aiua-2211	72	19	ia	ia	PROPN
aiua-2211	72	20	1	1	NUM
aiua-2211	72	21	332	332	NUM
aiua-2211	72	22	iv	iv	NUM
aiua-2211	72	23	5	5	NUM
aiua-2211	72	24	+	+	SYM
aiua-2211	72	25	5	5	NUM
aiua-2211	72	26	n+m+	n+m+	NOUN
aiua-2211	72	27	enantone	enantone	NOUN
aiua-2211	73	1	+	+	CCONJ
aiua-2211	73	2	casodex	casodex	PROPN
aiua-2211	73	3	1,68	1,68	NUM
aiua-2211	73	4	neg	neg	VERB
aiua-2211	73	5	2	2	NUM
aiua-2211	73	6	12	12	NUM
aiua-2211	73	7	iv	iv	NUM
aiua-2211	73	8	5	5	NUM
aiua-2211	73	9	+	+	SYM
aiua-2211	73	10	4	4	NUM
aiua-2211	73	11	n+m+	n+m+	NOUN
aiua-2211	73	12	eligard	eligard	NOUN
aiua-2211	73	13	+	+	CCONJ
aiua-2211	73	14	casodex	casodex	NOUN
aiua-2211	73	15	+	+	CCONJ
aiua-2211	73	16	rt	rt	PROPN
aiua-2211	73	17	+	+	CCONJ
aiua-2211	73	18	cht	cht	PROPN
aiua-2211	73	19	0,98	0,98	NOUN
aiua-2211	73	20	neg	neg	PROPN
aiua-2211	73	21	/	/	SYM
aiua-2211	73	22	psa	psa	NOUN
aiua-2211	73	23	*	*	SYM
aiua-2211	73	24	3	3	NUM
aiua-2211	73	25	136	136	NUM
aiua-2211	73	26	iv	iv	NUM
aiua-2211	73	27	4	4	NUM
aiua-2211	73	28	+	+	SYM
aiua-2211	73	29	4	4	NUM
aiua-2211	73	30	t4	t4	PROPN
aiua-2211	73	31	n+	n+	PUNCT
aiua-2211	73	32	m0	m0	PROPN
aiua-2211	73	33	casodex	casodex	NOUN
aiua-2211	73	34	50	50	NUM
aiua-2211	73	35	+	+	CCONJ
aiua-2211	73	36	rt	rt	PROPN
aiua-2211	73	37	0,49	0,49	NUM
aiua-2211	73	38	neg	neg	VERB
aiua-2211	73	39	4	4	NUM
aiua-2211	73	40	15	15	NUM
aiua-2211	73	41	iv	iv	NUM
aiua-2211	73	42	3	3	NUM
aiua-2211	73	43	+	+	SYM
aiua-2211	73	44	5	5	NUM
aiua-2211	73	45	n+	n+	ADP
aiua-2211	73	46	gonapeptyl	gonapeptyl	NOUN
aiua-2211	73	47	+	+	CCONJ
aiua-2211	73	48	casodex	casodex	NOUN
aiua-2211	73	49	rt	rt	PROPN
aiua-2211	73	50	52	52	NUM
aiua-2211	73	51	psa	psa	NOUN
aiua-2211	73	52	/	/	SYM
aiua-2211	73	53	psma	psma	NOUN
aiua-2211	73	54	5	5	NUM
aiua-2211	73	55	5,73	5,73	NUM
aiua-2211	73	56	iv	iv	ADP
aiua-2211	73	57	4	4	NUM
aiua-2211	73	58	+	+	SYM
aiua-2211	73	59	4	4	NUM
aiua-2211	73	60	pt4	pt4	NOUN
aiua-2211	73	61	rt	rt	PROPN
aiua-2211	73	62	0,01	0,01	NUM
aiua-2211	73	63	neg	neg	PROPN
aiua-2211	73	64	6	6	NUM
aiua-2211	73	65	7,05	7,05	NUM
aiua-2211	73	66	iv	iv	ADP
aiua-2211	73	67	5	5	NUM
aiua-2211	73	68	+	+	SYM
aiua-2211	73	69	3	3	NUM
aiua-2211	73	70	pt3b	pt3b	X
aiua-2211	73	71	m+	m+	NUM
aiua-2211	73	72	eligard	eligard	NOUN
aiua-2211	73	73	+	+	CCONJ
aiua-2211	73	74	rt	rt	PROPN
aiua-2211	73	75	15	15	NUM
aiua-2211	73	76	psa	psa	VERB
aiua-2211	73	77	7	7	NUM
aiua-2211	73	78	128	128	NUM
aiua-2211	73	79	iv	iv	NUM
aiua-2211	73	80	4	4	NUM
aiua-2211	73	81	+	+	SYM
aiua-2211	73	82	5	5	NUM
aiua-2211	73	83	n+	n+	NUM
aiua-2211	73	84	m+	m+	NOUN
aiua-2211	73	85	eligard	eligard	NOUN
aiua-2211	73	86	+	+	CCONJ
aiua-2211	73	87	casodex	casodex	NOUN
aiua-2211	73	88	+	+	CCONJ
aiua-2211	73	89	taxotere	taxotere	PROPN
aiua-2211	73	90	68,5	68,5	NUM
aiua-2211	73	91	psa	psa	NOUN
aiua-2211	73	92	/	/	SYM
aiua-2211	73	93	psma	psma	NOUN
aiua-2211	73	94	12	12	NUM
aiua-2211	73	95	9.8	9.8	NUM
aiua-2211	73	96	iv	iv	NUM
aiua-2211	73	97	4	4	NUM
aiua-2211	73	98	+	+	SYM
aiua-2211	73	99	4	4	NUM
aiua-2211	73	100	m+	m+	NUM
aiua-2211	73	101	casodex	casodex	NOUN
aiua-2211	73	102	+	+	CCONJ
aiua-2211	73	103	enantone	enantone	NOUN
aiua-2211	73	104	+	+	CCONJ
aiua-2211	73	105	zometa	zometa	ADJ
aiua-2211	73	106	9,29	9,29	NUM
aiua-2211	73	107	neg	neg	VERB
aiua-2211	73	108	13	13	NUM
aiua-2211	73	109	12	12	NUM
aiua-2211	73	110	iv	iv	NUM
aiua-2211	73	111	4	4	NUM
aiua-2211	73	112	+	+	SYM
aiua-2211	73	113	4	4	NUM
aiua-2211	73	114	t4	t4	PROPN
aiua-2211	73	115	rt	rt	PROPN
aiua-2211	73	116	casodex	casodex	PROPN
aiua-2211	73	117	suspension	suspension	VERB
aiua-2211	73	118	0,206	0,206	NUM
aiua-2211	73	119	neg	neg	VERB
aiua-2211	73	120	14	14	NUM
aiua-2211	73	121	8.9	8.9	NUM
aiua-2211	73	122	iv	iv	NUM
aiua-2211	73	123	3	3	NUM
aiua-2211	73	124	+	+	NUM
aiua-2211	73	125	5	5	NUM
aiua-2211	73	126	pt3b	pt3b	NOUN
aiua-2211	73	127	n+	n+	NUM
aiua-2211	73	128	rrp	rrp	PROPN
aiua-2211	73	129	r1	r1	PROPN
aiua-2211	73	130	(	(	PUNCT
aiua-2211	73	131	margins	margin	NOUN
aiua-2211	73	132	+	+	NOUN
aiua-2211	73	133	)	)	PUNCT
aiua-2211	73	134	0,03	0,03	NUM
aiua-2211	73	135	neg	neg	PROPN
aiua-2211	73	136	group	group	NOUN
aiua-2211	73	137	iib	iib	PROPN
aiua-2211	73	138	8	8	NUM
aiua-2211	73	139	6,95	6,95	NUM
aiua-2211	74	1	i	i	PRON
aiua-2211	74	2	3	3	NUM
aiua-2211	74	3	+	+	SYM
aiua-2211	74	4	3	3	NUM
aiua-2211	74	5	n0	n0	NOUN
aiua-2211	74	6	m0	m0	PROPN
aiua-2211	74	7	rrp	rrp	PROPN
aiua-2211	74	8	0,04	0,04	PROPN
aiua-2211	74	9	neg	neg	PROPN
aiua-2211	74	10	9	9	NUM
aiua-2211	74	11	9,24	9,24	NUM
aiua-2211	74	12	i	i	NOUN
aiua-2211	74	13	3	3	NUM
aiua-2211	74	14	+	+	SYM
aiua-2211	74	15	2	2	NUM
aiua-2211	74	16	n0	n0	NOUN
aiua-2211	74	17	m0	m0	PROPN
aiua-2211	74	18	eligard	eligard	PROPN
aiua-2211	74	19	0,04	0,04	PROPN
aiua-2211	74	20	neg	neg	PROPN
aiua-2211	74	21	10	10	NUM
aiua-2211	74	22	5,64	5,64	NUM
aiua-2211	74	23	i	i	PRON
aiua-2211	74	24	3	3	NUM
aiua-2211	74	25	+	+	SYM
aiua-2211	74	26	3	3	NUM
aiua-2211	74	27	n0	n0	X
aiua-2211	74	28	m0	m0	PROPN
aiua-2211	74	29	decapeptyl	decapeptyl	NOUN
aiua-2211	74	30	+	+	CCONJ
aiua-2211	74	31	casodex	casodex	NOUN
aiua-2211	74	32	+	+	CCONJ
aiua-2211	74	33	rt	rt	PROPN
aiua-2211	74	34	0,00	0,00	PROPN
aiua-2211	74	35	neg	neg	PROPN
aiua-2211	74	36	11	11	NUM
aiua-2211	74	37	9,83	9,83	NUM
aiua-2211	75	1	i	i	NOUN
aiua-2211	75	2	3	3	NUM
aiua-2211	75	3	+	+	SYM
aiua-2211	75	4	3	3	NUM
aiua-2211	75	5	n0	n0	X
aiua-2211	75	6	m0	m0	PROPN
aiua-2211	75	7	rt	rt	PROPN
aiua-2211	75	8	4,01	4,01	PROPN
aiua-2211	75	9	neg	neg	VERB
aiua-2211	75	10	15	15	NUM
aiua-2211	75	11	4.32	4.32	NUM
aiua-2211	75	12	i	i	NOUN
aiua-2211	75	13	3	3	NUM
aiua-2211	75	14	+	+	SYM
aiua-2211	75	15	3	3	NUM
aiua-2211	75	16	n0	n0	NOUN
aiua-2211	75	17	m0	m0	PROPN
aiua-2211	75	18	rrp	rrp	PROPN
aiua-2211	75	19	4,32	4,32	NUM
aiua-2211	75	20	neg	neg	VERB
aiua-2211	75	21	21	21	NUM
aiua-2211	75	22	7.13	7.13	NUM
aiua-2211	75	23	i	i	NOUN
aiua-2211	75	24	3	3	NUM
aiua-2211	75	25	+	+	SYM
aiua-2211	75	26	3	3	NUM
aiua-2211	75	27	n0	n0	NOUN
aiua-2211	75	28	m0	m0	PROPN
aiua-2211	75	29	casodex	casodex	PROPN
aiua-2211	75	30	0,04	0,04	PROPN
aiua-2211	75	31	neg	neg	PROPN
aiua-2211	75	32	group	group	PROPN
aiua-2211	75	33	iii	iii	PROPN
aiua-2211	75	34	16	16	NUM
aiua-2211	75	35	bph	bph	NOUN
aiua-2211	75	36	0,174	0,174	PRON
aiua-2211	75	37	neg	neg	VERB
aiua-2211	75	38	17	17	NUM
aiua-2211	75	39	bph	bph	NOUN
aiua-2211	75	40	1,52	1,52	PROPN
aiua-2211	75	41	neg	neg	PROPN
aiua-2211	75	42	18	18	NUM
aiua-2211	75	43	bph	bph	NOUN
aiua-2211	75	44	0,267	0,267	NUM
aiua-2211	75	45	neg	neg	PROPN
aiua-2211	75	46	19	19	NUM
aiua-2211	75	47	bph	bph	NOUN
aiua-2211	75	48	0,94	0,94	NOUN
aiua-2211	75	49	neg	neg	VERB
aiua-2211	75	50	20	20	NUM
aiua-2211	75	51	bph	bph	NOUN
aiua-2211	75	52	1,94	1,94	NUM
aiua-2211	75	53	neg	neg	PROPN
aiua-2211	75	54	table	table	NOUN
aiua-2211	75	55	1	1	NUM
aiua-2211	75	56	.	.	PUNCT
aiua-2211	76	1	therapeutic	therapeutic	ADJ
aiua-2211	76	2	informations	information	NOUN
aiua-2211	76	3	and	and	CCONJ
aiua-2211	76	4	pathological	pathological	ADJ
aiua-2211	76	5	characteristics	characteristic	NOUN
aiua-2211	76	6	of	of	ADP
aiua-2211	76	7	pca	pca	PROPN
aiua-2211	76	8	and	and	CCONJ
aiua-2211	76	9	control	control	NOUN
aiua-2211	76	10	patients	patient	NOUN
aiua-2211	76	11	,	,	PUNCT
aiua-2211	76	12	following	follow	VERB
aiua-2211	76	13	the	the	DET
aiua-2211	76	14	tnm	tnm	PROPN
aiua-2211	76	15	classification	classification	NOUN
aiua-2211	76	16	(	(	PUNCT
aiua-2211	76	17	uicc	uicc	NOUN
aiua-2211	76	18	,	,	PUNCT
aiua-2211	76	19	2009	2009	NUM
aiua-2211	76	20	)	)	PUNCT
aiua-2211	76	21	.	.	PUNCT
aiua-2211	77	1	tnm	tnm	PROPN
aiua-2211	77	2	=	=	NOUN
aiua-2211	77	3	cancer	cancer	NOUN
aiua-2211	77	4	staging	staging	NOUN
aiua-2211	77	5	system	system	NOUN
aiua-2211	77	6	;	;	PUNCT
aiua-2211	77	7	gs	gs	PROPN
aiua-2211	77	8	=	=	PUNCT
aiua-2211	77	9	gleason	gleason	PROPN
aiua-2211	77	10	score	score	NOUN
aiua-2211	77	11	(	(	PUNCT
aiua-2211	77	12	all	all	DET
aiua-2211	77	13	gs	gs	NOUN
aiua-2211	77	14	are	be	AUX
aiua-2211	77	15	“	"	PUNCT
aiua-2211	77	16	biopsy	biopsy	ADJ
aiua-2211	77	17	gs	gs	X
aiua-2211	77	18	”	"	PUNCT
aiua-2211	77	19	because	because	SCONJ
aiua-2211	77	20	they	they	PRON
aiua-2211	77	21	were	be	AUX
aiua-2211	77	22	not	not	PART
aiua-2211	77	23	submitted	submit	VERB
aiua-2211	77	24	to	to	ADP
aiua-2211	77	25	rrp	rrp	NOUN
aiua-2211	77	26	;	;	PUNCT
aiua-2211	77	27	only	only	ADV
aiua-2211	77	28	pts	pts	AUX
aiua-2211	77	29	8	8	NUM
aiua-2211	77	30	-	-	SYM
aiua-2211	77	31	14	14	NUM
aiua-2211	77	32	-	-	SYM
aiua-2211	77	33	15	15	NUM
aiua-2211	77	34	have	have	VERB
aiua-2211	77	35	“	"	PUNCT
aiua-2211	77	36	rp	rp	NOUN
aiua-2211	77	37	-	-	PUNCT
aiua-2211	77	38	gs	gs	NOUN
aiua-2211	77	39	”	"	PUNCT
aiua-2211	77	40	)	)	PUNCT
aiua-2211	77	41	;	;	PUNCT
aiua-2211	77	42	adna	adna	PROPN
aiua-2211	77	43	markers	markers	PROPN
aiua-2211	77	44	:	:	PUNCT
aiua-2211	77	45	psa	psa	PROPN
aiua-2211	77	46	,	,	PUNCT
aiua-2211	77	47	psma	psma	NOUN
aiua-2211	77	48	,	,	PUNCT
aiua-2211	77	49	egfr	egfr	X
aiua-2211	77	50	;	;	PUNCT
aiua-2211	77	51	bph	bph	NOUN
aiua-2211	77	52	=	=	SYM
aiua-2211	77	53	benign	benign	ADJ
aiua-2211	77	54	prostate	prostate	NOUN
aiua-2211	77	55	hypertrophy	hypertrophy	NOUN
aiua-2211	77	56	.	.	PUNCT
aiua-2211	78	1	all	all	DET
aiua-2211	78	2	15	15	NUM
aiua-2211	78	3	healthy	healthy	ADJ
aiua-2211	78	4	normal	normal	ADJ
aiua-2211	78	5	controls	control	NOUN
aiua-2211	78	6	resulted	result	VERB
aiua-2211	78	7	as	as	ADP
aiua-2211	78	8	negative	negative	ADJ
aiua-2211	78	9	for	for	ADP
aiua-2211	78	10	the	the	DET
aiua-2211	78	11	three	three	NUM
aiua-2211	78	12	adna	adna	PROPN
aiua-2211	78	13	markers	marker	NOUN
aiua-2211	78	14	.	.	PUNCT
aiua-2211	79	1	a	a	DET
aiua-2211	79	2	)	)	PUNCT
aiua-2211	79	3	group	group	NOUN
aiua-2211	79	4	i	i	PRON
aiua-2211	79	5	patients	patient	NOUN
aiua-2211	79	6	belong	belong	VERB
aiua-2211	79	7	to	to	ADP
aiua-2211	79	8	stage	stage	NOUN
aiua-2211	79	9	iv	iv	NUM
aiua-2211	79	10	of	of	ADP
aiua-2211	79	11	pca	pca	NOUN
aiua-2211	79	12	disease	disease	NOUN
aiua-2211	79	13	,	,	PUNCT
aiua-2211	79	14	as	as	SCONJ
aiua-2211	79	15	reported	report	VERB
aiua-2211	79	16	in	in	ADP
aiua-2211	79	17	tnm	tnm	PROPN
aiua-2211	79	18	classification	classification	NOUN
aiua-2211	79	19	of	of	ADP
aiua-2211	79	20	malignant	malignant	ADJ
aiua-2211	79	21	tumors	tumor	NOUN
aiua-2211	79	22	.	.	PUNCT
aiua-2211	80	1	uicc	uicc	ADJ
aiua-2211	80	2	international	international	PROPN
aiua-2211	80	3	union	union	NOUN
aiua-2211	80	4	against	against	ADP
aiua-2211	80	5	cancer	cancer	NOUN
aiua-2211	80	6	.	.	PUNCT
aiua-2211	81	1	7th	7th	ADJ
aiua-2211	81	2	edn	edn	PROPN
aiua-2211	81	3	,	,	PUNCT
aiua-2211	81	4	2009	2009	NUM
aiua-2211	81	5	(	(	PUNCT
aiua-2211	81	6	ref	ref	NOUN
aiua-2211	81	7	.	.	NOUN
aiua-2211	81	8	39	39	NUM
aiua-2211	81	9	)	)	PUNCT
aiua-2211	81	10	.	.	PUNCT
aiua-2211	82	1	b	b	X
aiua-2211	82	2	)	)	PUNCT
aiua-2211	82	3	as	as	SCONJ
aiua-2211	82	4	reported	report	VERB
aiua-2211	82	5	in	in	ADP
aiua-2211	82	6	the	the	DET
aiua-2211	82	7	text	text	NOUN
aiua-2211	82	8	,	,	PUNCT
aiua-2211	82	9	group	group	NOUN
aiua-2211	82	10	ii	ii	PROPN
aiua-2211	82	11	patients	patient	NOUN
aiua-2211	82	12	includes	include	VERB
aiua-2211	82	13	low	low	ADJ
aiua-2211	82	14	-	-	PUNCT
aiua-2211	82	15	risk	risk	NOUN
aiua-2211	82	16	progression	progression	NOUN
aiua-2211	82	17	pca	pca	NOUN
aiua-2211	82	18	individuals	individual	NOUN
aiua-2211	82	19	,	,	PUNCT
aiua-2211	82	20	as	as	SCONJ
aiua-2211	82	21	indicated	indicate	VERB
aiua-2211	82	22	in	in	ADP
aiua-2211	82	23	the	the	DET
aiua-2211	82	24	reference	reference	NOUN
aiua-2211	82	25	(	(	PUNCT
aiua-2211	82	26	25	25	NUM
aiua-2211	82	27	)	)	PUNCT
aiua-2211	82	28	.	.	PUNCT
aiua-2211	83	1	*	*	PUNCT
aiua-2211	83	2	patient	patient	ADJ
aiua-2211	83	3	n.	n.	NOUN
aiua-2211	83	4	2	2	NUM
aiua-2211	83	5	was	be	AUX
aiua-2211	83	6	firstly	firstly	ADV
aiua-2211	83	7	negative	negative	ADJ
aiua-2211	83	8	at	at	ADP
aiua-2211	83	9	the	the	DET
aiua-2211	83	10	adnagene	adnagene	ADJ
aiua-2211	83	11	test	test	NOUN
aiua-2211	83	12	,	,	PUNCT
aiua-2211	83	13	but	but	CCONJ
aiua-2211	83	14	five	five	NUM
aiua-2211	83	15	month	month	NOUN
aiua-2211	83	16	later	later	ADV
aiua-2211	83	17	(	(	PUNCT
aiua-2211	83	18	following	follow	VERB
aiua-2211	83	19	the	the	DET
aiua-2211	83	20	disease	disease	NOUN
aiua-2211	83	21	progression	progression	NOUN
aiua-2211	83	22	)	)	PUNCT
aiua-2211	83	23	resulted	result	VERB
aiua-2211	83	24	as	as	ADP
aiua-2211	83	25	positive	positive	ADJ
aiua-2211	83	26	.	.	PUNCT
aiua-2211	84	1	167archivio	167archivio	NUM
aiua-2211	84	2	italiano	italiano	NOUN
aiua-2211	84	3	di	di	X
aiua-2211	84	4	urologia	urologia	PROPN
aiua-2211	84	5	e	e	PROPN
aiua-2211	84	6	andrologia	andrologia	NOUN
aiua-2211	84	7	2013	2013	NUM
aiua-2211	84	8	;	;	PUNCT
aiua-2211	84	9	85	85	NUM
aiua-2211	84	10	,	,	PUNCT
aiua-2211	84	11	4	4	NUM
aiua-2211	84	12	potential	potential	ADJ
aiua-2211	84	13	usefulness	usefulness	NOUN
aiua-2211	84	14	of	of	ADP
aiua-2211	84	15	ctc	ctc	NOUN
aiua-2211	84	16	detection	detection	NOUN
aiua-2211	84	17	in	in	ADP
aiua-2211	84	18	follow	follow	NOUN
aiua-2211	84	19	up	up	ADP
aiua-2211	84	20	of	of	ADP
aiua-2211	84	21	prostate	prostate	NOUN
aiua-2211	84	22	cancer	cancer	NOUN
aiua-2211	84	23	patients	patient	NOUN
aiua-2211	84	24	.	.	PUNCT
aiua-2211	85	1	a	a	DET
aiua-2211	85	2	preliminary	preliminary	ADJ
aiua-2211	85	3	report	report	NOUN
aiua-2211	85	4	obtained	obtain	VERB
aiua-2211	85	5	by	by	ADP
aiua-2211	85	6	using	use	VERB
aiua-2211	85	7	adnagene	adnagene	ADJ
aiua-2211	85	8	platform	platform	NOUN
aiua-2211	85	9	has	have	AUX
aiua-2211	85	10	confirmed	confirm	VERB
aiua-2211	85	11	the	the	DET
aiua-2211	85	12	disease	disease	NOUN
aiua-2211	85	13	status	status	NOUN
aiua-2211	85	14	;	;	PUNCT
aiua-2211	85	15	under	under	ADP
aiua-2211	85	16	strict	strict	ADJ
aiua-2211	85	17	radiological	radiological	ADJ
aiua-2211	85	18	follow	follow	NOUN
aiua-2211	85	19	up	up	ADP
aiua-2211	85	20	,	,	PUNCT
aiua-2211	85	21	at	at	ADP
aiua-2211	85	22	distance	distance	NOUN
aiua-2211	85	23	metastases	metastasis	NOUN
aiua-2211	85	24	became	become	VERB
aiua-2211	85	25	evident	evident	ADJ
aiua-2211	85	26	three	three	NUM
aiua-2211	85	27	months	month	NOUN
aiua-2211	85	28	later	later	ADV
aiua-2211	85	29	the	the	DET
aiua-2211	85	30	molecular	molecular	ADJ
aiua-2211	85	31	test	test	NOUN
aiua-2211	85	32	resulted	result	VERB
aiua-2211	85	33	positive	positive	ADJ
aiua-2211	85	34	.	.	PUNCT
aiua-2211	86	1	patient	patient	ADJ
aiua-2211	86	2	n.	n.	NOUN
aiua-2211	86	3	3	3	NUM
aiua-2211	86	4	:	:	PUNCT
aiua-2211	86	5	the	the	DET
aiua-2211	86	6	test	test	NOUN
aiua-2211	86	7	confirmed	confirm	VERB
aiua-2211	86	8	the	the	DET
aiua-2211	86	9	efficacy	efficacy	NOUN
aiua-2211	86	10	of	of	ADP
aiua-2211	86	11	enlarged	enlarged	ADJ
aiua-2211	86	12	radiotherapy	radiotherapy	NOUN
aiua-2211	86	13	;	;	PUNCT
aiua-2211	86	14	patient	patient	ADJ
aiua-2211	86	15	n.	n.	NOUN
aiua-2211	86	16	4	4	NUM
aiua-2211	86	17	:	:	PUNCT
aiua-2211	86	18	after	after	ADP
aiua-2211	86	19	lymphadenectomy	lymphadenectomy	NOUN
aiua-2211	86	20	,	,	PUNCT
aiua-2211	86	21	positive	positive	ADJ
aiua-2211	86	22	obturator	obturator	NOUN
aiua-2211	86	23	lymph	lymph	NOUN
aiua-2211	86	24	nodes	node	NOUN
aiua-2211	86	25	were	be	AUX
aiua-2211	86	26	found	find	VERB
aiua-2211	86	27	at	at	ADP
aiua-2211	86	28	the	the	DET
aiua-2211	86	29	extemporary	extemporary	NOUN
aiua-2211	86	30	frozen	frozen	ADJ
aiua-2211	86	31	histological	histological	ADJ
aiua-2211	86	32	section	section	NOUN
aiua-2211	86	33	:	:	PUNCT
aiua-2211	86	34	therefore	therefore	ADV
aiua-2211	86	35	radical	radical	ADJ
aiua-2211	86	36	prostatectomy	prostatectomy	NOUN
aiua-2211	86	37	was	be	AUX
aiua-2211	86	38	not	not	PART
aiua-2211	86	39	performed	perform	VERB
aiua-2211	86	40	but	but	CCONJ
aiua-2211	86	41	enlarged	enlarged	ADJ
aiua-2211	86	42	radiotherapy	radiotherapy	NOUN
aiua-2211	86	43	and	and	CCONJ
aiua-2211	86	44	total	total	ADJ
aiua-2211	86	45	androgen	androgen	NOUN
aiua-2211	86	46	blockade	blockade	NOUN
aiua-2211	86	47	were	be	AUX
aiua-2211	86	48	administered	administer	VERB
aiua-2211	86	49	.	.	PUNCT
aiua-2211	87	1	since	since	SCONJ
aiua-2211	87	2	patient	patient	NOUN
aiua-2211	87	3	has	have	AUX
aiua-2211	87	4	become	become	VERB
aiua-2211	87	5	refractory	refractory	NOUN
aiua-2211	87	6	to	to	ADP
aiua-2211	87	7	total	total	VERB
aiua-2211	87	8	androgen	androgen	NOUN
aiua-2211	87	9	blockade	blockade	NOUN
aiua-2211	87	10	,	,	PUNCT
aiua-2211	87	11	an	an	DET
aiua-2211	87	12	“	"	PUNCT
aiua-2211	87	13	anti	anti	ADJ
aiua-2211	87	14	-	-	ADJ
aiua-2211	87	15	androgen	androgen	ADJ
aiua-2211	87	16	withdrawal	withdrawal	NOUN
aiua-2211	87	17	”	"	PUNCT
aiua-2211	87	18	was	be	AUX
aiua-2211	87	19	started	start	VERB
aiua-2211	87	20	;	;	PUNCT
aiua-2211	87	21	patient	patient	ADJ
aiua-2211	87	22	n.	n.	NOUN
aiua-2211	87	23	5	5	NUM
aiua-2211	87	24	:	:	PUNCT
aiua-2211	87	25	adnatest	adnate	ADJ
aiua-2211	87	26	confirmed	confirm	VERB
aiua-2211	87	27	the	the	DET
aiua-2211	87	28	efficacy	efficacy	NOUN
aiua-2211	87	29	of	of	ADP
aiua-2211	87	30	adjuvant	adjuvant	ADJ
aiua-2211	87	31	postoperative	postoperative	PROPN
aiua-2211	87	32	rt	rt	PROPN
aiua-2211	87	33	;	;	PUNCT
aiua-2211	87	34	patient	patient	ADJ
aiua-2211	87	35	n.	n.	NOUN
aiua-2211	87	36	6	6	NUM
aiua-2211	87	37	:	:	PUNCT
aiua-2211	87	38	he	he	PRON
aiua-2211	87	39	is	be	AUX
aiua-2211	87	40	currently	currently	ADV
aiua-2211	87	41	under	under	ADP
aiua-2211	87	42	chemotherapy	chemotherapy	NOUN
aiua-2211	87	43	treatment	treatment	NOUN
aiua-2211	87	44	because	because	SCONJ
aiua-2211	87	45	of	of	ADP
aiua-2211	87	46	the	the	DET
aiua-2211	87	47	resistance	resistance	NOUN
aiua-2211	87	48	also	also	ADV
aiua-2211	87	49	to	to	ADP
aiua-2211	87	50	second	second	ADJ
aiua-2211	87	51	-	-	PUNCT
aiua-2211	87	52	line	line	NOUN
aiua-2211	87	53	hormonal	hormonal	ADJ
aiua-2211	87	54	therapy	therapy	NOUN
aiua-2211	87	55	patient	patient	NOUN
aiua-2211	87	56	n.	n.	NOUN
aiua-2211	87	57	7	7	NUM
aiua-2211	87	58	:	:	PUNCT
aiua-2211	87	59	he	he	PRON
aiua-2211	87	60	is	be	AUX
aiua-2211	87	61	no	no	ADV
aiua-2211	87	62	longer	long	ADV
aiua-2211	87	63	responsive	responsive	ADJ
aiua-2211	87	64	to	to	ADP
aiua-2211	87	65	chemotherapy	chemotherapy	NOUN
aiua-2211	87	66	since	since	SCONJ
aiua-2211	87	67	he	he	PRON
aiua-2211	87	68	showing	show	VERB
aiua-2211	87	69	constant	constant	ADJ
aiua-2211	87	70	disease	disease	NOUN
aiua-2211	87	71	progression	progression	NOUN
aiua-2211	87	72	;	;	PUNCT
aiua-2211	87	73	patient	patient	ADJ
aiua-2211	87	74	n.	n.	NOUN
aiua-2211	87	75	12	12	NUM
aiua-2211	87	76	:	:	PUNCT
aiua-2211	87	77	despite	despite	SCONJ
aiua-2211	87	78	a	a	DET
aiua-2211	87	79	psa	psa	NOUN
aiua-2211	87	80	increase	increase	NOUN
aiua-2211	87	81	was	be	AUX
aiua-2211	87	82	registered	register	VERB
aiua-2211	87	83	,	,	PUNCT
aiua-2211	87	84	disease	disease	NOUN
aiua-2211	87	85	progression	progression	NOUN
aiua-2211	87	86	is	be	AUX
aiua-2211	87	87	not	not	PART
aiua-2211	87	88	yet	yet	ADV
aiua-2211	87	89	evident	evident	ADJ
aiua-2211	87	90	.	.	PUNCT
aiua-2211	88	1	since	since	SCONJ
aiua-2211	88	2	adnatest	adnate	ADJ
aiua-2211	88	3	negative	negative	ADJ
aiua-2211	88	4	,	,	PUNCT
aiua-2211	88	5	a	a	DET
aiua-2211	88	6	strict	strict	ADJ
aiua-2211	88	7	monitoring	monitoring	NOUN
aiua-2211	88	8	of	of	ADP
aiua-2211	88	9	psa	psa	NOUN
aiua-2211	88	10	and	and	CCONJ
aiua-2211	88	11	ctcs	ctcs	PROPN
aiua-2211	88	12	overtime	overtime	NOUN
aiua-2211	88	13	has	have	AUX
aiua-2211	88	14	been	be	AUX
aiua-2211	88	15	planned	plan	VERB
aiua-2211	88	16	.	.	PUNCT
aiua-2211	89	1	patient	patient	ADJ
aiua-2211	89	2	n.	n.	PROPN
aiua-2211	89	3	13	13	NUM
aiua-2211	89	4	:	:	PUNCT
aiua-2211	89	5	adnatest	adnate	ADJ
aiua-2211	89	6	confirmed	confirm	VERB
aiua-2211	89	7	the	the	DET
aiua-2211	89	8	good	good	ADJ
aiua-2211	89	9	compliance	compliance	NOUN
aiua-2211	89	10	associated	associate	VERB
aiua-2211	89	11	to	to	ADP
aiua-2211	89	12	anti	anti	ADJ
aiua-2211	89	13	-	-	ADJ
aiua-2211	89	14	androgen	androgen	ADJ
aiua-2211	89	15	therapy	therapy	NOUN
aiua-2211	89	16	suspension	suspension	NOUN
aiua-2211	89	17	after	after	ADP
aiua-2211	89	18	radiotherapy	radiotherapy	NOUN
aiua-2211	89	19	;	;	PUNCT
aiua-2211	89	20	patient	patient	ADJ
aiua-2211	89	21	n.	n.	NOUN
aiua-2211	89	22	14	14	NUM
aiua-2211	89	23	:	:	PUNCT
aiua-2211	89	24	adnatest	adnate	ADJ
aiua-2211	89	25	supported	support	VERB
aiua-2211	89	26	the	the	DET
aiua-2211	89	27	efficacy	efficacy	NOUN
aiua-2211	89	28	of	of	ADP
aiua-2211	89	29	adjuvant	adjuvant	ADJ
aiua-2211	89	30	radiotherapy	radiotherapy	NOUN
aiua-2211	89	31	after	after	ADP
aiua-2211	89	32	surgery	surgery	NOUN
aiua-2211	89	33	;	;	PUNCT
aiua-2211	89	34	patient	patient	ADJ
aiua-2211	89	35	n.	n.	NOUN
aiua-2211	89	36	16	16	NUM
aiua-2211	89	37	:	:	PUNCT
aiua-2211	89	38	(	(	PUNCT
aiua-2211	89	39	group	group	NOUN
aiua-2211	89	40	ii	ii	PROPN
aiua-2211	89	41	)	)	PUNCT
aiua-2211	89	42	.	.	PUNCT
aiua-2211	90	1	adnatest	adnate	ADJ
aiua-2211	90	2	,	,	PUNCT
aiua-2211	90	3	performed	perform	VERB
aiua-2211	90	4	before	before	ADP
aiua-2211	90	5	surgery	surgery	NOUN
aiua-2211	90	6	,	,	PUNCT
aiua-2211	90	7	confirmed	confirm	VERB
aiua-2211	90	8	the	the	DET
aiua-2211	90	9	preoperative	preoperative	NOUN
aiua-2211	90	10	staging	staging	NOUN
aiua-2211	90	11	(	(	PUNCT
aiua-2211	90	12	definitive	definitive	ADJ
aiua-2211	90	13	histological	histological	ADJ
aiua-2211	90	14	examination	examination	NOUN
aiua-2211	90	15	:	:	PUNCT
aiua-2211	90	16	pt2b	pt2b	PROPN
aiua-2211	90	17	r0	r0	PROPN
aiua-2211	90	18	n0	n0	NUM
aiua-2211	90	19	)	)	PUNCT
aiua-2211	90	20	.	.	PUNCT
aiua-2211	91	1	we	we	PRON
aiua-2211	91	2	underline	underline	VERB
aiua-2211	91	3	that	that	SCONJ
aiua-2211	91	4	patients	patient	NOUN
aiua-2211	91	5	who	who	PRON
aiua-2211	91	6	responded	respond	VERB
aiua-2211	91	7	to	to	ADP
aiua-2211	91	8	the	the	DET
aiua-2211	91	9	therapies	therapy	NOUN
aiua-2211	91	10	listed	list	VERB
aiua-2211	91	11	in	in	ADP
aiua-2211	91	12	table	table	NOUN
aiua-2211	91	13	2	2	NUM
aiua-2211	91	14	were	be	AUX
aiua-2211	91	15	always	always	ADV
aiua-2211	91	16	negative	negative	ADJ
aiua-2211	91	17	for	for	ADP
aiua-2211	91	18	adna	adna	NOUN
aiua-2211	91	19	markers	marker	NOUN
aiua-2211	91	20	,	,	PUNCT
aiua-2211	91	21	while	while	SCONJ
aiua-2211	91	22	the	the	DET
aiua-2211	91	23	non	non	ADJ
aiua-2211	91	24	-	-	ADJ
aiua-2211	91	25	responder	responder	NOUN
aiua-2211	91	26	resulted	result	VERB
aiua-2211	91	27	as	as	ADP
aiua-2211	91	28	positive	positive	ADJ
aiua-2211	91	29	for	for	ADP
aiua-2211	91	30	both	both	PRON
aiua-2211	91	31	serum	serum	NOUN
aiua-2211	91	32	psa	psa	NOUN
aiua-2211	91	33	increases	increase	NOUN
aiua-2211	91	34	and	and	CCONJ
aiua-2211	91	35	prostate	prostate	NOUN
aiua-2211	91	36	ctc	ctc	PROPN
aiua-2211	91	37	markers	marker	NOUN
aiua-2211	91	38	.	.	PUNCT
aiua-2211	92	1	discussion	discussion	NOUN
aiua-2211	92	2	several	several	ADJ
aiua-2211	92	3	reports	report	NOUN
aiua-2211	92	4	showed	show	VERB
aiua-2211	92	5	that	that	SCONJ
aiua-2211	92	6	circulating	circulate	VERB
aiua-2211	92	7	tumor	tumor	NOUN
aiua-2211	92	8	cell	cell	NOUN
aiua-2211	92	9	counts	count	NOUN
aiua-2211	92	10	correlate	correlate	VERB
aiua-2211	92	11	with	with	ADP
aiua-2211	92	12	prognosis	prognosis	NOUN
aiua-2211	92	13	in	in	ADP
aiua-2211	92	14	patients	patient	NOUN
aiua-2211	92	15	with	with	ADP
aiua-2211	92	16	advanced	advanced	ADJ
aiua-2211	92	17	breast	breast	NOUN
aiua-2211	92	18	,	,	PUNCT
aiua-2211	92	19	prostate	prostate	NOUN
aiua-2211	92	20	and	and	CCONJ
aiua-2211	92	21	colorectal	colorectal	ADJ
aiua-2211	92	22	cancers	cancer	NOUN
aiua-2211	92	23	,	,	PUNCT
aiua-2211	92	24	treated	treat	VERB
aiua-2211	92	25	by	by	ADP
aiua-2211	92	26	conventional	conventional	ADJ
aiua-2211	92	27	and/or	and/or	CCONJ
aiua-2211	92	28	hormonal	hormonal	ADJ
aiua-2211	92	29	therapy	therapy	NOUN
aiua-2211	92	30	,	,	PUNCT
aiua-2211	92	31	suggesting	suggest	VERB
aiua-2211	92	32	the	the	DET
aiua-2211	92	33	use	use	NOUN
aiua-2211	92	34	of	of	ADP
aiua-2211	92	35	ctcs	ctcs	NOUN
aiua-2211	92	36	in	in	ADP
aiua-2211	92	37	the	the	DET
aiua-2211	92	38	clinical	clinical	ADJ
aiua-2211	92	39	management	management	NOUN
aiua-2211	92	40	of	of	ADP
aiua-2211	92	41	cancer	cancer	NOUN
aiua-2211	92	42	patients	patient	NOUN
aiua-2211	92	43	(	(	PUNCT
aiua-2211	92	44	18	18	NUM
aiua-2211	92	45	,	,	PUNCT
aiua-2211	92	46	27	27	NUM
aiua-2211	92	47	,	,	PUNCT
aiua-2211	92	48	28	28	NUM
aiua-2211	92	49	)	)	PUNCT
aiua-2211	92	50	.	.	PUNCT
aiua-2211	93	1	furthermore	furthermore	ADV
aiua-2211	93	2	,	,	PUNCT
aiua-2211	93	3	for	for	ADP
aiua-2211	93	4	prognostic	prognostic	ADJ
aiua-2211	93	5	and	and	CCONJ
aiua-2211	93	6	predictive	predictive	ADJ
aiua-2211	93	7	purposes	purpose	NOUN
aiua-2211	93	8	,	,	PUNCT
aiua-2211	93	9	ctcs	ctcs	ADJ
aiua-2211	93	10	detection	detection	NOUN
aiua-2211	93	11	,	,	PUNCT
aiua-2211	93	12	when	when	SCONJ
aiua-2211	93	13	coupled	couple	VERB
aiua-2211	93	14	to	to	ADP
aiua-2211	93	15	molecular	molecular	ADJ
aiua-2211	93	16	characterisation	characterisation	NOUN
aiua-2211	93	17	of	of	ADP
aiua-2211	93	18	specific	specific	ADJ
aiua-2211	93	19	cell	cell	NOUN
aiua-2211	93	20	transcripts	transcript	NOUN
aiua-2211	93	21	or	or	CCONJ
aiua-2211	93	22	biomarkers	biomarker	NOUN
aiua-2211	93	23	,	,	PUNCT
aiua-2211	93	24	could	could	AUX
aiua-2211	93	25	provide	provide	VERB
aiua-2211	93	26	important	important	ADJ
aiua-2211	93	27	clinical	clinical	ADJ
aiua-2211	93	28	information	information	NOUN
aiua-2211	93	29	in	in	ADP
aiua-2211	93	30	terms	term	NOUN
aiua-2211	93	31	of	of	ADP
aiua-2211	93	32	monitoring	monitoring	NOUN
aiua-2211	93	33	of	of	ADP
aiua-2211	93	34	efficacy	efficacy	NOUN
aiua-2211	93	35	or	or	CCONJ
aiua-2211	93	36	resistance	resistance	NOUN
aiua-2211	93	37	to	to	ADP
aiua-2211	93	38	targeted	target	VERB
aiua-2211	93	39	therapy	therapy	NOUN
aiua-2211	93	40	:	:	PUNCT
aiua-2211	93	41	in	in	ADP
aiua-2211	93	42	this	this	DET
aiua-2211	93	43	way	way	NOUN
aiua-2211	93	44	,	,	PUNCT
aiua-2211	93	45	ctcs	ctcs	PROPN
aiua-2211	93	46	represent	represent	VERB
aiua-2211	93	47	an	an	DET
aiua-2211	93	48	accurate	accurate	ADJ
aiua-2211	93	49	laboratory	laboratory	NOUN
aiua-2211	93	50	clinical	clinical	ADJ
aiua-2211	93	51	tool	tool	NOUN
aiua-2211	93	52	for	for	ADP
aiua-2211	93	53	predicting	predict	VERB
aiua-2211	93	54	patient	patient	NOUN
aiua-2211	93	55	’s	’s	PART
aiua-2211	93	56	outcome	outcome	NOUN
aiua-2211	93	57	also	also	ADV
aiua-2211	93	58	in	in	ADP
aiua-2211	93	59	prostate	prostate	NOUN
aiua-2211	93	60	cancer	cancer	NOUN
aiua-2211	93	61	and	and	CCONJ
aiua-2211	93	62	providing	provide	VERB
aiua-2211	93	63	significant	significant	ADJ
aiua-2211	93	64	advantages	advantage	NOUN
aiua-2211	93	65	in	in	ADP
aiua-2211	93	66	the	the	DET
aiua-2211	93	67	view	view	NOUN
aiua-2211	93	68	of	of	ADP
aiua-2211	93	69	personalised	personalised	ADJ
aiua-2211	93	70	medicine	medicine	NOUN
aiua-2211	93	71	(	(	PUNCT
aiua-2211	93	72	29	29	NUM
aiua-2211	93	73	)	)	PUNCT
aiua-2211	93	74	.	.	PUNCT
aiua-2211	94	1	over	over	ADP
aiua-2211	94	2	the	the	DET
aiua-2211	94	3	past	past	ADJ
aiua-2211	94	4	few	few	ADJ
aiua-2211	94	5	years	year	NOUN
aiua-2211	94	6	,	,	PUNCT
aiua-2211	94	7	different	different	ADJ
aiua-2211	94	8	approaches	approach	NOUN
aiua-2211	94	9	for	for	ADP
aiua-2211	94	10	enrichment	enrichment	NOUN
aiua-2211	94	11	of	of	ADP
aiua-2211	94	12	ctcs	ctcs	NOUN
aiua-2211	94	13	in	in	ADP
aiua-2211	94	14	blood	blood	NOUN
aiua-2211	94	15	have	have	AUX
aiua-2211	94	16	been	be	AUX
aiua-2211	94	17	developed	develop	VERB
aiua-2211	94	18	(	(	PUNCT
aiua-2211	94	19	5	5	NUM
aiua-2211	94	20	,	,	PUNCT
aiua-2211	94	21	30	30	NUM
aiua-2211	94	22	-	-	SYM
aiua-2211	94	23	33	33	NUM
aiua-2211	94	24	)	)	PUNCT
aiua-2211	94	25	,	,	PUNCT
aiua-2211	94	26	associated	associate	VERB
aiua-2211	94	27	or	or	CCONJ
aiua-2211	94	28	not	not	PART
aiua-2211	94	29	to	to	PART
aiua-2211	94	30	molecular	molecular	ADJ
aiua-2211	94	31	approaches	approach	NOUN
aiua-2211	94	32	and/or	and/or	CCONJ
aiua-2211	94	33	to	to	ADP
aiua-2211	94	34	immunological	immunological	ADJ
aiua-2211	94	35	characterization	characterization	NOUN
aiua-2211	94	36	,	,	PUNCT
aiua-2211	94	37	respectively	respectively	ADV
aiua-2211	94	38	(	(	PUNCT
aiua-2211	94	39	34	34	NUM
aiua-2211	94	40	-	-	SYM
aiua-2211	94	41	35	35	NUM
aiua-2211	94	42	)	)	PUNCT
aiua-2211	94	43	.	.	PUNCT
aiua-2211	95	1	the	the	DET
aiua-2211	95	2	present	present	ADJ
aiua-2211	95	3	preliminary	preliminary	ADJ
aiua-2211	95	4	study	study	NOUN
aiua-2211	95	5	was	be	AUX
aiua-2211	95	6	aimed	aim	VERB
aiua-2211	95	7	to	to	PART
aiua-2211	95	8	assess	assess	VERB
aiua-2211	95	9	the	the	DET
aiua-2211	95	10	usefulness	usefulness	NOUN
aiua-2211	95	11	of	of	ADP
aiua-2211	95	12	adnatest	adnate	ADJ
aiua-2211	95	13	prostate	prostate	NOUN
aiua-2211	95	14	cancer	cancer	NOUN
aiua-2211	95	15	for	for	ADP
aiua-2211	95	16	detection	detection	NOUN
aiua-2211	95	17	of	of	ADP
aiua-2211	95	18	ctcs	ctcs	NOUN
aiua-2211	95	19	in	in	ADP
aiua-2211	95	20	two	two	NUM
aiua-2211	95	21	groups	group	NOUN
aiua-2211	95	22	of	of	ADP
aiua-2211	95	23	pca	pca	NOUN
aiua-2211	95	24	patients	patient	NOUN
aiua-2211	95	25	(	(	PUNCT
aiua-2211	95	26	with	with	ADP
aiua-2211	95	27	low	low	ADJ
aiua-2211	95	28	and	and	CCONJ
aiua-2211	95	29	high	high	ADJ
aiua-2211	95	30	risk	risk	NOUN
aiua-2211	95	31	)	)	PUNCT
aiua-2211	95	32	as	as	SCONJ
aiua-2211	95	33	compared	compare	VERB
aiua-2211	95	34	to	to	ADP
aiua-2211	95	35	non	non	PROPN
aiua-2211	95	36	pca	pca	PROPN
aiua-2211	95	37	individuals	individual	NOUN
aiua-2211	95	38	,	,	PUNCT
aiua-2211	95	39	in	in	ADP
aiua-2211	95	40	order	order	NOUN
aiua-2211	95	41	to	to	PART
aiua-2211	95	42	establish	establish	VERB
aiua-2211	95	43	if	if	SCONJ
aiua-2211	95	44	the	the	DET
aiua-2211	95	45	molecular	molecular	ADJ
aiua-2211	95	46	result	result	NOUN
aiua-2211	95	47	given	give	VERB
aiua-2211	95	48	by	by	ADP
aiua-2211	95	49	this	this	DET
aiua-2211	95	50	assay	assay	NOUN
aiua-2211	95	51	could	could	AUX
aiua-2211	95	52	be	be	AUX
aiua-2211	95	53	helpful	helpful	ADJ
aiua-2211	95	54	for	for	ADP
aiua-2211	95	55	the	the	DET
aiua-2211	95	56	clinical	clinical	ADJ
aiua-2211	95	57	and	and	CCONJ
aiua-2211	95	58	drug	drug	NOUN
aiua-2211	95	59	management	management	NOUN
aiua-2211	95	60	of	of	ADP
aiua-2211	95	61	pca	pca	NOUN
aiua-2211	95	62	patients	patient	NOUN
aiua-2211	95	63	.	.	PUNCT
aiua-2211	96	1	this	this	DET
aiua-2211	96	2	test	test	NOUN
aiua-2211	96	3	is	be	AUX
aiua-2211	96	4	,	,	PUNCT
aiua-2211	96	5	in	in	ADP
aiua-2211	96	6	fact	fact	NOUN
aiua-2211	96	7	,	,	PUNCT
aiua-2211	96	8	able	able	ADJ
aiua-2211	96	9	to	to	PART
aiua-2211	96	10	detect	detect	VERB
aiua-2211	96	11	some	some	DET
aiua-2211	96	12	prostate	prostate	NOUN
aiua-2211	96	13	or	or	CCONJ
aiua-2211	96	14	cancer	cancer	NOUN
aiua-2211	96	15	-	-	PUNCT
aiua-2211	96	16	specific	specific	ADJ
aiua-2211	96	17	markers	marker	NOUN
aiua-2211	96	18	such	such	ADJ
aiua-2211	96	19	as	as	ADP
aiua-2211	96	20	psa	psa	NOUN
aiua-2211	96	21	,	,	PUNCT
aiua-2211	96	22	psma	psma	NOUN
aiua-2211	96	23	and	and	CCONJ
aiua-2211	96	24	egfr	egfr	NOUN
aiua-2211	96	25	(	(	PUNCT
aiua-2211	96	26	23	23	NUM
aiua-2211	96	27	,	,	PUNCT
aiua-2211	96	28	24	24	NUM
aiua-2211	96	29	)	)	PUNCT
aiua-2211	96	30	.	.	PUNCT
aiua-2211	97	1	in	in	ADP
aiua-2211	97	2	our	our	PRON
aiua-2211	97	3	study	study	NOUN
aiua-2211	97	4	we	we	PRON
aiua-2211	97	5	found	find	VERB
aiua-2211	97	6	that	that	SCONJ
aiua-2211	97	7	adnatest	adnate	ADJ
aiua-2211	97	8	:	:	PUNCT
aiua-2211	97	9	a	a	X
aiua-2211	97	10	)	)	PUNCT
aiua-2211	97	11	identified	identify	VERB
aiua-2211	97	12	patients	patient	NOUN
aiua-2211	97	13	with	with	ADP
aiua-2211	97	14	disease	disease	NOUN
aiua-2211	97	15	progression	progression	NOUN
aiua-2211	97	16	or	or	CCONJ
aiua-2211	97	17	with	with	ADP
aiua-2211	97	18	biochemical	biochemical	ADJ
aiua-2211	97	19	relapse	relapse	NOUN
aiua-2211	97	20	;	;	PUNCT
aiua-2211	97	21	b	b	X
aiua-2211	97	22	)	)	PUNCT
aiua-2211	97	23	confirmed	confirm	VERB
aiua-2211	97	24	the	the	DET
aiua-2211	97	25	clinical	clinical	ADJ
aiua-2211	97	26	staging	staging	NOUN
aiua-2211	97	27	of	of	ADP
aiua-2211	97	28	patient	patient	NOUN
aiua-2211	97	29	n.1	n.1	NOUN
aiua-2211	97	30	,	,	PUNCT
aiua-2211	97	31	who	who	PRON
aiua-2211	97	32	showed	show	VERB
aiua-2211	97	33	biologically	biologically	ADV
aiua-2211	97	34	aggressive	aggressive	ADJ
aiua-2211	97	35	disease	disease	NOUN
aiua-2211	97	36	(	(	PUNCT
aiua-2211	97	37	gs	gs	INTJ
aiua-2211	97	38	10	10	NUM
aiua-2211	97	39	)	)	PUNCT
aiua-2211	97	40	and	and	CCONJ
aiua-2211	97	41	biochemical	biochemical	ADJ
aiua-2211	97	42	tumor	tumor	NOUN
aiua-2211	97	43	progression	progression	NOUN
aiua-2211	97	44	in	in	ADP
aiua-2211	97	45	spite	spite	NOUN
aiua-2211	97	46	of	of	ADP
aiua-2211	97	47	total	total	ADJ
aiua-2211	97	48	androgen	androgen	NOUN
aiua-2211	97	49	blockade	blockade	NOUN
aiua-2211	97	50	or	or	CCONJ
aiua-2211	97	51	combined	combine	VERB
aiua-2211	97	52	androgen	androgen	NOUN
aiua-2211	97	53	blockade	blockade	NOUN
aiua-2211	97	54	;	;	PUNCT
aiua-2211	97	55	c	c	X
aiua-2211	97	56	)	)	PUNCT
aiua-2211	97	57	likewise	likewise	ADV
aiua-2211	97	58	,	,	PUNCT
aiua-2211	97	59	in	in	ADP
aiua-2211	97	60	patient	patient	ADJ
aiua-2211	97	61	n.	n.	NOUN
aiua-2211	97	62	2	2	NUM
aiua-2211	97	63	,	,	PUNCT
aiua-2211	97	64	molecular	molecular	ADJ
aiua-2211	97	65	test	test	NOUN
aiua-2211	97	66	agreed	agree	VERB
aiua-2211	97	67	firstly	firstly	ADV
aiua-2211	97	68	with	with	ADP
aiua-2211	97	69	the	the	DET
aiua-2211	97	70	efficacy	efficacy	NOUN
aiua-2211	97	71	of	of	ADP
aiua-2211	97	72	chemotherapy	chemotherapy	NOUN
aiua-2211	97	73	,	,	PUNCT
aiua-2211	97	74	due	due	ADP
aiua-2211	97	75	to	to	ADP
aiua-2211	97	76	the	the	DET
aiua-2211	97	77	blood	blood	NOUN
aiua-2211	97	78	negativity	negativity	NOUN
aiua-2211	97	79	for	for	ADP
aiua-2211	97	80	adnatest	adnate	ADJ
aiua-2211	97	81	during	during	ADP
aiua-2211	97	82	the	the	DET
aiua-2211	97	83	first	first	ADJ
aiua-2211	97	84	line	line	NOUN
aiua-2211	97	85	of	of	ADP
aiua-2211	97	86	cht	cht	PROPN
aiua-2211	97	87	,	,	PUNCT
aiua-2211	97	88	while	while	SCONJ
aiua-2211	97	89	only	only	ADV
aiua-2211	97	90	five	five	NUM
aiua-2211	97	91	months	month	NOUN
aiua-2211	97	92	later	later	ADV
aiua-2211	97	93	adnatest	adnatest	ADV
aiua-2211	97	94	resulted	result	VERB
aiua-2211	97	95	as	as	ADP
aiua-2211	97	96	positive	positive	ADJ
aiua-2211	97	97	,	,	PUNCT
aiua-2211	97	98	anticipating	anticipate	VERB
aiua-2211	97	99	the	the	DET
aiua-2211	97	100	results	result	NOUN
aiua-2211	97	101	of	of	ADP
aiua-2211	97	102	radiological	radiological	ADJ
aiua-2211	97	103	examination	examination	NOUN
aiua-2211	97	104	(	(	PUNCT
aiua-2211	97	105	the	the	DET
aiua-2211	97	106	latter	latter	ADJ
aiua-2211	97	107	indicating	indicate	VERB
aiua-2211	97	108	at	at	ADP
aiua-2211	97	109	distance	distance	NOUN
aiua-2211	97	110	metastases	metastasis	NOUN
aiua-2211	97	111	only	only	ADV
aiua-2211	97	112	after	after	ADP
aiua-2211	97	113	three	three	NUM
aiua-2211	97	114	months	month	NOUN
aiua-2211	97	115	from	from	ADP
aiua-2211	97	116	the	the	DET
aiua-2211	97	117	evidence	evidence	NOUN
aiua-2211	97	118	of	of	ADP
aiua-2211	97	119	a	a	DET
aiua-2211	97	120	positive	positive	ADJ
aiua-2211	97	121	test	test	NOUN
aiua-2211	97	122	for	for	ADP
aiua-2211	97	123	ctcs	ctcs	NOUN
aiua-2211	97	124	)	)	PUNCT
aiua-2211	97	125	;	;	PUNCT
aiua-2211	97	126	d	d	X
aiua-2211	97	127	)	)	PUNCT
aiua-2211	97	128	adnatest	adnate	ADJ
aiua-2211	97	129	was	be	AUX
aiua-2211	97	130	an	an	DET
aiua-2211	97	131	useful	useful	ADJ
aiua-2211	97	132	predictive	predictive	ADJ
aiua-2211	97	133	indicator	indicator	NOUN
aiua-2211	97	134	for	for	ADP
aiua-2211	97	135	patient	patient	NOUN
aiua-2211	97	136	n.12	n.12	NOUN
aiua-2211	97	137	,	,	PUNCT
aiua-2211	97	138	who	who	PRON
aiua-2211	97	139	was	be	AUX
aiua-2211	97	140	no	no	PRON
aiua-2211	97	141	more	more	ADV
aiua-2211	97	142	responsive	responsive	ADJ
aiua-2211	97	143	to	to	ADP
aiua-2211	97	144	chemical	chemical	ADJ
aiua-2211	97	145	castration	castration	NOUN
aiua-2211	97	146	so	so	SCONJ
aiua-2211	97	147	that	that	SCONJ
aiua-2211	97	148	anti	anti	ADJ
aiua-2211	97	149	-	-	ADJ
aiua-2211	97	150	androgen	androgen	ADJ
aiua-2211	97	151	therapy	therapy	NOUN
aiua-2211	97	152	was	be	AUX
aiua-2211	97	153	currently	currently	ADV
aiua-2211	97	154	discontinued	discontinue	VERB
aiua-2211	97	155	.	.	PUNCT
aiua-2211	98	1	patients	patient	NOUN
aiua-2211	98	2	enrolled	enrol	VERB
aiua-2211	98	3	in	in	ADP
aiua-2211	98	4	the	the	DET
aiua-2211	98	5	present	present	ADJ
aiua-2211	98	6	study	study	NOUN
aiua-2211	98	7	are	be	AUX
aiua-2211	98	8	now	now	ADV
aiua-2211	98	9	under	under	ADP
aiua-2211	98	10	stringent	stringent	ADJ
aiua-2211	98	11	follow	follow	NOUN
aiua-2211	98	12	-	-	PUNCT
aiua-2211	98	13	up	up	NOUN
aiua-2211	98	14	,	,	PUNCT
aiua-2211	98	15	since	since	SCONJ
aiua-2211	98	16	they	they	PRON
aiua-2211	98	17	group	group	NOUN
aiua-2211	98	18	i	i	PRON
aiua-2211	98	19	patients	patient	NOUN
aiua-2211	98	20	psa	psa	VERB
aiua-2211	98	21	t0	t0	PROPN
aiua-2211	98	22	gs	gs	PROPN
aiua-2211	99	1	tnm	tnm	PROPN
aiua-2211	99	2	therapy	therapy	PROPN
aiua-2211	99	3	current	current	ADJ
aiua-2211	99	4	psa	psa	PROPN
aiua-2211	99	5	adna	adna	PROPN
aiua-2211	99	6	markers	markers	PROPN
aiua-2211	99	7	responders	responder	VERB
aiua-2211	99	8	1	1	NUM
aiua-2211	99	9	332	332	NUM
aiua-2211	99	10	5	5	NUM
aiua-2211	99	11	+	+	SYM
aiua-2211	99	12	5	5	NUM
aiua-2211	99	13	n+m+	n+m+	NOUN
aiua-2211	99	14	enantone	enantone	NOUN
aiua-2211	100	1	+	+	CCONJ
aiua-2211	100	2	casodex	casodex	PROPN
aiua-2211	100	3	1,68	1,68	NUM
aiua-2211	100	4	neg	neg	VERB
aiua-2211	100	5	2	2	NUM
aiua-2211	100	6	*	*	SYM
aiua-2211	100	7	12	12	NUM
aiua-2211	100	8	5	5	NUM
aiua-2211	100	9	+	+	SYM
aiua-2211	100	10	4	4	NUM
aiua-2211	100	11	n+m+	n+m+	NOUN
aiua-2211	100	12	eligard	eligard	NOUN
aiua-2211	100	13	+	+	CCONJ
aiua-2211	100	14	casodex	casodex	NOUN
aiua-2211	100	15	+	+	CCONJ
aiua-2211	100	16	rt	rt	PROPN
aiua-2211	100	17	+	+	CCONJ
aiua-2211	100	18	cht	cht	PROPN
aiua-2211	100	19	0,98	0,98	PRON
aiua-2211	100	20	neg	neg	VERB
aiua-2211	100	21	3	3	NUM
aiua-2211	100	22	136	136	NUM
aiua-2211	100	23	4	4	NUM
aiua-2211	100	24	+	+	SYM
aiua-2211	100	25	4	4	NUM
aiua-2211	100	26	t4	t4	PROPN
aiua-2211	100	27	n+	n+	PUNCT
aiua-2211	100	28	m0	m0	PROPN
aiua-2211	100	29	casodex	casodex	NOUN
aiua-2211	100	30	50	50	NUM
aiua-2211	101	1	+	+	CCONJ
aiua-2211	101	2	rt	rt	PROPN
aiua-2211	101	3	0,49	0,49	NUM
aiua-2211	101	4	neg	neg	VERB
aiua-2211	101	5	5	5	NUM
aiua-2211	101	6	5,73	5,73	NUM
aiua-2211	101	7	4	4	NUM
aiua-2211	101	8	+	+	SYM
aiua-2211	101	9	4	4	NUM
aiua-2211	101	10	pt4	pt4	NOUN
aiua-2211	101	11	rt	rt	PROPN
aiua-2211	101	12	0,01	0,01	NUM
aiua-2211	101	13	neg	neg	PROPN
aiua-2211	101	14	12	12	NUM
aiua-2211	101	15	9.8	9.8	NUM
aiua-2211	101	16	4	4	NUM
aiua-2211	101	17	+	+	SYM
aiua-2211	101	18	4	4	NUM
aiua-2211	101	19	m+	m+	NUM
aiua-2211	101	20	casodex	casodex	NOUN
aiua-2211	101	21	+	+	CCONJ
aiua-2211	101	22	enantone	enantone	NOUN
aiua-2211	101	23	+	+	CCONJ
aiua-2211	101	24	zometa	zometa	ADJ
aiua-2211	101	25	9,29	9,29	NUM
aiua-2211	101	26	neg	neg	VERB
aiua-2211	101	27	13	13	NUM
aiua-2211	101	28	12	12	NUM
aiua-2211	101	29	4	4	NUM
aiua-2211	101	30	+	+	SYM
aiua-2211	101	31	4	4	NUM
aiua-2211	101	32	t3a	t3a	NOUN
aiua-2211	101	33	rt	rt	PROPN
aiua-2211	101	34	casodex	casodex	PROPN
aiua-2211	101	35	suspension	suspension	VERB
aiua-2211	101	36	0,206	0,206	NUM
aiua-2211	101	37	neg	neg	VERB
aiua-2211	101	38	14	14	NUM
aiua-2211	101	39	8.9	8.9	NUM
aiua-2211	101	40	3	3	NUM
aiua-2211	101	41	+	+	SYM
aiua-2211	101	42	5	5	NUM
aiua-2211	101	43	pt3b	pt3b	NOUN
aiua-2211	101	44	n+	n+	NUM
aiua-2211	101	45	rrp	rrp	PROPN
aiua-2211	101	46	r1	r1	PROPN
aiua-2211	101	47	(	(	PUNCT
aiua-2211	101	48	margins	margin	NOUN
aiua-2211	101	49	+	+	NOUN
aiua-2211	101	50	)	)	PUNCT
aiua-2211	101	51	0,03	0,03	NOUN
aiua-2211	101	52	neg	neg	VERB
aiua-2211	101	53	not	not	PART
aiua-2211	101	54	responders	responder	VERB
aiua-2211	101	55	4	4	NUM
aiua-2211	101	56	15	15	NUM
aiua-2211	101	57	3	3	NUM
aiua-2211	101	58	+	+	SYM
aiua-2211	101	59	5	5	NUM
aiua-2211	101	60	n+	n+	ADP
aiua-2211	101	61	gonapeptyl	gonapeptyl	NOUN
aiua-2211	101	62	+	+	CCONJ
aiua-2211	101	63	casodex	casodex	NOUN
aiua-2211	101	64	rt	rt	PROPN
aiua-2211	101	65	52	52	NUM
aiua-2211	101	66	psa	psa	NOUN
aiua-2211	101	67	/	/	SYM
aiua-2211	101	68	psma	psma	NOUN
aiua-2211	101	69	6	6	NUM
aiua-2211	101	70	7,05	7,05	NUM
aiua-2211	101	71	5	5	NUM
aiua-2211	101	72	+	+	SYM
aiua-2211	101	73	3	3	NUM
aiua-2211	101	74	pt3b	pt3b	X
aiua-2211	101	75	m+	m+	NUM
aiua-2211	101	76	eligard	eligard	NOUN
aiua-2211	102	1	+	+	CCONJ
aiua-2211	102	2	rt	rt	PROPN
aiua-2211	102	3	15	15	NUM
aiua-2211	102	4	psa	psa	VERB
aiua-2211	102	5	7	7	NUM
aiua-2211	102	6	128	128	NUM
aiua-2211	102	7	4	4	NUM
aiua-2211	102	8	+	+	SYM
aiua-2211	102	9	5	5	NUM
aiua-2211	102	10	n+	n+	NUM
aiua-2211	102	11	m+	m+	NOUN
aiua-2211	102	12	eligard	eligard	NOUN
aiua-2211	102	13	+	+	CCONJ
aiua-2211	102	14	casodex	casodex	NOUN
aiua-2211	102	15	+	+	CCONJ
aiua-2211	102	16	taxotere	taxotere	PROPN
aiua-2211	102	17	68,5	68,5	NUM
aiua-2211	102	18	psa	psa	NOUN
aiua-2211	102	19	/	/	SYM
aiua-2211	102	20	psma	psma	NOUN
aiua-2211	102	21	responder	responder	NOUN
aiua-2211	102	22	patient	patient	NOUN
aiua-2211	102	23	became	become	VERB
aiua-2211	102	24	not	not	PART
aiua-2211	102	25	-	-	PUNCT
aiua-2211	102	26	responder	responder	NOUN
aiua-2211	102	27	2	2	NUM
aiua-2211	102	28	*	*	NOUN
aiua-2211	102	29	12	12	NUM
aiua-2211	102	30	5	5	NUM
aiua-2211	102	31	+	+	SYM
aiua-2211	102	32	4	4	NUM
aiua-2211	102	33	n+m+	n+m+	NOUN
aiua-2211	102	34	eligard	eligard	NOUN
aiua-2211	102	35	+	+	CCONJ
aiua-2211	102	36	casodex	casodex	NOUN
aiua-2211	102	37	+	+	CCONJ
aiua-2211	102	38	rt	rt	PROPN
aiua-2211	103	1	+	+	CCONJ
aiua-2211	103	2	cht	cht	PROPN
aiua-2211	103	3	6,81	6,81	NUM
aiua-2211	103	4	pos	pos	NOUN
aiua-2211	103	5	*	*	NOUN
aiua-2211	103	6	table	table	NOUN
aiua-2211	103	7	2	2	NUM
aiua-2211	103	8	.	.	PUNCT
aiua-2211	103	9	patient	patient	ADJ
aiua-2211	103	10	stratification	stratification	NOUN
aiua-2211	103	11	based	base	VERB
aiua-2211	103	12	on	on	ADP
aiua-2211	103	13	response	response	NOUN
aiua-2211	103	14	to	to	ADP
aiua-2211	103	15	single	single	ADJ
aiua-2211	103	16	or	or	CCONJ
aiua-2211	103	17	combined	combined	ADJ
aiua-2211	103	18	therapies	therapy	NOUN
aiua-2211	103	19	.	.	PUNCT
aiua-2211	104	1	archivio	archivio	NOUN
aiua-2211	104	2	italiano	italiano	X
aiua-2211	104	3	di	di	PROPN
aiua-2211	104	4	urologia	urologia	PROPN
aiua-2211	104	5	e	e	PROPN
aiua-2211	104	6	andrologia	andrologia	NOUN
aiua-2211	104	7	2013	2013	NUM
aiua-2211	104	8	;	;	PUNCT
aiua-2211	104	9	85	85	NUM
aiua-2211	104	10	,	,	PUNCT
aiua-2211	104	11	4	4	NUM
aiua-2211	104	12	g.	g.	NOUN
aiua-2211	104	13	albino	albino	PROPN
aiua-2211	104	14	,	,	PUNCT
aiua-2211	104	15	f.	f.	PROPN
aiua-2211	104	16	vendittelli	vendittelli	PROPN
aiua-2211	104	17	,	,	PUNCT
aiua-2211	104	18	c.	c.	PROPN
aiua-2211	104	19	paolillo	paolillo	PROPN
aiua-2211	104	20	,	,	PUNCT
aiua-2211	104	21	c.	c.	PROPN
aiua-2211	104	22	zuppi	zuppi	PROPN
aiua-2211	104	23	,	,	PUNCT
aiua-2211	104	24	e.	e.	PROPN
aiua-2211	104	25	capoluongo	capoluongo	PROPN
aiua-2211	104	26	168	168	NUM
aiua-2211	104	27	are	be	AUX
aiua-2211	104	28	followed	follow	VERB
aiua-2211	104	29	by	by	ADP
aiua-2211	104	30	psa	psa	NOUN
aiua-2211	104	31	assays	assay	NOUN
aiua-2211	104	32	overtime	overtime	NOUN
aiua-2211	104	33	(	(	PUNCT
aiua-2211	104	34	every	every	DET
aiua-2211	104	35	four	four	NUM
aiua-2211	104	36	months	month	NOUN
aiua-2211	104	37	)	)	PUNCT
aiua-2211	104	38	,	,	PUNCT
aiua-2211	104	39	and	and	CCONJ
aiua-2211	104	40	ct	ct	NOUN
aiua-2211	104	41	scan	scan	VERB
aiua-2211	104	42	every	every	DET
aiua-2211	104	43	six	six	NUM
aiua-2211	104	44	months	month	NOUN
aiua-2211	104	45	,	,	PUNCT
aiua-2211	104	46	in	in	ADP
aiua-2211	104	47	order	order	NOUN
aiua-2211	104	48	to	to	PART
aiua-2211	104	49	plan	plan	VERB
aiua-2211	104	50	other	other	ADJ
aiua-2211	104	51	ctc	ctc	NOUN
aiua-2211	104	52	tests	test	NOUN
aiua-2211	104	53	for	for	ADP
aiua-2211	104	54	monitoring	monitoring	NOUN
aiua-2211	104	55	of	of	ADP
aiua-2211	104	56	disease	disease	NOUN
aiua-2211	104	57	progression	progression	NOUN
aiua-2211	104	58	.	.	PUNCT
aiua-2211	105	1	regarding	regard	VERB
aiua-2211	105	2	the	the	DET
aiua-2211	105	3	molecular	molecular	ADJ
aiua-2211	105	4	typing	typing	NOUN
aiua-2211	105	5	performed	perform	VERB
aiua-2211	105	6	after	after	ADP
aiua-2211	105	7	enrichment	enrichment	NOUN
aiua-2211	105	8	,	,	PUNCT
aiua-2211	105	9	the	the	DET
aiua-2211	105	10	use	use	NOUN
aiua-2211	105	11	of	of	ADP
aiua-2211	105	12	multiplex	multiplex	PROPN
aiua-2211	105	13	adnagen	adnagen	PROPN
aiua-2211	105	14	pcr	pcr	PROPN
aiua-2211	105	15	may	may	AUX
aiua-2211	105	16	improve	improve	VERB
aiua-2211	105	17	the	the	DET
aiua-2211	105	18	detection	detection	NOUN
aiua-2211	105	19	of	of	ADP
aiua-2211	105	20	at	at	ADV
aiua-2211	105	21	least	least	ADV
aiua-2211	105	22	one	one	NUM
aiua-2211	105	23	marker	marker	NOUN
aiua-2211	105	24	potentially	potentially	ADV
aiua-2211	105	25	associated	associate	VERB
aiua-2211	105	26	to	to	ADP
aiua-2211	105	27	circulating	circulate	VERB
aiua-2211	105	28	prostate	prostate	NOUN
aiua-2211	105	29	tumor	tumor	NOUN
aiua-2211	105	30	cells	cell	NOUN
aiua-2211	105	31	and	and	CCONJ
aiua-2211	105	32	possibly	possibly	ADV
aiua-2211	105	33	associated	associate	VERB
aiua-2211	105	34	to	to	ADP
aiua-2211	105	35	poor	poor	ADJ
aiua-2211	105	36	prognosis	prognosis	NOUN
aiua-2211	105	37	.	.	PUNCT
aiua-2211	106	1	although	although	SCONJ
aiua-2211	106	2	mrna	mrna	NOUN
aiua-2211	106	3	-	-	PUNCT
aiua-2211	106	4	psa	psa	NOUN
aiua-2211	106	5	is	be	AUX
aiua-2211	106	6	not	not	PART
aiua-2211	106	7	unanimously	unanimously	ADV
aiua-2211	106	8	considered	consider	VERB
aiua-2211	106	9	as	as	ADP
aiua-2211	106	10	a	a	DET
aiua-2211	106	11	better	well	ADJ
aiua-2211	106	12	independent	independent	ADJ
aiua-2211	106	13	prognostic	prognostic	ADJ
aiua-2211	106	14	factor	factor	NOUN
aiua-2211	106	15	as	as	SCONJ
aiua-2211	106	16	compared	compare	VERB
aiua-2211	106	17	to	to	ADP
aiua-2211	106	18	serum	serum	NOUN
aiua-2211	106	19	psa	psa	NOUN
aiua-2211	106	20	detection	detection	NOUN
aiua-2211	106	21	(	(	PUNCT
aiua-2211	106	22	36	36	NUM
aiua-2211	106	23	)	)	PUNCT
aiua-2211	106	24	,	,	PUNCT
aiua-2211	106	25	a	a	DET
aiua-2211	106	26	limit	limit	NOUN
aiua-2211	106	27	of	of	ADP
aiua-2211	106	28	this	this	DET
aiua-2211	106	29	test	test	NOUN
aiua-2211	106	30	is	be	AUX
aiua-2211	106	31	that	that	SCONJ
aiua-2211	106	32	tumor	tumor	NOUN
aiua-2211	106	33	-	-	PUNCT
aiua-2211	106	34	associated	associate	VERB
aiua-2211	106	35	proteins	protein	NOUN
aiua-2211	106	36	,	,	PUNCT
aiua-2211	106	37	like	like	ADP
aiua-2211	106	38	psa	psa	NOUN
aiua-2211	106	39	,	,	PUNCT
aiua-2211	106	40	are	be	AUX
aiua-2211	106	41	also	also	ADV
aiua-2211	106	42	expressed	express	VERB
aiua-2211	106	43	in	in	ADP
aiua-2211	106	44	normal	normal	ADJ
aiua-2211	106	45	cells	cell	NOUN
aiua-2211	106	46	.	.	PUNCT
aiua-2211	107	1	nevertheless	nevertheless	ADV
aiua-2211	107	2	,	,	PUNCT
aiua-2211	107	3	in	in	ADP
aiua-2211	107	4	our	our	PRON
aiua-2211	107	5	test	test	NOUN
aiua-2211	107	6	,	,	PUNCT
aiua-2211	107	7	when	when	SCONJ
aiua-2211	107	8	the	the	DET
aiua-2211	107	9	suggested	suggest	VERB
aiua-2211	107	10	cut	cut	NOUN
aiua-2211	107	11	-	-	PUNCT
aiua-2211	107	12	off	off	NOUN
aiua-2211	107	13	of	of	ADP
aiua-2211	107	14	10	10	NUM
aiua-2211	107	15	ng	ng	NOUN
aiua-2211	107	16	/	/	SYM
aiua-2211	107	17	ml	ml	PROPN
aiua-2211	107	18	was	be	AUX
aiua-2211	107	19	used	use	VERB
aiua-2211	107	20	,	,	PUNCT
aiua-2211	107	21	no	no	DET
aiua-2211	107	22	false	false	ADJ
aiua-2211	107	23	-	-	PUNCT
aiua-2211	107	24	positive	positive	ADJ
aiua-2211	107	25	results	result	NOUN
aiua-2211	107	26	,	,	PUNCT
aiua-2211	107	27	particularly	particularly	ADV
aiua-2211	107	28	in	in	ADP
aiua-2211	107	29	bph	bph	NOUN
aiua-2211	107	30	patients	patient	NOUN
aiua-2211	107	31	,	,	PUNCT
aiua-2211	107	32	were	be	AUX
aiua-2211	107	33	found	find	VERB
aiua-2211	107	34	.	.	PUNCT
aiua-2211	108	1	furthermore	furthermore	ADV
aiua-2211	108	2	,	,	PUNCT
aiua-2211	108	3	several	several	ADJ
aiua-2211	108	4	studies	study	NOUN
aiua-2211	108	5	suggested	suggest	VERB
aiua-2211	108	6	the	the	DET
aiua-2211	108	7	use	use	NOUN
aiua-2211	108	8	of	of	ADP
aiua-2211	108	9	psma	psma	NOUN
aiua-2211	108	10	,	,	PUNCT
aiua-2211	108	11	alone	alone	ADV
aiua-2211	108	12	or	or	CCONJ
aiua-2211	108	13	combined	combine	VERB
aiua-2211	108	14	to	to	PART
aiua-2211	108	15	psa	psa	VERB
aiua-2211	108	16	-	-	PUNCT
aiua-2211	108	17	mrna	mrna	NOUN
aiua-2211	108	18	,	,	PUNCT
aiua-2211	108	19	to	to	PART
aiua-2211	108	20	increase	increase	VERB
aiua-2211	108	21	assay	assay	ADJ
aiua-2211	108	22	specificity	specificity	NOUN
aiua-2211	108	23	in	in	ADP
aiua-2211	108	24	pca	pca	NOUN
aiua-2211	108	25	patients	patient	NOUN
aiua-2211	108	26	(	(	PUNCT
aiua-2211	108	27	36	36	NUM
aiua-2211	108	28	)	)	PUNCT
aiua-2211	108	29	,	,	PUNCT
aiua-2211	108	30	psma	psma	NOUN
aiua-2211	108	31	being	be	AUX
aiua-2211	108	32	over	over	ADV
aiua-2211	108	33	-	-	PUNCT
aiua-2211	108	34	expressed	express	VERB
aiua-2211	108	35	in	in	ADP
aiua-2211	108	36	advanced	advanced	ADJ
aiua-2211	108	37	or	or	CCONJ
aiua-2211	108	38	in	in	ADP
aiua-2211	108	39	castration	castration	NOUN
aiua-2211	108	40	resistant	resistant	ADJ
aiua-2211	108	41	pca	pca	NOUN
aiua-2211	108	42	(	(	PUNCT
aiua-2211	108	43	37	37	NUM
aiua-2211	108	44	)	)	PUNCT
aiua-2211	108	45	and	and	CCONJ
aiua-2211	108	46	preferentially	preferentially	ADV
aiua-2211	108	47	expressed	express	VERB
aiua-2211	108	48	in	in	ADP
aiua-2211	108	49	anaplastic	anaplastic	ADJ
aiua-2211	108	50	cells	cell	NOUN
aiua-2211	108	51	,	,	PUNCT
aiua-2211	108	52	hormone	hormone	NOUN
aiua-2211	108	53	-	-	PUNCT
aiua-2211	108	54	refractory	refractory	NOUN
aiua-2211	108	55	cells	cell	NOUN
aiua-2211	108	56	and	and	CCONJ
aiua-2211	108	57	bone	bone	NOUN
aiua-2211	108	58	metastases	metastasis	NOUN
aiua-2211	108	59	(	(	PUNCT
aiua-2211	108	60	38	38	NUM
aiua-2211	108	61	)	)	PUNCT
aiua-2211	108	62	.	.	PUNCT
aiua-2211	109	1	conclusions	conclusion	NOUN
aiua-2211	109	2	in	in	ADP
aiua-2211	109	3	our	our	PRON
aiua-2211	109	4	opinion	opinion	NOUN
aiua-2211	109	5	,	,	PUNCT
aiua-2211	109	6	molecular	molecular	ADJ
aiua-2211	109	7	analysis	analysis	NOUN
aiua-2211	109	8	of	of	ADP
aiua-2211	109	9	ctcs	ctcs	NOUN
aiua-2211	109	10	through	through	ADP
aiua-2211	109	11	psma	psma	PROPN
aiua-2211	109	12	mrna	mrna	PROPN
aiua-2211	109	13	detection	detection	NOUN
aiua-2211	109	14	could	could	AUX
aiua-2211	109	15	provide	provide	VERB
aiua-2211	109	16	important	important	ADJ
aiua-2211	109	17	information	information	NOUN
aiua-2211	109	18	for	for	ADP
aiua-2211	109	19	clinicians	clinician	NOUN
aiua-2211	109	20	in	in	ADP
aiua-2211	109	21	terms	term	NOUN
aiua-2211	109	22	of	of	ADP
aiua-2211	109	23	prediction	prediction	NOUN
aiua-2211	109	24	of	of	ADP
aiua-2211	109	25	disease	disease	NOUN
aiua-2211	109	26	recurrence	recurrence	NOUN
aiua-2211	109	27	,	,	PUNCT
aiua-2211	109	28	before	before	ADP
aiua-2211	109	29	imaging	imaging	NOUN
aiua-2211	109	30	findings	finding	NOUN
aiua-2211	109	31	.	.	PUNCT
aiua-2211	110	1	this	this	DET
aiua-2211	110	2	finding	finding	NOUN
aiua-2211	110	3	demonstrates	demonstrate	VERB
aiua-2211	110	4	the	the	DET
aiua-2211	110	5	potential	potential	ADJ
aiua-2211	110	6	role	role	NOUN
aiua-2211	110	7	of	of	ADP
aiua-2211	110	8	ctcs	ctcs	NOUN
aiua-2211	110	9	in	in	ADP
aiua-2211	110	10	the	the	DET
aiua-2211	110	11	follow	follow	NOUN
aiua-2211	110	12	up	up	ADP
aiua-2211	110	13	of	of	ADP
aiua-2211	110	14	the	the	DET
aiua-2211	110	15	prostatic	prostatic	ADJ
aiua-2211	110	16	cancer	cancer	NOUN
aiua-2211	110	17	;	;	PUNCT
aiua-2211	110	18	it	it	PRON
aiua-2211	110	19	can	can	AUX
aiua-2211	110	20	be	be	AUX
aiua-2211	110	21	obtained	obtain	VERB
aiua-2211	110	22	in	in	ADP
aiua-2211	110	23	a	a	DET
aiua-2211	110	24	routine	routine	ADJ
aiua-2211	110	25	practice	practice	NOUN
aiua-2211	110	26	setting	setting	NOUN
aiua-2211	110	27	,	,	PUNCT
aiua-2211	110	28	by	by	ADP
aiua-2211	110	29	a	a	DET
aiua-2211	110	30	simple	simple	ADJ
aiua-2211	110	31	blood	blood	NOUN
aiua-2211	110	32	sampling	sampling	NOUN
aiua-2211	110	33	.	.	PUNCT
aiua-2211	111	1	we	we	PRON
aiua-2211	111	2	underline	underline	VERB
aiua-2211	111	3	that	that	SCONJ
aiua-2211	111	4	although	although	SCONJ
aiua-2211	111	5	the	the	DET
aiua-2211	111	6	present	present	ADJ
aiua-2211	111	7	study	study	NOUN
aiua-2211	111	8	did	do	AUX
aiua-2211	111	9	not	not	PART
aiua-2211	111	10	compare	compare	VERB
aiua-2211	111	11	the	the	DET
aiua-2211	111	12	efficiency	efficiency	NOUN
aiua-2211	111	13	of	of	ADP
aiua-2211	111	14	adnatest	adnatest	NOUN
aiua-2211	111	15	with	with	ADP
aiua-2211	111	16	that	that	PRON
aiua-2211	111	17	of	of	ADP
aiua-2211	111	18	other	other	ADJ
aiua-2211	111	19	platforms	platform	NOUN
aiua-2211	111	20	(	(	PUNCT
aiua-2211	111	21	in	in	ADP
aiua-2211	111	22	particular	particular	ADJ
aiua-2211	111	23	the	the	DET
aiua-2211	111	24	cellsearch	cellsearch	ADJ
aiua-2211	111	25	system	system	NOUN
aiua-2211	111	26	)	)	PUNCT
aiua-2211	111	27	,	,	PUNCT
aiua-2211	111	28	we	we	PRON
aiua-2211	111	29	can	can	AUX
aiua-2211	111	30	assume	assume	VERB
aiua-2211	111	31	that	that	SCONJ
aiua-2211	111	32	our	our	PRON
aiua-2211	111	33	test	test	NOUN
aiua-2211	111	34	may	may	AUX
aiua-2211	111	35	be	be	AUX
aiua-2211	111	36	considered	consider	VERB
aiua-2211	111	37	as	as	ADP
aiua-2211	111	38	reliable	reliable	ADJ
aiua-2211	111	39	:	:	PUNCT
aiua-2211	111	40	in	in	ADP
aiua-2211	111	41	fact	fact	NOUN
aiua-2211	111	42	,	,	PUNCT
aiua-2211	111	43	in	in	ADP
aiua-2211	111	44	this	this	DET
aiua-2211	111	45	regard	regard	NOUN
aiua-2211	111	46	,	,	PUNCT
aiua-2211	111	47	andreopoulou	andreopoulou	PROPN
aiua-2211	111	48	e	e	ADP
aiua-2211	111	49	et	et	NOUN
aiua-2211	111	50	al	al	PROPN
aiua-2211	111	51	have	have	AUX
aiua-2211	111	52	recently	recently	ADV
aiua-2211	111	53	reported	report	VERB
aiua-2211	111	54	the	the	DET
aiua-2211	111	55	concordance	concordance	NOUN
aiua-2211	111	56	between	between	ADP
aiua-2211	111	57	these	these	DET
aiua-2211	111	58	two	two	NUM
aiua-2211	111	59	methods	method	NOUN
aiua-2211	111	60	(	(	PUNCT
aiua-2211	111	61	40	40	NUM
aiua-2211	111	62	)	)	PUNCT
aiua-2211	111	63	.	.	PUNCT
aiua-2211	112	1	finally	finally	ADV
aiua-2211	112	2	,	,	PUNCT
aiua-2211	112	3	our	our	PRON
aiua-2211	112	4	results	result	NOUN
aiua-2211	112	5	should	should	AUX
aiua-2211	112	6	be	be	AUX
aiua-2211	112	7	confirmed	confirm	VERB
aiua-2211	112	8	on	on	ADP
aiua-2211	112	9	larger	large	ADJ
aiua-2211	112	10	cohorts	cohort	NOUN
aiua-2211	112	11	of	of	ADP
aiua-2211	112	12	patients	patient	NOUN
aiua-2211	112	13	also	also	ADV
aiua-2211	112	14	considering	consider	VERB
aiua-2211	112	15	that	that	SCONJ
aiua-2211	112	16	this	this	DET
aiua-2211	112	17	type	type	NOUN
aiua-2211	112	18	of	of	ADP
aiua-2211	112	19	test	test	NOUN
aiua-2211	112	20	should	should	AUX
aiua-2211	112	21	be	be	AUX
aiua-2211	112	22	performed	perform	VERB
aiua-2211	112	23	in	in	ADP
aiua-2211	112	24	laboratories	laboratory	NOUN
aiua-2211	112	25	with	with	ADP
aiua-2211	112	26	high	high	ADJ
aiua-2211	112	27	expertise	expertise	NOUN
aiua-2211	112	28	personnel	personnel	NOUN
aiua-2211	112	29	in	in	ADP
aiua-2211	112	30	strict	strict	ADJ
aiua-2211	112	31	relationships	relationship	NOUN
aiua-2211	112	32	with	with	ADP
aiua-2211	112	33	clinical	clinical	ADJ
aiua-2211	112	34	departments	department	NOUN
aiua-2211	112	35	.	.	PUNCT
aiua-2211	113	1	references	reference	NOUN
aiua-2211	113	2	1	1	NUM
aiua-2211	113	3	.	.	PUNCT
aiua-2211	114	1	heidenreich	heidenreich	PRON
aiua-2211	114	2	a	a	PRON
aiua-2211	114	3	,	,	PUNCT
aiua-2211	114	4	bolla	bolla	PROPN
aiua-2211	114	5	m	m	PROPN
aiua-2211	114	6	,	,	PUNCT
aiua-2211	114	7	joniau	joniau	PROPN
aiua-2211	114	8	s	s	PROPN
aiua-2211	114	9	,	,	PUNCT
aiua-2211	114	10	et	et	PROPN
aiua-2211	114	11	al	al	PROPN
aiua-2211	114	12	.	.	PUNCT
aiua-2211	114	13	guidelines	guideline	NOUN
aiua-2211	114	14	on	on	ADP
aiua-2211	114	15	prostate	prostate	NOUN
aiua-2211	114	16	cancer	cancer	NOUN
aiua-2211	114	17	eur	eur	PROPN
aiua-2211	114	18	urol	urol	PROPN
aiua-2211	114	19	.	.	PUNCT
aiua-2211	115	1	2011	2011	NUM
aiua-2211	115	2	;	;	PUNCT
aiua-2211	115	3	59:61	59:61	NUM
aiua-2211	115	4	-	-	SYM
aiua-2211	115	5	71	71	NUM
aiua-2211	115	6	and	and	CCONJ
aiua-2211	115	7	59:572	59:572	NUM
aiua-2211	115	8	-	-	SYM
aiua-2211	115	9	83	83	NUM
aiua-2211	115	10	.	.	PUNCT
aiua-2211	116	1	2	2	NUM
aiua-2211	116	2	.	.	X
aiua-2211	116	3	taplin	taplin	PROPN
aiua-2211	116	4	me	me	PROPN
aiua-2211	116	5	,	,	PUNCT
aiua-2211	116	6	bubley	bubley	PROPN
aiua-2211	116	7	gj	gj	PROPN
aiua-2211	116	8	,	,	PUNCT
aiua-2211	116	9	shuster	shuster	PROPN
aiua-2211	116	10	td	td	PROPN
aiua-2211	116	11	,	,	PUNCT
aiua-2211	116	12	et	et	PROPN
aiua-2211	116	13	al	al	PROPN
aiua-2211	116	14	.	.	PROPN
aiua-2211	117	1	mutation	mutation	NOUN
aiua-2211	117	2	of	of	ADP
aiua-2211	117	3	the	the	DET
aiua-2211	117	4	androgen	androgen	NOUN
aiua-2211	117	5	-	-	PUNCT
aiua-2211	117	6	receptor	receptor	NOUN
aiua-2211	117	7	gene	gene	NOUN
aiua-2211	117	8	in	in	ADP
aiua-2211	117	9	metastatic	metastatic	ADJ
aiua-2211	117	10	androgen	androgen	NOUN
aiua-2211	117	11	-	-	PUNCT
aiua-2211	117	12	independent	independent	ADJ
aiua-2211	117	13	prostate	prostate	NOUN
aiua-2211	117	14	cancer	cancer	NOUN
aiua-2211	117	15	.	.	PUNCT
aiua-2211	118	1	n	n	PROPN
aiua-2211	118	2	engl	engl	PROPN
aiua-2211	118	3	j	j	PROPN
aiua-2211	118	4	med	med	PROPN
aiua-2211	118	5	.	.	PUNCT
aiua-2211	118	6	1995	1995	NUM
aiua-2211	118	7	;	;	PUNCT
aiua-2211	118	8	332:1393	332:1393	NUM
aiua-2211	118	9	-	-	SYM
aiua-2211	118	10	8	8	NUM
aiua-2211	118	11	.	.	NOUN
aiua-2211	119	1	3	3	X
aiua-2211	119	2	.	.	X
aiua-2211	119	3	chi	chi	PROPN
aiua-2211	119	4	kn	kn	PROPN
aiua-2211	119	5	,	,	PUNCT
aiua-2211	119	6	bjartell	bjartell	VERB
aiua-2211	119	7	a	a	PRON
aiua-2211	119	8	,	,	PUNCT
aiua-2211	119	9	dearnaley	dearnaley	PROPN
aiua-2211	119	10	d	d	PROPN
aiua-2211	119	11	,	,	PUNCT
aiua-2211	119	12	et	et	PROPN
aiua-2211	119	13	al	al	PROPN
aiua-2211	119	14	.	.	PUNCT
aiua-2211	120	1	castration	castration	NOUN
aiua-2211	120	2	-	-	PUNCT
aiua-2211	120	3	resistant	resistant	ADJ
aiua-2211	120	4	prostate	prostate	NOUN
aiua-2211	120	5	cancer	cancer	NOUN
aiua-2211	120	6	:	:	PUNCT
aiua-2211	120	7	from	from	ADP
aiua-2211	120	8	new	new	ADJ
aiua-2211	120	9	pathophysiology	pathophysiology	NOUN
aiua-2211	120	10	to	to	ADP
aiua-2211	120	11	new	new	ADJ
aiua-2211	120	12	treatment	treatment	NOUN
aiua-2211	120	13	targets	target	NOUN
aiua-2211	120	14	.	.	PUNCT
aiua-2211	121	1	eur	eur	PROPN
aiua-2211	121	2	urol	urol	PROPN
aiua-2211	121	3	.	.	PUNCT
aiua-2211	121	4	2009	2009	NUM
aiua-2211	121	5	,	,	PUNCT
aiua-2211	121	6	56:594	56:594	NUM
aiua-2211	121	7	-	-	SYM
aiua-2211	121	8	605	605	NUM
aiua-2211	121	9	.	.	NOUN
aiua-2211	122	1	4	4	NUM
aiua-2211	122	2	.	.	X
aiua-2211	123	1	kruck	kruck	PROPN
aiua-2211	123	2	s	s	PROPN
aiua-2211	123	3	,	,	PUNCT
aiua-2211	123	4	gakis	gakis	PRON
aiua-2211	123	5	g	g	NOUN
aiua-2211	123	6	,	,	PUNCT
aiua-2211	123	7	stenzl	stenzl	ADJ
aiua-2211	123	8	a.	a.	NOUN
aiua-2211	123	9	circulating	circulating	NOUN
aiua-2211	123	10	and	and	CCONJ
aiua-2211	123	11	disseminated	disseminate	VERB
aiua-2211	123	12	tumor	tumor	NOUN
aiua-2211	123	13	cells	cell	NOUN
aiua-2211	123	14	in	in	ADP
aiua-2211	123	15	the	the	DET
aiua-2211	123	16	management	management	NOUN
aiua-2211	123	17	of	of	ADP
aiua-2211	123	18	advanced	advanced	ADJ
aiua-2211	123	19	prostate	prostate	NOUN
aiua-2211	123	20	cancer	cancer	NOUN
aiua-2211	123	21	.	.	PUNCT
aiua-2211	124	1	adv	adv	PROPN
aiua-2211	124	2	urol	urol	PROPN
aiua-2211	124	3	.	.	PUNCT
aiua-2211	125	1	2012;135281	2012;135281	X
aiua-2211	125	2	.	.	PUNCT
aiua-2211	126	1	epub	epub	PROPN
aiua-2211	126	2	2011	2011	NUM
aiua-2211	126	3	aug	aug	PROPN
aiua-2211	126	4	21	21	NUM
aiua-2211	126	5	.	.	X
aiua-2211	127	1	5	5	X
aiua-2211	127	2	.	.	X
aiua-2211	127	3	paterlini	paterlini	NOUN
aiua-2211	127	4	-	-	PUNCT
aiua-2211	127	5	brechot	brechot	NOUN
aiua-2211	127	6	p	p	NOUN
aiua-2211	127	7	,	,	PUNCT
aiua-2211	127	8	benali	benali	PROPN
aiua-2211	127	9	nl	nl	PROPN
aiua-2211	127	10	.	.	PUNCT
aiua-2211	128	1	circulating	circulate	VERB
aiua-2211	128	2	tumor	tumor	NOUN
aiua-2211	128	3	cells	cell	NOUN
aiua-2211	128	4	(	(	PUNCT
aiua-2211	128	5	ctc	ctc	NOUN
aiua-2211	128	6	)	)	PUNCT
aiua-2211	128	7	detection	detection	NOUN
aiua-2211	128	8	:	:	PUNCT
aiua-2211	128	9	clinical	clinical	ADJ
aiua-2211	128	10	impact	impact	NOUN
aiua-2211	128	11	and	and	CCONJ
aiua-2211	128	12	future	future	ADJ
aiua-2211	128	13	directions	direction	NOUN
aiua-2211	128	14	.	.	PUNCT
aiua-2211	129	1	cancer	cancer	NOUN
aiua-2211	129	2	lett	lett	PROPN
aiua-2211	129	3	.	.	PUNCT
aiua-2211	130	1	2007	2007	NUM
aiua-2211	130	2	;	;	PUNCT
aiua-2211	130	3	253:180	253:180	NUM
aiua-2211	130	4	-	-	SYM
aiua-2211	130	5	204	204	NUM
aiua-2211	130	6	.	.	PUNCT
aiua-2211	131	1	6	6	NUM
aiua-2211	131	2	.	.	X
aiua-2211	131	3	pantel	pantel	PROPN
aiua-2211	131	4	k	k	PROPN
aiua-2211	131	5	,	,	PUNCT
aiua-2211	131	6	brakenhoff	brakenhoff	PROPN
aiua-2211	131	7	rh	rh	PROPN
aiua-2211	131	8	,	,	PUNCT
aiua-2211	131	9	brandt	brandt	PROPN
aiua-2211	131	10	b.	b.	PROPN
aiua-2211	131	11	detection	detection	PROPN
aiua-2211	131	12	,	,	PUNCT
aiua-2211	131	13	clinical	clinical	ADJ
aiua-2211	131	14	relevance	relevance	NOUN
aiua-2211	131	15	and	and	CCONJ
aiua-2211	131	16	specific	specific	ADJ
aiua-2211	131	17	biological	biological	ADJ
aiua-2211	131	18	properties	property	NOUN
aiua-2211	131	19	of	of	ADP
aiua-2211	131	20	disseminating	disseminate	VERB
aiua-2211	131	21	tumour	tumour	ADJ
aiua-2211	131	22	cells	cell	NOUN
aiua-2211	131	23	.	.	PUNCT
aiua-2211	132	1	nat	nat	PROPN
aiua-2211	132	2	rev	rev	PROPN
aiua-2211	132	3	cancer	cancer	NOUN
aiua-2211	132	4	.	.	PUNCT
aiua-2211	132	5	2008	2008	NUM
aiua-2211	132	6	;	;	PUNCT
aiua-2211	132	7	8:329	8:329	NUM
aiua-2211	132	8	-	-	SYM
aiua-2211	132	9	40	40	NUM
aiua-2211	132	10	.	.	PUNCT
aiua-2211	133	1	7	7	X
aiua-2211	133	2	.	.	X
aiua-2211	133	3	allard	allard	PROPN
aiua-2211	133	4	wj	wj	PROPN
aiua-2211	133	5	,	,	PUNCT
aiua-2211	133	6	matera	matera	PROPN
aiua-2211	133	7	j	j	PROPN
aiua-2211	133	8	,	,	PUNCT
aiua-2211	133	9	miller	miller	PROPN
aiua-2211	133	10	mc	mc	PROPN
aiua-2211	133	11	,	,	PUNCT
aiua-2211	133	12	et	et	PROPN
aiua-2211	134	1	al	al	PROPN
aiua-2211	134	2	.	.	PUNCT
aiua-2211	134	3	tumor	tumor	NOUN
aiua-2211	134	4	cells	cell	NOUN
aiua-2211	134	5	circulate	circulate	VERB
aiua-2211	134	6	in	in	ADP
aiua-2211	134	7	the	the	DET
aiua-2211	134	8	peripheral	peripheral	ADJ
aiua-2211	134	9	blood	blood	NOUN
aiua-2211	134	10	of	of	ADP
aiua-2211	134	11	all	all	DET
aiua-2211	134	12	major	major	ADJ
aiua-2211	134	13	carcinomas	carcinoma	NOUN
aiua-2211	134	14	but	but	CCONJ
aiua-2211	134	15	not	not	PART
aiua-2211	134	16	in	in	ADP
aiua-2211	134	17	healthy	healthy	ADJ
aiua-2211	134	18	subjects	subject	NOUN
aiua-2211	134	19	or	or	CCONJ
aiua-2211	134	20	patients	patient	NOUN
aiua-2211	134	21	with	with	ADP
aiua-2211	134	22	non	non	ADJ
aiua-2211	134	23	-	-	ADJ
aiua-2211	134	24	malignant	malignant	ADJ
aiua-2211	134	25	diseases	disease	NOUN
aiua-2211	134	26	.	.	PUNCT
aiua-2211	135	1	clin	clin	PROPN
aiua-2211	135	2	cancer	cancer	NOUN
aiua-2211	135	3	res	re	NOUN
aiua-2211	135	4	.	.	PUNCT
aiua-2211	135	5	2004	2004	NUM
aiua-2211	135	6	;	;	PUNCT
aiua-2211	135	7	10:6897	10:6897	NUM
aiua-2211	135	8	-	-	SYM
aiua-2211	135	9	904	904	NUM
aiua-2211	135	10	.	.	PUNCT
aiua-2211	136	1	8	8	NUM
aiua-2211	136	2	.	.	X
aiua-2211	136	3	jost	jost	PROPN
aiua-2211	136	4	m	m	PROPN
aiua-2211	136	5	,	,	PUNCT
aiua-2211	136	6	day	day	PROPN
aiua-2211	136	7	jr	jr	PROPN
aiua-2211	136	8	,	,	PUNCT
aiua-2211	136	9	slaughter	slaughter	NOUN
aiua-2211	136	10	r	r	NOUN
aiua-2211	136	11	,	,	PUNCT
aiua-2211	136	12	et	et	PROPN
aiua-2211	136	13	al	al	PROPN
aiua-2211	136	14	.	.	PROPN
aiua-2211	137	1	molecular	molecular	ADJ
aiua-2211	137	2	assays	assay	NOUN
aiua-2211	137	3	for	for	ADP
aiua-2211	137	4	the	the	DET
aiua-2211	137	5	detection	detection	NOUN
aiua-2211	137	6	of	of	ADP
aiua-2211	137	7	prostate	prostate	NOUN
aiua-2211	137	8	tumor	tumor	NOUN
aiua-2211	137	9	derived	derive	VERB
aiua-2211	137	10	nucleic	nucleic	ADJ
aiua-2211	137	11	acids	acid	NOUN
aiua-2211	137	12	in	in	ADP
aiua-2211	137	13	peripheral	peripheral	ADJ
aiua-2211	137	14	blood	blood	NOUN
aiua-2211	137	15	.	.	PUNCT
aiua-2211	138	1	mol	mol	ADP
aiua-2211	138	2	cancer	cancer	NOUN
aiua-2211	138	3	.	.	PUNCT
aiua-2211	139	1	2010	2010	NUM
aiua-2211	139	2	;	;	PUNCT
aiua-2211	140	1	2:174	2:174	NUM
aiua-2211	140	2	.	.	PUNCT
aiua-2211	141	1	figure	figure	NOUN
aiua-2211	141	2	1a	1a	PROPN
aiua-2211	141	3	-	-	PUNCT
aiua-2211	141	4	b.	b.	NOUN
aiua-2211	141	5	amplification	amplification	NOUN
aiua-2211	141	6	results	result	NOUN
aiua-2211	141	7	obtained	obtain	VERB
aiua-2211	141	8	on	on	ADP
aiua-2211	141	9	a	a	DET
aiua-2211	141	10	group	group	NOUN
aiua-2211	141	11	of	of	ADP
aiua-2211	141	12	pca	pca	PROPN
aiua-2211	141	13	patients	patient	NOUN
aiua-2211	141	14	.	.	PUNCT
aiua-2211	142	1	adnatest	adnate	ADJ
aiua-2211	142	2	results	result	NOUN
aiua-2211	142	3	on	on	ADP
aiua-2211	142	4	some	some	PRON
aiua-2211	142	5	of	of	ADP
aiua-2211	142	6	patient	patient	ADJ
aiua-2211	142	7	samples	sample	NOUN
aiua-2211	142	8	analyzed	analyze	VERB
aiua-2211	142	9	with	with	ADP
aiua-2211	142	10	the	the	DET
aiua-2211	142	11	experion	experion	NOUN
aiua-2211	142	12	instrument	instrument	NOUN
aiua-2211	142	13	(	(	PUNCT
aiua-2211	142	14	biorad	biorad	NOUN
aiua-2211	142	15	)	)	PUNCT
aiua-2211	142	16	.	.	PUNCT
aiua-2211	143	1	dna	dna	PROPN
aiua-2211	143	2	size	size	NOUN
aiua-2211	143	3	standards	standard	NOUN
aiua-2211	143	4	(	(	PUNCT
aiua-2211	143	5	ladder	ladder	NOUN
aiua-2211	143	6	)	)	PUNCT
aiua-2211	143	7	and	and	CCONJ
aiua-2211	143	8	the	the	DET
aiua-2211	143	9	pcr	pcr	ADJ
aiua-2211	143	10	positive	positive	ADJ
aiua-2211	143	11	control	control	NOUN
aiua-2211	143	12	are	be	AUX
aiua-2211	143	13	shown	show	VERB
aiua-2211	143	14	in	in	ADP
aiua-2211	143	15	the	the	DET
aiua-2211	143	16	first	first	ADJ
aiua-2211	143	17	and	and	CCONJ
aiua-2211	143	18	in	in	ADP
aiua-2211	143	19	the	the	DET
aiua-2211	143	20	last	last	ADJ
aiua-2211	143	21	lanes	lane	NOUN
aiua-2211	143	22	.	.	PUNCT
aiua-2211	144	1	the	the	DET
aiua-2211	144	2	positive	positive	ADJ
aiua-2211	144	3	control	control	NOUN
aiua-2211	144	4	generates	generate	VERB
aiua-2211	144	5	fragments	fragment	NOUN
aiua-2211	144	6	of	of	ADP
aiua-2211	144	7	following	follow	VERB
aiua-2211	144	8	sizes	size	NOUN
aiua-2211	144	9	:	:	PUNCT
aiua-2211	144	10	psma	psma	PROPN
aiua-2211	144	11	:	:	PUNCT
aiua-2211	144	12	449	449	NUM
aiua-2211	144	13	bp	bp	NOUN
aiua-2211	144	14	,	,	PUNCT
aiua-2211	144	15	psa	psa	VERB
aiua-2211	144	16	:	:	PUNCT
aiua-2211	144	17	357	357	NUM
aiua-2211	144	18	bp	bp	NOUN
aiua-2211	144	19	,	,	PUNCT
aiua-2211	144	20	egfr	egfr	NOUN
aiua-2211	144	21	:	:	PUNCT
aiua-2211	144	22	163	163	NUM
aiua-2211	144	23	bp	bp	NOUN
aiua-2211	144	24	,	,	PUNCT
aiua-2211	144	25	actin	actin	NOUN
aiua-2211	144	26	:	:	PUNCT
aiua-2211	144	27	111	111	NUM
aiua-2211	144	28	bp	bp	NOUN
aiua-2211	144	29	.	.	PUNCT
aiua-2211	145	1	patients	patient	NOUN
aiua-2211	145	2	4	4	NUM
aiua-2211	145	3	and	and	CCONJ
aiua-2211	145	4	7	7	NUM
aiua-2211	145	5	,	,	PUNCT
aiua-2211	145	6	are	be	AUX
aiua-2211	145	7	positive	positive	ADJ
aiua-2211	145	8	for	for	ADP
aiua-2211	145	9	psa	psa	NOUN
aiua-2211	145	10	and	and	CCONJ
aiua-2211	145	11	psma	psma	NOUN
aiua-2211	145	12	targets	target	NOUN
aiua-2211	145	13	.	.	PUNCT
aiua-2211	146	1	patient	patient	ADJ
aiua-2211	146	2	6	6	NUM
aiua-2211	146	3	is	be	AUX
aiua-2211	146	4	positive	positive	ADJ
aiua-2211	146	5	only	only	ADV
aiua-2211	146	6	for	for	ADP
aiua-2211	146	7	psa	psa	PROPN
aiua-2211	146	8	mrna	mrna	PROPN
aiua-2211	146	9	.	.	PUNCT
aiua-2211	147	1	the	the	DET
aiua-2211	147	2	remaining	remain	VERB
aiua-2211	147	3	lanes	lane	NOUN
aiua-2211	147	4	are	be	AUX
aiua-2211	147	5	negative	negative	ADJ
aiua-2211	147	6	for	for	ADP
aiua-2211	147	7	any	any	DET
aiua-2211	147	8	tumour	tumour	NOUN
aiua-2211	147	9	associated	associate	VERB
aiua-2211	147	10	-	-	PUNCT
aiua-2211	147	11	markers	marker	NOUN
aiua-2211	147	12	and	and	CCONJ
aiua-2211	147	13	show	show	VERB
aiua-2211	147	14	only	only	ADV
aiua-2211	147	15	the	the	DET
aiua-2211	147	16	actin	actin	NOUN
aiua-2211	147	17	band	band	NOUN
aiua-2211	147	18	as	as	ADP
aiua-2211	147	19	internal	internal	ADJ
aiua-2211	147	20	control	control	NOUN
aiua-2211	147	21	.	.	PUNCT
aiua-2211	148	1	adnatest	adnate	ADJ
aiua-2211	148	2	result	result	NOUN
aiua-2211	148	3	of	of	ADP
aiua-2211	148	4	patient	patient	ADJ
aiua-2211	148	5	n.	n.	NOUN
aiua-2211	148	6	2	2	NUM
aiua-2211	148	7	on	on	ADP
aiua-2211	148	8	4	4	NUM
aiua-2211	148	9	%	%	NOUN
aiua-2211	148	10	agarose	agarose	NOUN
aiua-2211	148	11	gel	gel	NOUN
aiua-2211	148	12	after	after	ADP
aiua-2211	148	13	five	five	NUM
aiua-2211	148	14	months	month	NOUN
aiua-2211	148	15	from	from	ADP
aiua-2211	148	16	first	first	ADJ
aiua-2211	148	17	-	-	PUNCT
aiua-2211	148	18	line	line	NOUN
aiua-2211	148	19	of	of	ADP
aiua-2211	148	20	cht	cht	PROPN
aiua-2211	148	21	administered	administer	VERB
aiua-2211	148	22	.	.	PUNCT
aiua-2211	149	1	ladder	ladder	NOUN
aiua-2211	149	2	1	1	NUM
aiua-2211	149	3	2	2	NUM
aiua-2211	149	4	3	3	NUM
aiua-2211	149	5	4	4	NUM
aiua-2211	149	6	6	6	NUM
aiua-2211	149	7	7	7	NUM
aiua-2211	149	8	10	10	NUM
aiua-2211	149	9	11	11	NUM
aiua-2211	149	10	+	+	CCONJ
aiua-2211	149	11	2	2	NUM
aiua-2211	149	12	ladder	ladder	NOUN
aiua-2211	149	13	+	+	CCONJ
aiua-2211	149	14	1a	1a	PROPN
aiua-2211	149	15	1b	1b	NUM
aiua-2211	149	16	1500	1500	NUM
aiua-2211	149	17	850	850	NUM
aiua-2211	149	18	700	700	NUM
aiua-2211	149	19	500	500	NUM
aiua-2211	149	20	400	400	NUM
aiua-2211	149	21	300	300	NUM
aiua-2211	149	22	200	200	NUM
aiua-2211	149	23	150	150	NUM
aiua-2211	149	24	100	100	NUM
aiua-2211	149	25	50	50	NUM
aiua-2211	149	26	15	15	NUM
aiua-2211	149	27	169archivio	169archivio	PROPN
aiua-2211	149	28	italiano	italiano	NOUN
aiua-2211	149	29	di	di	X
aiua-2211	149	30	urologia	urologia	PROPN
aiua-2211	149	31	e	e	PROPN
aiua-2211	149	32	andrologia	andrologia	NOUN
aiua-2211	149	33	2013	2013	NUM
aiua-2211	149	34	;	;	PUNCT
aiua-2211	149	35	85	85	NUM
aiua-2211	149	36	,	,	PUNCT
aiua-2211	149	37	4	4	NUM
aiua-2211	149	38	potential	potential	ADJ
aiua-2211	149	39	usefulness	usefulness	NOUN
aiua-2211	149	40	of	of	ADP
aiua-2211	149	41	ctc	ctc	NOUN
aiua-2211	149	42	detection	detection	NOUN
aiua-2211	149	43	in	in	ADP
aiua-2211	149	44	follow	follow	NOUN
aiua-2211	149	45	up	up	ADP
aiua-2211	149	46	of	of	ADP
aiua-2211	149	47	prostate	prostate	NOUN
aiua-2211	149	48	cancer	cancer	NOUN
aiua-2211	149	49	patients	patient	NOUN
aiua-2211	149	50	.	.	PUNCT
aiua-2211	150	1	a	a	DET
aiua-2211	150	2	preliminary	preliminary	ADJ
aiua-2211	150	3	report	report	NOUN
aiua-2211	150	4	obtained	obtain	VERB
aiua-2211	150	5	by	by	ADP
aiua-2211	150	6	using	use	VERB
aiua-2211	150	7	adnagene	adnagene	ADJ
aiua-2211	150	8	platform	platform	NOUN
aiua-2211	150	9	9	9	NUM
aiua-2211	150	10	.	.	PUNCT
aiua-2211	151	1	moreno	moreno	PROPN
aiua-2211	151	2	jg	jg	PROPN
aiua-2211	151	3	,	,	PUNCT
aiua-2211	151	4	croce	croce	PROPN
aiua-2211	151	5	cm	cm	PROPN
aiua-2211	151	6	,	,	PUNCT
aiua-2211	151	7	fischer	fischer	PROPN
aiua-2211	151	8	r	r	PROPN
aiua-2211	151	9	,	,	PUNCT
aiua-2211	151	10	et	et	PROPN
aiua-2211	151	11	al	al	PROPN
aiua-2211	151	12	.	.	PUNCT
aiua-2211	151	13	detection	detection	NOUN
aiua-2211	151	14	of	of	ADP
aiua-2211	151	15	hematogenous	hematogenous	ADJ
aiua-2211	151	16	micrometastasis	micrometastasis	NOUN
aiua-2211	151	17	in	in	ADP
aiua-2211	151	18	patients	patient	NOUN
aiua-2211	151	19	with	with	ADP
aiua-2211	151	20	prostate	prostate	NOUN
aiua-2211	151	21	cancer	cancer	NOUN
aiua-2211	151	22	.	.	PUNCT
aiua-2211	152	1	cancer	cancer	NOUN
aiua-2211	152	2	res	re	NOUN
aiua-2211	152	3	.	.	PROPN
aiua-2211	152	4	1992	1992	NUM
aiua-2211	152	5	;	;	PUNCT
aiua-2211	152	6	52:6110	52:6110	PROPN
aiua-2211	152	7	-	-	SYM
aiua-2211	152	8	12	12	NUM
aiua-2211	152	9	.	.	PUNCT
aiua-2211	153	1	10	10	NUM
aiua-2211	153	2	.	.	PUNCT
aiua-2211	154	1	katz	katz	PROPN
aiua-2211	154	2	ae	ae	PROPN
aiua-2211	154	3	,	,	PUNCT
aiua-2211	154	4	olsson	olsson	PROPN
aiua-2211	154	5	ca	can	AUX
aiua-2211	154	6	,	,	PUNCT
aiua-2211	154	7	raffo	raffo	PROPN
aiua-2211	154	8	aj	aj	PROPN
aiua-2211	154	9	,	,	PUNCT
aiua-2211	154	10	et	et	PROPN
aiua-2211	154	11	al	al	PROPN
aiua-2211	154	12	.	.	PROPN
aiua-2211	154	13	molecular	molecular	ADJ
aiua-2211	154	14	staging	staging	NOUN
aiua-2211	154	15	of	of	ADP
aiua-2211	154	16	prostate	prostate	NOUN
aiua-2211	154	17	cancer	cancer	NOUN
aiua-2211	154	18	with	with	ADP
aiua-2211	154	19	the	the	DET
aiua-2211	154	20	use	use	NOUN
aiua-2211	154	21	of	of	ADP
aiua-2211	154	22	an	an	DET
aiua-2211	154	23	enhanced	enhanced	ADJ
aiua-2211	154	24	reverse	reverse	NOUN
aiua-2211	154	25	transcriptasepcr	transcriptasepcr	ADV
aiua-2211	154	26	assay	assay	VERB
aiua-2211	154	27	.	.	PUNCT
aiua-2211	155	1	urology	urology	NOUN
aiua-2211	155	2	.	.	PUNCT
aiua-2211	155	3	1994	1994	NUM
aiua-2211	155	4	;	;	PUNCT
aiua-2211	155	5	43:765	43:765	NUM
aiua-2211	155	6	-	-	SYM
aiua-2211	155	7	75	75	NUM
aiua-2211	155	8	.	.	PUNCT
aiua-2211	155	9	11	11	NUM
aiua-2211	155	10	.	.	PUNCT
aiua-2211	156	1	sokoloff	sokoloff	PROPN
aiua-2211	156	2	mh	mh	PROPN
aiua-2211	156	3	,	,	PUNCT
aiua-2211	156	4	tso	tso	PROPN
aiua-2211	156	5	cl	cl	PROPN
aiua-2211	156	6	,	,	PUNCT
aiua-2211	156	7	kaboo	kaboo	ADJ
aiua-2211	156	8	r	r	NOUN
aiua-2211	156	9	,	,	PUNCT
aiua-2211	156	10	et	et	PROPN
aiua-2211	156	11	al	al	PROPN
aiua-2211	156	12	.	.	PROPN
aiua-2211	156	13	quantitative	quantitative	ADJ
aiua-2211	156	14	polymerase	polymerase	NOUN
aiua-2211	156	15	chain	chain	NOUN
aiua-2211	156	16	reaction	reaction	NOUN
aiua-2211	156	17	does	do	AUX
aiua-2211	156	18	not	not	PART
aiua-2211	156	19	improve	improve	VERB
aiua-2211	156	20	preoperative	preoperative	ADJ
aiua-2211	156	21	prostate	prostate	NOUN
aiua-2211	156	22	cancer	cancer	NOUN
aiua-2211	156	23	staging	staging	NOUN
aiua-2211	156	24	:	:	PUNCT
aiua-2211	156	25	a	a	DET
aiua-2211	156	26	clinicopathological	clinicopathological	ADJ
aiua-2211	156	27	molecular	molecular	ADJ
aiua-2211	156	28	analysis	analysis	NOUN
aiua-2211	156	29	of	of	ADP
aiua-2211	156	30	121	121	NUM
aiua-2211	156	31	patients	patient	NOUN
aiua-2211	156	32	.	.	PUNCT
aiua-2211	157	1	j	j	PROPN
aiua-2211	157	2	urol	urol	PROPN
aiua-2211	157	3	1996	1996	NUM
aiua-2211	157	4	;	;	PUNCT
aiua-2211	157	5	156:1560	156:1560	NUM
aiua-2211	157	6	-	-	SYM
aiua-2211	157	7	66	66	NUM
aiua-2211	157	8	.	.	PUNCT
aiua-2211	157	9	12	12	NUM
aiua-2211	157	10	.	.	PUNCT
aiua-2211	158	1	thiounn	thiounn	NOUN
aiua-2211	158	2	n	n	CCONJ
aiua-2211	158	3	,	,	PUNCT
aiua-2211	158	4	saporta	saporta	PROPN
aiua-2211	158	5	f	f	PROPN
aiua-2211	158	6	,	,	PUNCT
aiua-2211	158	7	flam	flam	PROPN
aiua-2211	158	8	ta	ta	PROPN
aiua-2211	158	9	,	,	PUNCT
aiua-2211	158	10	et	et	PROPN
aiua-2211	158	11	al	al	PROPN
aiua-2211	158	12	.	.	PUNCT
aiua-2211	158	13	positive	positive	ADJ
aiua-2211	158	14	prostate	prostate	NOUN
aiua-2211	158	15	-	-	PUNCT
aiua-2211	158	16	specific	specific	ADJ
aiua-2211	158	17	antigen	antigen	NOUN
aiua-2211	158	18	circulating	circulate	VERB
aiua-2211	158	19	cells	cell	NOUN
aiua-2211	158	20	detected	detect	VERB
aiua-2211	158	21	by	by	ADP
aiua-2211	158	22	reverse	reverse	ADJ
aiua-2211	158	23	transcriptase	transcriptase	NOUN
aiua-2211	158	24	-	-	PUNCT
aiua-2211	158	25	polymerase	polymerase	NOUN
aiua-2211	158	26	chain	chain	NOUN
aiua-2211	158	27	reaction	reaction	NOUN
aiua-2211	158	28	does	do	AUX
aiua-2211	158	29	not	not	PART
aiua-2211	158	30	imply	imply	VERB
aiua-2211	158	31	the	the	DET
aiua-2211	158	32	presence	presence	NOUN
aiua-2211	158	33	of	of	ADP
aiua-2211	158	34	prostatic	prostatic	ADJ
aiua-2211	158	35	micrometastases	micrometastase	NOUN
aiua-2211	158	36	.	.	PUNCT
aiua-2211	159	1	urology	urology	NOUN
aiua-2211	159	2	.	.	PUNCT
aiua-2211	160	1	1997	1997	NUM
aiua-2211	160	2	;	;	PUNCT
aiua-2211	160	3	50:245	50:245	NUM
aiua-2211	160	4	-	-	SYM
aiua-2211	160	5	50	50	NUM
aiua-2211	160	6	.	.	NOUN
aiua-2211	161	1	13	13	NUM
aiua-2211	161	2	.	.	X
aiua-2211	162	1	smalla	smalla	PROPN
aiua-2211	162	2	ac	ac	PROPN
aiua-2211	162	3	,	,	PUNCT
aiua-2211	162	4	gonga	gonga	VERB
aiua-2211	162	5	y	y	PROPN
aiua-2211	162	6	,	,	PUNCT
aiua-2211	162	7	oh	oh	INTJ
aiua-2211	162	8	wk	wk	INTJ
aiua-2211	162	9	,	,	PUNCT
aiua-2211	162	10	et	et	PROPN
aiua-2211	162	11	al	al	PROPN
aiua-2211	162	12	.	.	PUNCT
aiua-2211	163	1	the	the	DET
aiua-2211	163	2	emerging	emerge	VERB
aiua-2211	163	3	role	role	NOUN
aiua-2211	163	4	of	of	ADP
aiua-2211	163	5	circulating	circulate	VERB
aiua-2211	163	6	tumor	tumor	NOUN
aiua-2211	163	7	cell	cell	NOUN
aiua-2211	163	8	detection	detection	NOUN
aiua-2211	163	9	in	in	ADP
aiua-2211	163	10	genitourinary	genitourinary	ADJ
aiua-2211	163	11	cancer	cancer	NOUN
aiua-2211	163	12	.	.	PUNCT
aiua-2211	164	1	j	j	PROPN
aiua-2211	164	2	urol	urol	PROPN
aiua-2211	164	3	.	.	PUNCT
aiua-2211	164	4	2012	2012	NUM
aiua-2211	164	5	;	;	PUNCT
aiua-2211	164	6	188:21	188:21	NUM
aiua-2211	164	7	-	-	SYM
aiua-2211	164	8	6	6	NUM
aiua-2211	164	9	.	.	NOUN
aiua-2211	164	10	14	14	NUM
aiua-2211	164	11	.	.	PUNCT
aiua-2211	165	1	nagrath	nagrath	PROPN
aiua-2211	165	2	s	s	PROPN
aiua-2211	165	3	,	,	PUNCT
aiua-2211	165	4	sequist	sequist	PROPN
aiua-2211	165	5	lv	lv	PROPN
aiua-2211	165	6	,	,	PUNCT
aiua-2211	165	7	maheswaran	maheswaran	NOUN
aiua-2211	165	8	s	s	PROPN
aiua-2211	165	9	,	,	PUNCT
aiua-2211	165	10	et	et	PROPN
aiua-2211	165	11	al	al	PROPN
aiua-2211	165	12	.	.	PUNCT
aiua-2211	165	13	isolation	isolation	NOUN
aiua-2211	165	14	of	of	ADP
aiua-2211	165	15	rare	rare	ADJ
aiua-2211	165	16	circulating	circulate	VERB
aiua-2211	165	17	tumour	tumour	NOUN
aiua-2211	165	18	cells	cell	NOUN
aiua-2211	165	19	in	in	ADP
aiua-2211	165	20	cancer	cancer	NOUN
aiua-2211	165	21	patients	patient	NOUN
aiua-2211	165	22	by	by	ADP
aiua-2211	165	23	microchip	microchip	NOUN
aiua-2211	165	24	technology	technology	NOUN
aiua-2211	165	25	.	.	PUNCT
aiua-2211	166	1	nature	nature	NOUN
aiua-2211	166	2	.	.	PUNCT
aiua-2211	167	1	2007	2007	NUM
aiua-2211	167	2	;	;	PUNCT
aiua-2211	167	3	450:1235	450:1235	NUM
aiua-2211	167	4	-	-	SYM
aiua-2211	167	5	9	9	NUM
aiua-2211	167	6	.	.	NOUN
aiua-2211	167	7	15	15	NUM
aiua-2211	167	8	.	.	PUNCT
aiua-2211	168	1	ellis	ellis	PROPN
aiua-2211	168	2	wj	wj	PROPN
aiua-2211	168	3	,	,	PUNCT
aiua-2211	168	4	pfitzenmaier	pfitzenmaier	NOUN
aiua-2211	168	5	j	j	PROPN
aiua-2211	168	6	,	,	PUNCT
aiua-2211	168	7	colli	colli	PROPN
aiua-2211	168	8	j	j	PROPN
aiua-2211	168	9	,	,	PUNCT
aiua-2211	168	10	et	et	PROPN
aiua-2211	168	11	al	al	PROPN
aiua-2211	168	12	.	.	PUNCT
aiua-2211	168	13	detection	detection	NOUN
aiua-2211	168	14	and	and	CCONJ
aiua-2211	168	15	isolation	isolation	NOUN
aiua-2211	168	16	of	of	ADP
aiua-2211	168	17	prostate	prostate	NOUN
aiua-2211	168	18	cancer	cancer	NOUN
aiua-2211	168	19	cells	cell	NOUN
aiua-2211	168	20	from	from	ADP
aiua-2211	168	21	peripheral	peripheral	ADJ
aiua-2211	168	22	blood	blood	NOUN
aiua-2211	168	23	and	and	CCONJ
aiua-2211	168	24	bone	bone	NOUN
aiua-2211	168	25	marrow	marrow	NOUN
aiua-2211	168	26	.	.	PUNCT
aiua-2211	169	1	urology	urology	NOUN
aiua-2211	169	2	.	.	PUNCT
aiua-2211	170	1	2003	2003	NUM
aiua-2211	170	2	;	;	PUNCT
aiua-2211	170	3	61:277	61:277	NUM
aiua-2211	170	4	-	-	PUNCT
aiua-2211	170	5	81	81	NUM
aiua-2211	170	6	.	.	PUNCT
aiua-2211	171	1	16	16	NUM
aiua-2211	171	2	.	.	PUNCT
aiua-2211	172	1	moreno	moreno	PROPN
aiua-2211	172	2	jg	jg	PROPN
aiua-2211	172	3	,	,	PUNCT
aiua-2211	172	4	miller	miller	PROPN
aiua-2211	172	5	mc	mc	PROPN
aiua-2211	172	6	,	,	PUNCT
aiua-2211	172	7	gross	gross	PROPN
aiua-2211	172	8	s	s	PROPN
aiua-2211	172	9	,	,	PUNCT
aiua-2211	172	10	et	et	PROPN
aiua-2211	172	11	al	al	PROPN
aiua-2211	172	12	.	.	PUNCT
aiua-2211	173	1	circulating	circulate	VERB
aiua-2211	173	2	tumor	tumor	NOUN
aiua-2211	173	3	cells	cell	NOUN
aiua-2211	173	4	predict	predict	VERB
aiua-2211	173	5	survival	survival	NOUN
aiua-2211	173	6	in	in	ADP
aiua-2211	173	7	patients	patient	NOUN
aiua-2211	173	8	with	with	ADP
aiua-2211	173	9	metastatic	metastatic	ADJ
aiua-2211	173	10	prostate	prostate	NOUN
aiua-2211	173	11	cancer	cancer	NOUN
aiua-2211	173	12	.	.	PUNCT
aiua-2211	174	1	urology	urology	NOUN
aiua-2211	174	2	.	.	PUNCT
aiua-2211	175	1	2005	2005	NUM
aiua-2211	175	2	;	;	PUNCT
aiua-2211	175	3	65:713	65:713	NUM
aiua-2211	175	4	-	-	SYM
aiua-2211	175	5	18	18	NUM
aiua-2211	175	6	.	.	PUNCT
aiua-2211	176	1	17	17	NUM
aiua-2211	176	2	.	.	PUNCT
aiua-2211	177	1	danila	danila	PROPN
aiua-2211	177	2	dc	dc	PROPN
aiua-2211	177	3	,	,	PUNCT
aiua-2211	177	4	heller	heller	NOUN
aiua-2211	177	5	g	g	PROPN
aiua-2211	177	6	,	,	PUNCT
aiua-2211	177	7	gignac	gignac	PROPN
aiua-2211	177	8	ga	ga	PROPN
aiua-2211	177	9	,	,	PUNCT
aiua-2211	177	10	et	et	PROPN
aiua-2211	177	11	al	al	PROPN
aiua-2211	177	12	.	.	PUNCT
aiua-2211	177	13	circulating	circulate	VERB
aiua-2211	177	14	tumor	tumor	NOUN
aiua-2211	177	15	cell	cell	NOUN
aiua-2211	177	16	number	number	NOUN
aiua-2211	177	17	and	and	CCONJ
aiua-2211	177	18	prognosis	prognosis	NOUN
aiua-2211	177	19	in	in	ADP
aiua-2211	177	20	progressive	progressive	ADJ
aiua-2211	177	21	castration	castration	NOUN
aiua-2211	177	22	-	-	PUNCT
aiua-2211	177	23	resistant	resistant	ADJ
aiua-2211	177	24	prostate	prostate	NOUN
aiua-2211	177	25	cancer	cancer	NOUN
aiua-2211	177	26	.	.	PUNCT
aiua-2211	178	1	clin	clin	PROPN
aiua-2211	178	2	cancer	cancer	NOUN
aiua-2211	178	3	res	re	NOUN
aiua-2211	178	4	.	.	PUNCT
aiua-2211	178	5	2007	2007	NUM
aiua-2211	178	6	;	;	PUNCT
aiua-2211	178	7	13:7053	13:7053	NUM
aiua-2211	178	8	-	-	SYM
aiua-2211	178	9	58	58	NUM
aiua-2211	178	10	.	.	PUNCT
aiua-2211	179	1	18	18	NUM
aiua-2211	179	2	.	.	X
aiua-2211	179	3	de	de	X
aiua-2211	179	4	bono	bono	X
aiua-2211	179	5	js	js	PROPN
aiua-2211	179	6	,	,	PUNCT
aiua-2211	179	7	scher	scher	PROPN
aiua-2211	179	8	hi	hi	PROPN
aiua-2211	179	9	,	,	PUNCT
aiua-2211	179	10	montgomery	montgomery	PROPN
aiua-2211	179	11	rb	rb	PROPN
aiua-2211	179	12	,	,	PUNCT
aiua-2211	179	13	et	et	PROPN
aiua-2211	179	14	al	al	PROPN
aiua-2211	179	15	.	.	PUNCT
aiua-2211	180	1	circulating	circulate	VERB
aiua-2211	180	2	tumor	tumor	NOUN
aiua-2211	180	3	cells	cell	NOUN
aiua-2211	180	4	predict	predict	VERB
aiua-2211	180	5	survival	survival	NOUN
aiua-2211	180	6	benefit	benefit	NOUN
aiua-2211	180	7	from	from	ADP
aiua-2211	180	8	treatment	treatment	NOUN
aiua-2211	180	9	in	in	ADP
aiua-2211	180	10	metastatic	metastatic	ADJ
aiua-2211	180	11	castration	castration	NOUN
aiua-2211	180	12	resistant	resistant	ADJ
aiua-2211	180	13	prostate	prostate	NOUN
aiua-2211	180	14	cancer	cancer	NOUN
aiua-2211	180	15	.	.	PUNCT
aiua-2211	181	1	clin	clin	PROPN
aiua-2211	181	2	cancer	cancer	NOUN
aiua-2211	181	3	res	re	NOUN
aiua-2211	181	4	.	.	PUNCT
aiua-2211	181	5	2008	2008	NUM
aiua-2211	181	6	;	;	PUNCT
aiua-2211	181	7	14:6302	14:6302	NUM
aiua-2211	181	8	-	-	SYM
aiua-2211	181	9	09	09	NUM
aiua-2211	181	10	.	.	PUNCT
aiua-2211	182	1	19	19	NUM
aiua-2211	182	2	.	.	X
aiua-2211	183	1	scher	scher	PROPN
aiua-2211	183	2	hi	hi	PROPN
aiua-2211	183	3	,	,	PUNCT
aiua-2211	183	4	jia	jia	PROPN
aiua-2211	183	5	x	x	PROPN
aiua-2211	183	6	,	,	PUNCT
aiua-2211	183	7	de	de	X
aiua-2211	183	8	bono	bono	X
aiua-2211	183	9	js	js	PROPN
aiua-2211	183	10	,	,	PUNCT
aiua-2211	183	11	et	et	PROPN
aiua-2211	183	12	al	al	PROPN
aiua-2211	183	13	.	.	PUNCT
aiua-2211	184	1	circulating	circulate	VERB
aiua-2211	184	2	tumour	tumour	NOUN
aiua-2211	184	3	cells	cell	NOUN
aiua-2211	184	4	as	as	ADP
aiua-2211	184	5	prognostic	prognostic	ADJ
aiua-2211	184	6	markers	marker	NOUN
aiua-2211	184	7	in	in	ADP
aiua-2211	184	8	progressive	progressive	ADJ
aiua-2211	184	9	,	,	PUNCT
aiua-2211	184	10	castration	castration	NOUN
aiua-2211	184	11	-	-	PUNCT
aiua-2211	184	12	resistant	resistant	ADJ
aiua-2211	184	13	prostate	prostate	NOUN
aiua-2211	184	14	cancer	cancer	NOUN
aiua-2211	184	15	:	:	PUNCT
aiua-2211	184	16	a	a	DET
aiua-2211	184	17	reanalysis	reanalysis	NOUN
aiua-2211	184	18	of	of	ADP
aiua-2211	184	19	immc38	immc38	ADJ
aiua-2211	184	20	trial	trial	NOUN
aiua-2211	184	21	data	datum	NOUN
aiua-2211	184	22	.	.	PUNCT
aiua-2211	185	1	lancet	lancet	PROPN
aiua-2211	185	2	oncol	oncol	PROPN
aiua-2211	185	3	.	.	PUNCT
aiua-2211	186	1	2009	2009	NUM
aiua-2211	186	2	;	;	PUNCT
aiua-2211	186	3	10:233	10:233	NUM
aiua-2211	186	4	-	-	SYM
aiua-2211	186	5	9	9	NUM
aiua-2211	186	6	.	.	NOUN
aiua-2211	186	7	20	20	NUM
aiua-2211	186	8	.	.	PUNCT
aiua-2211	187	1	stott	stott	PROPN
aiua-2211	187	2	sl	sl	PROPN
aiua-2211	187	3	,	,	PUNCT
aiua-2211	187	4	lee	lee	PROPN
aiua-2211	187	5	rj	rj	PROPN
aiua-2211	187	6	,	,	PUNCT
aiua-2211	187	7	nagrath	nagrath	PROPN
aiua-2211	187	8	s	s	PROPN
aiua-2211	187	9	,	,	PUNCT
aiua-2211	187	10	et	et	PROPN
aiua-2211	187	11	al	al	PROPN
aiua-2211	187	12	.	.	PUNCT
aiua-2211	187	13	isolation	isolation	NOUN
aiua-2211	187	14	and	and	CCONJ
aiua-2211	187	15	characterization	characterization	NOUN
aiua-2211	187	16	of	of	ADP
aiua-2211	187	17	circulating	circulate	VERB
aiua-2211	187	18	tumor	tumor	NOUN
aiua-2211	187	19	cells	cell	NOUN
aiua-2211	187	20	from	from	ADP
aiua-2211	187	21	patients	patient	NOUN
aiua-2211	187	22	with	with	ADP
aiua-2211	187	23	localized	localized	ADJ
aiua-2211	187	24	and	and	CCONJ
aiua-2211	187	25	metastatic	metastatic	ADJ
aiua-2211	187	26	prostate	prostate	NOUN
aiua-2211	187	27	cancer	cancer	NOUN
aiua-2211	187	28	.	.	PUNCT
aiua-2211	188	1	sci	sci	PROPN
aiua-2211	188	2	transl	transl	PROPN
aiua-2211	188	3	med	med	PROPN
aiua-2211	188	4	.	.	PUNCT
aiua-2211	189	1	2010	2010	NUM
aiua-2211	189	2	;	;	PUNCT
aiua-2211	189	3	2:25ra23	2:25ra23	NUM
aiua-2211	189	4	.	.	NOUN
aiua-2211	189	5	21	21	NUM
aiua-2211	189	6	.	.	PUNCT
aiua-2211	190	1	rosenberg	rosenberg	PROPN
aiua-2211	190	2	r	r	PROPN
aiua-2211	190	3	,	,	PUNCT
aiua-2211	190	4	gertler	gertler	NOUN
aiua-2211	190	5	r	r	NOUN
aiua-2211	190	6	,	,	PUNCT
aiua-2211	190	7	friederichs	friederichs	PROPN
aiua-2211	190	8	j	j	PROPN
aiua-2211	190	9	,	,	PUNCT
aiua-2211	190	10	et	et	PROPN
aiua-2211	190	11	al	al	PROPN
aiua-2211	190	12	.	.	PROPN
aiua-2211	190	13	comparison	comparison	NOUN
aiua-2211	190	14	of	of	ADP
aiua-2211	190	15	two	two	NUM
aiua-2211	190	16	density	density	NOUN
aiua-2211	190	17	gradient	gradient	NOUN
aiua-2211	190	18	centrifugation	centrifugation	NOUN
aiua-2211	190	19	systems	system	NOUN
aiua-2211	190	20	for	for	ADP
aiua-2211	190	21	the	the	DET
aiua-2211	190	22	enrichment	enrichment	NOUN
aiua-2211	190	23	of	of	ADP
aiua-2211	190	24	disseminated	disseminate	VERB
aiua-2211	190	25	tumor	tumor	NOUN
aiua-2211	190	26	cells	cell	NOUN
aiua-2211	190	27	in	in	ADP
aiua-2211	190	28	blood	blood	NOUN
aiua-2211	190	29	.	.	PUNCT
aiua-2211	191	1	cytometry	cytometry	NOUN
aiua-2211	191	2	.	.	PUNCT
aiua-2211	192	1	2002;49:150	2002;49:150	NUM
aiua-2211	192	2	-	-	SYM
aiua-2211	192	3	58	58	NUM
aiua-2211	192	4	.	.	PUNCT
aiua-2211	193	1	22	22	NUM
aiua-2211	193	2	.	.	PUNCT
aiua-2211	193	3	todenhöfer	todenhöfer	NOUN
aiua-2211	193	4	t	t	PROPN
aiua-2211	193	5	,	,	PUNCT
aiua-2211	193	6	hennenlotter	hennenlotter	PROPN
aiua-2211	193	7	j	j	PROPN
aiua-2211	193	8	,	,	PUNCT
aiua-2211	193	9	feyerabend	feyerabend	PROPN
aiua-2211	193	10	s	s	PROPN
aiua-2211	193	11	,	,	PUNCT
aiua-2211	193	12	et	et	PROPN
aiua-2211	193	13	al	al	PROPN
aiua-2211	193	14	.	.	PROPN
aiua-2211	194	1	preliminary	preliminary	ADJ
aiua-2211	194	2	experience	experience	NOUN
aiua-2211	194	3	on	on	ADP
aiua-2211	194	4	the	the	DET
aiua-2211	194	5	use	use	NOUN
aiua-2211	194	6	of	of	ADP
aiua-2211	194	7	the	the	DET
aiua-2211	194	8	adnatest	adnate	ADJ
aiua-2211	194	9	®	®	NOUN
aiua-2211	194	10	system	system	NOUN
aiua-2211	194	11	for	for	ADP
aiua-2211	194	12	detection	detection	NOUN
aiua-2211	194	13	of	of	ADP
aiua-2211	194	14	circulating	circulate	VERB
aiua-2211	194	15	tumor	tumor	NOUN
aiua-2211	194	16	cells	cell	NOUN
aiua-2211	194	17	in	in	ADP
aiua-2211	194	18	prostate	prostate	NOUN
aiua-2211	194	19	cancer	cancer	NOUN
aiua-2211	194	20	patients	patient	NOUN
aiua-2211	194	21	.	.	PUNCT
aiua-2211	195	1	anticancer	anticancer	NOUN
aiua-2211	195	2	res	re	NOUN
aiua-2211	195	3	.	.	PUNCT
aiua-2211	195	4	2012	2012	NUM
aiua-2211	195	5	;	;	PUNCT
aiua-2211	195	6	32:3507	32:3507	NUM
aiua-2211	195	7	-	-	X
aiua-2211	195	8	13	13	NUM
aiua-2211	195	9	.	.	PUNCT
aiua-2211	195	10	23	23	NUM
aiua-2211	195	11	.	.	PUNCT
aiua-2211	196	1	reynolds	reynolds	PROPN
aiua-2211	196	2	ma	ma	PROPN
aiua-2211	196	3	.	.	PROPN
aiua-2211	196	4	molecular	molecular	ADJ
aiua-2211	196	5	alterations	alteration	NOUN
aiua-2211	196	6	in	in	ADP
aiua-2211	196	7	prostate	prostate	NOUN
aiua-2211	196	8	cancer	cancer	NOUN
aiua-2211	196	9	.	.	PUNCT
aiua-2211	197	1	cancer	cancer	PROPN
aiua-2211	197	2	lett	lett	PROPN
aiua-2211	197	3	.	.	PUNCT
aiua-2211	197	4	2008	2008	NUM
aiua-2211	197	5	;	;	PUNCT
aiua-2211	198	1	271:13	271:13	X
aiua-2211	198	2	-	-	SYM
aiua-2211	198	3	24	24	NUM
aiua-2211	198	4	.	.	PUNCT
aiua-2211	198	5	24	24	NUM
aiua-2211	198	6	.	.	PUNCT
aiua-2211	199	1	bickers	bicker	NOUN
aiua-2211	199	2	b	b	NUM
aiua-2211	199	3	,	,	PUNCT
aiua-2211	199	4	aukim	aukim	NOUN
aiua-2211	199	5	-	-	PUNCT
aiua-2211	199	6	hastie	hastie	PROPN
aiua-2211	199	7	c.	c.	PROPN
aiua-2211	199	8	new	new	ADJ
aiua-2211	199	9	molecular	molecular	ADJ
aiua-2211	199	10	biomarkers	biomarker	NOUN
aiua-2211	199	11	for	for	ADP
aiua-2211	199	12	the	the	DET
aiua-2211	199	13	prognosis	prognosis	NOUN
aiua-2211	199	14	and	and	CCONJ
aiua-2211	199	15	management	management	NOUN
aiua-2211	199	16	of	of	ADP
aiua-2211	199	17	prostate	prostate	NOUN
aiua-2211	199	18	cancer	cancer	NOUN
aiua-2211	199	19	--	--	PUNCT
aiua-2211	199	20	the	the	DET
aiua-2211	199	21	post	post	NOUN
aiua-2211	199	22	psa	psa	PROPN
aiua-2211	199	23	era	era	NOUN
aiua-2211	199	24	.	.	PUNCT
aiua-2211	200	1	anticancer	anticancer	NOUN
aiua-2211	200	2	res	re	NOUN
aiua-2211	200	3	.	.	PUNCT
aiua-2211	200	4	2009	2009	NUM
aiua-2211	200	5	;	;	PUNCT
aiua-2211	200	6	29:3289	29:3289	NUM
aiua-2211	200	7	-	-	PUNCT
aiua-2211	200	8	98	98	NUM
aiua-2211	200	9	.	.	PUNCT
aiua-2211	201	1	25	25	NUM
aiua-2211	201	2	.	.	PUNCT
aiua-2211	202	1	d’amico	d’amico	PROPN
aiua-2211	202	2	av	av	PROPN
aiua-2211	202	3	,	,	PUNCT
aiua-2211	202	4	whittington	whittington	PROPN
aiua-2211	202	5	r	r	PROPN
aiua-2211	202	6	,	,	PUNCT
aiua-2211	202	7	broderick	broderick	PROPN
aiua-2211	202	8	ga	ga	PROPN
aiua-2211	202	9	.	.	PROPN
aiua-2211	202	10	biochemical	biochemical	ADJ
aiua-2211	202	11	outcome	outcome	NOUN
aiua-2211	202	12	after	after	ADP
aiua-2211	202	13	radical	radical	ADJ
aiua-2211	202	14	prostatectomy	prostatectomy	NOUN
aiua-2211	202	15	,	,	PUNCT
aiua-2211	202	16	external	external	ADJ
aiua-2211	202	17	beam	beam	NOUN
aiua-2211	202	18	radiation	radiation	NOUN
aiua-2211	202	19	therapy	therapy	NOUN
aiua-2211	202	20	or	or	CCONJ
aiua-2211	202	21	interstitial	interstitial	ADJ
aiua-2211	202	22	radiation	radiation	NOUN
aiua-2211	202	23	therapy	therapy	NOUN
aiua-2211	202	24	for	for	ADP
aiua-2211	202	25	clinically	clinically	ADV
aiua-2211	202	26	localized	localize	VERB
aiua-2211	202	27	prostate	prostate	NOUN
aiua-2211	202	28	cancer	cancer	NOUN
aiua-2211	202	29	.	.	PUNCT
aiua-2211	203	1	jama	jama	PROPN
aiua-2211	203	2	.	.	PUNCT
aiua-2211	204	1	1998	1998	NUM
aiua-2211	204	2	;	;	PUNCT
aiua-2211	204	3	280:969	280:969	PROPN
aiua-2211	204	4	-	-	PUNCT
aiua-2211	204	5	74	74	NUM
aiua-2211	204	6	.	.	PUNCT
aiua-2211	204	7	26	26	NUM
aiua-2211	204	8	.	.	PUNCT
aiua-2211	204	9	benoy	benoy	VERB
aiua-2211	204	10	ih	ih	NOUN
aiua-2211	204	11	,	,	PUNCT
aiua-2211	204	12	elst	elst	PROPN
aiua-2211	204	13	h	h	PROPN
aiua-2211	204	14	,	,	PUNCT
aiua-2211	204	15	van	van	PROPN
aiua-2211	204	16	dam	dam	PROPN
aiua-2211	204	17	p	p	NOUN
aiua-2211	204	18	,	,	PUNCT
aiua-2211	204	19	et	et	PROPN
aiua-2211	204	20	al	al	PROPN
aiua-2211	204	21	.	.	PUNCT
aiua-2211	205	1	detection	detection	NOUN
aiua-2211	205	2	of	of	ADP
aiua-2211	205	3	circulating	circulate	VERB
aiua-2211	205	4	tumour	tumour	NOUN
aiua-2211	205	5	cells	cell	NOUN
aiua-2211	205	6	in	in	ADP
aiua-2211	205	7	blood	blood	NOUN
aiua-2211	205	8	by	by	ADP
aiua-2211	205	9	quantitative	quantitative	ADJ
aiua-2211	205	10	real	real	ADJ
aiua-2211	205	11	-	-	PUNCT
aiua-2211	205	12	time	time	NOUN
aiua-2211	205	13	rt	rt	NOUN
aiua-2211	205	14	-	-	PUNCT
aiua-2211	205	15	pcr	pcr	ADJ
aiua-2211	205	16	:	:	PUNCT
aiua-2211	205	17	effect	effect	NOUN
aiua-2211	205	18	of	of	ADP
aiua-2211	205	19	pre	pre	ADJ
aiua-2211	205	20	-	-	ADJ
aiua-2211	205	21	analytical	analytical	ADJ
aiua-2211	205	22	time	time	NOUN
aiua-2211	205	23	.	.	PUNCT
aiua-2211	206	1	clin	clin	PROPN
aiua-2211	206	2	chem	chem	NOUN
aiua-2211	206	3	lab	lab	NOUN
aiua-2211	206	4	med	me	VERB
aiua-2211	206	5	.	.	PUNCT
aiua-2211	206	6	2006	2006	NUM
aiua-2211	206	7	;	;	PUNCT
aiua-2211	206	8	44:1082	44:1082	X
aiua-2211	206	9	-	-	PUNCT
aiua-2211	206	10	7	7	NUM
aiua-2211	206	11	.	.	NOUN
aiua-2211	206	12	27	27	NUM
aiua-2211	206	13	.	.	PUNCT
aiua-2211	207	1	cohen	cohen	PROPN
aiua-2211	207	2	sj	sj	PROPN
aiua-2211	207	3	,	,	PUNCT
aiua-2211	207	4	punt	punt	VERB
aiua-2211	207	5	c	c	PROPN
aiua-2211	207	6	j	j	PROPN
aiua-2211	207	7	,	,	PUNCT
aiua-2211	207	8	iannotti	iannotti	PROPN
aiua-2211	207	9	n	n	CCONJ
aiua-2211	207	10	,	,	PUNCT
aiua-2211	207	11	et	et	PROPN
aiua-2211	207	12	al	al	PROPN
aiua-2211	207	13	.	.	PROPN
aiua-2211	207	14	relationship	relationship	NOUN
aiua-2211	207	15	of	of	ADP
aiua-2211	207	16	circulating	circulate	VERB
aiua-2211	207	17	tumor	tumor	NOUN
aiua-2211	207	18	cells	cell	NOUN
aiua-2211	207	19	to	to	ADP
aiua-2211	207	20	tumor	tumor	NOUN
aiua-2211	207	21	response	response	NOUN
aiua-2211	207	22	,	,	PUNCT
aiua-2211	207	23	progression	progression	NOUN
aiua-2211	207	24	-	-	PUNCT
aiua-2211	207	25	free	free	ADJ
aiua-2211	207	26	survival	survival	NOUN
aiua-2211	207	27	,	,	PUNCT
aiua-2211	207	28	and	and	CCONJ
aiua-2211	207	29	overall	overall	ADJ
aiua-2211	207	30	survival	survival	NOUN
aiua-2211	207	31	in	in	ADP
aiua-2211	207	32	patients	patient	NOUN
aiua-2211	207	33	with	with	ADP
aiua-2211	207	34	metastatic	metastatic	ADJ
aiua-2211	207	35	colorectal	colorectal	ADJ
aiua-2211	207	36	cancer	cancer	NOUN
aiua-2211	207	37	.	.	PUNCT
aiua-2211	208	1	j	j	PROPN
aiua-2211	208	2	clin	clin	PROPN
aiua-2211	208	3	oncol	oncol	PROPN
aiua-2211	208	4	.	.	PUNCT
aiua-2211	209	1	2008	2008	NUM
aiua-2211	209	2	;	;	PUNCT
aiua-2211	209	3	26:3213	26:3213	NUM
aiua-2211	209	4	-	-	SYM
aiua-2211	209	5	21	21	NUM
aiua-2211	209	6	.	.	PUNCT
aiua-2211	210	1	28	28	NUM
aiua-2211	210	2	.	.	PUNCT
aiua-2211	211	1	torino	torino	PROPN
aiua-2211	211	2	f	f	PROPN
aiua-2211	211	3	,	,	PUNCT
aiua-2211	211	4	bonmassar	bonmassar	ADJ
aiua-2211	211	5	e	e	NOUN
aiua-2211	211	6	,	,	PUNCT
aiua-2211	211	7	bonmassar	bonmassar	PROPN
aiua-2211	211	8	l	l	NOUN
aiua-2211	211	9	,	,	PUNCT
aiua-2211	211	10	et	et	PROPN
aiua-2211	211	11	al	al	PROPN
aiua-2211	211	12	.	.	PROPN
aiua-2211	212	1	circulating	circulate	VERB
aiua-2211	212	2	tumor	tumor	NOUN
aiua-2211	212	3	cells	cell	NOUN
aiua-2211	212	4	in	in	ADP
aiua-2211	212	5	colorectal	colorectal	ADJ
aiua-2211	212	6	cancer	cancer	NOUN
aiua-2211	212	7	patients	patient	NOUN
aiua-2211	212	8	.	.	PUNCT
aiua-2211	213	1	treat	treat	PROPN
aiua-2211	213	2	rev	rev	PROPN
aiua-2211	213	3	.	.	PROPN
aiua-2211	213	4	2013	2013	NUM
aiua-2211	213	5	jan	jan	PROPN
aiua-2211	213	6	30	30	NUM
aiua-2211	213	7	.	.	PUNCT
aiua-2211	214	1	doi	doi	NOUN
aiua-2211	214	2	:	:	PUNCT
aiua-2211	214	3	pii	pii	NOUN
aiua-2211	214	4	:	:	PUNCT
aiua-2211	214	5	s0305	s0305	NOUN
aiua-2211	214	6	-	-	PUNCT
aiua-2211	214	7	7372(13)00002	7372(13)00002	NOUN
aiua-2211	214	8	-	-	NOUN
aiua-2211	214	9	9	9	NUM
aiua-2211	214	10	.	.	PUNCT
aiua-2211	215	1	10.1016	10.1016	NUM
aiua-2211	215	2	/	/	SYM
aiua-2211	215	3	j.ctrv.2012.12.007	j.ctrv.2012.12.007	NOUN
aiua-2211	215	4	.	.	PUNCT
aiua-2211	216	1	29	29	NUM
aiua-2211	216	2	.	.	PUNCT
aiua-2211	217	1	farace	farace	PROPN
aiua-2211	217	2	f	f	PROPN
aiua-2211	217	3	,	,	PUNCT
aiua-2211	217	4	massard	massard	NOUN
aiua-2211	217	5	c	c	NOUN
aiua-2211	217	6	,	,	PUNCT
aiua-2211	217	7	vimond	vimond	ADJ
aiua-2211	217	8	n	n	CCONJ
aiua-2211	217	9	,	,	PUNCT
aiua-2211	217	10	et	et	PROPN
aiua-2211	217	11	al	al	PROPN
aiua-2211	217	12	.	.	PUNCT
aiua-2211	218	1	a	a	DET
aiua-2211	218	2	direct	direct	ADJ
aiua-2211	218	3	comparison	comparison	NOUN
aiua-2211	218	4	of	of	ADP
aiua-2211	218	5	cellsearch	cellsearch	NOUN
aiua-2211	218	6	and	and	CCONJ
aiua-2211	218	7	iset	iset	VERB
aiua-2211	218	8	for	for	ADP
aiua-2211	218	9	circulating	circulate	VERB
aiua-2211	218	10	tumour	tumour	NOUN
aiua-2211	218	11	-	-	PUNCT
aiua-2211	218	12	cell	cell	NOUN
aiua-2211	218	13	detection	detection	NOUN
aiua-2211	218	14	in	in	ADP
aiua-2211	218	15	patients	patient	NOUN
aiua-2211	218	16	with	with	ADP
aiua-2211	218	17	metastatic	metastatic	ADJ
aiua-2211	218	18	carcinomas	carcinoma	NOUN
aiua-2211	218	19	.	.	PUNCT
aiua-2211	219	1	british	british	ADJ
aiua-2211	219	2	journal	journal	PROPN
aiua-2211	219	3	of	of	ADP
aiua-2211	219	4	cancer	cancer	NOUN
aiua-2211	219	5	.	.	PUNCT
aiua-2211	220	1	2011	2011	NUM
aiua-2211	220	2	;	;	PUNCT
aiua-2211	220	3	105:847	105:847	NUM
aiua-2211	220	4	-	-	SYM
aiua-2211	220	5	53	53	NUM
aiua-2211	220	6	.	.	PUNCT
aiua-2211	220	7	30	30	NUM
aiua-2211	220	8	.	.	PUNCT
aiua-2211	221	1	alix	alix	PROPN
aiua-2211	221	2	-	-	PUNCT
aiua-2211	221	3	panabieres	panabiere	NOUN
aiua-2211	221	4	c	c	NOUN
aiua-2211	221	5	,	,	PUNCT
aiua-2211	221	6	riethdorf	riethdorf	PROPN
aiua-2211	221	7	s	s	PROPN
aiua-2211	221	8	,	,	PUNCT
aiua-2211	221	9	pantel	pantel	PROPN
aiua-2211	221	10	k.	k.	PROPN
aiua-2211	221	11	circulating	circulate	VERB
aiua-2211	221	12	tumor	tumor	NOUN
aiua-2211	221	13	cells	cell	NOUN
aiua-2211	221	14	and	and	CCONJ
aiua-2211	221	15	bone	bone	NOUN
aiua-2211	221	16	marrow	marrow	NOUN
aiua-2211	221	17	micrometastasis	micrometastasis	PROPN
aiua-2211	221	18	clin	clin	PROPN
aiua-2211	221	19	.	.	PUNCT
aiua-2211	222	1	cancer	cancer	NOUN
aiua-2211	222	2	res	re	NOUN
aiua-2211	222	3	2008	2008	NUM
aiua-2211	222	4	;	;	PUNCT
aiua-2211	222	5	14:5013	14:5013	NUM
aiua-2211	222	6	-	-	SYM
aiua-2211	222	7	21	21	NUM
aiua-2211	222	8	.	.	PUNCT
aiua-2211	223	1	31	31	NUM
aiua-2211	223	2	.	.	PUNCT
aiua-2211	224	1	allan	allan	PROPN
aiua-2211	224	2	al	al	PROPN
aiua-2211	224	3	,	,	PUNCT
aiua-2211	224	4	vantyghem	vantyghem	PROPN
aiua-2211	224	5	sa	sa	PROPN
aiua-2211	224	6	,	,	PUNCT
aiua-2211	224	7	tuck	tuck	PROPN
aiua-2211	224	8	ab	ab	PROPN
aiua-2211	224	9	,	,	PUNCT
aiua-2211	224	10	et	et	PROPN
aiua-2211	224	11	al	al	PROPN
aiua-2211	224	12	.	.	PUNCT
aiua-2211	224	13	detection	detection	NOUN
aiua-2211	224	14	and	and	CCONJ
aiua-2211	224	15	quantification	quantification	NOUN
aiua-2211	224	16	of	of	ADP
aiua-2211	224	17	circulating	circulate	VERB
aiua-2211	224	18	tumor	tumor	NOUN
aiua-2211	224	19	cells	cell	NOUN
aiua-2211	224	20	in	in	ADP
aiua-2211	224	21	mouse	mouse	NOUN
aiua-2211	224	22	models	model	NOUN
aiua-2211	224	23	of	of	ADP
aiua-2211	224	24	human	human	ADJ
aiua-2211	224	25	breast	breast	NOUN
aiua-2211	224	26	cancer	cancer	NOUN
aiua-2211	224	27	using	use	VERB
aiua-2211	224	28	immunomagnetic	immunomagnetic	ADJ
aiua-2211	224	29	enrichment	enrichment	NOUN
aiua-2211	224	30	and	and	CCONJ
aiua-2211	224	31	multiparameter	multiparameter	NOUN
aiua-2211	224	32	flow	flow	NOUN
aiua-2211	224	33	cytometry	cytometry	NOUN
aiua-2211	224	34	.	.	PUNCT
aiua-2211	225	1	cytometry	cytometry	NOUN
aiua-2211	225	2	.	.	PUNCT
aiua-2211	226	1	2005	2005	NUM
aiua-2211	226	2	;	;	PUNCT
aiua-2211	226	3	65:4	65:4	NUM
aiua-2211	226	4	-	-	SYM
aiua-2211	226	5	14	14	NUM
aiua-2211	226	6	.	.	PUNCT
aiua-2211	227	1	32	32	NUM
aiua-2211	227	2	.	.	PUNCT
aiua-2211	228	1	wiedswang	wiedswang	PROPN
aiua-2211	228	2	g	g	PROPN
aiua-2211	228	3	,	,	PUNCT
aiua-2211	228	4	borgen	borgen	PROPN
aiua-2211	228	5	e	e	PROPN
aiua-2211	228	6	,	,	PUNCT
aiua-2211	228	7	schirmer	schirmer	PROPN
aiua-2211	228	8	c	c	PROPN
aiua-2211	228	9	,	,	PUNCT
aiua-2211	228	10	et	et	PROPN
aiua-2211	228	11	al	al	PROPN
aiua-2211	228	12	.	.	PROPN
aiua-2211	228	13	comparison	comparison	NOUN
aiua-2211	228	14	of	of	ADP
aiua-2211	228	15	the	the	DET
aiua-2211	228	16	clinical	clinical	ADJ
aiua-2211	228	17	significance	significance	NOUN
aiua-2211	228	18	of	of	ADP
aiua-2211	228	19	occult	occult	NOUN
aiua-2211	228	20	tumor	tumor	NOUN
aiua-2211	228	21	cells	cell	NOUN
aiua-2211	228	22	in	in	ADP
aiua-2211	228	23	blood	blood	NOUN
aiua-2211	228	24	and	and	CCONJ
aiua-2211	228	25	bone	bone	NOUN
aiua-2211	228	26	marrow	marrow	NOUN
aiua-2211	228	27	in	in	ADP
aiua-2211	228	28	breast	breast	NOUN
aiua-2211	228	29	cancer	cancer	NOUN
aiua-2211	228	30	.	.	PUNCT
aiua-2211	229	1	int	int	NOUN
aiua-2211	229	2	j	j	PROPN
aiua-2211	229	3	cancer	cancer	NOUN
aiua-2211	229	4	.	.	PUNCT
aiua-2211	230	1	2006	2006	NUM
aiua-2211	230	2	;	;	PUNCT
aiua-2211	230	3	118:2013	118:2013	NUM
aiua-2211	230	4	-	-	SYM
aiua-2211	230	5	19	19	NUM
aiua-2211	230	6	.	.	NOUN
aiua-2211	230	7	33	33	NUM
aiua-2211	230	8	.	.	PUNCT
aiua-2211	231	1	wong	wong	PROPN
aiua-2211	231	2	ns	ns	PROPN
aiua-2211	231	3	,	,	PUNCT
aiua-2211	231	4	kahn	kahn	PROPN
aiua-2211	231	5	hj	hj	PROPN
aiua-2211	231	6	,	,	PUNCT
aiua-2211	231	7	zhang	zhang	PROPN
aiua-2211	231	8	l	l	PROPN
aiua-2211	231	9	,	,	PUNCT
aiua-2211	231	10	et	et	PROPN
aiua-2211	231	11	al	al	PROPN
aiua-2211	231	12	.	.	PUNCT
aiua-2211	232	1	prognostic	prognostic	ADJ
aiua-2211	232	2	significance	significance	NOUN
aiua-2211	232	3	of	of	ADP
aiua-2211	232	4	circulating	circulate	VERB
aiua-2211	232	5	tumour	tumour	ADJ
aiua-2211	232	6	cells	cell	NOUN
aiua-2211	232	7	enumerated	enumerate	VERB
aiua-2211	232	8	after	after	ADP
aiua-2211	232	9	filtration	filtration	NOUN
aiua-2211	232	10	enrichment	enrichment	NOUN
aiua-2211	232	11	in	in	ADP
aiua-2211	232	12	early	early	ADJ
aiua-2211	232	13	and	and	CCONJ
aiua-2211	232	14	metastatic	metastatic	ADJ
aiua-2211	232	15	breast	breast	NOUN
aiua-2211	232	16	cancer	cancer	NOUN
aiua-2211	232	17	patients	patient	NOUN
aiua-2211	232	18	.	.	PUNCT
aiua-2211	233	1	breast	breast	NOUN
aiua-2211	233	2	cancer	cancer	NOUN
aiua-2211	233	3	res	re	NOUN
aiua-2211	233	4	treat	treat	NOUN
aiua-2211	233	5	.	.	PUNCT
aiua-2211	234	1	2006	2006	NUM
aiua-2211	234	2	;	;	PUNCT
aiua-2211	234	3	99:63	99:63	NUM
aiua-2211	234	4	-	-	SYM
aiua-2211	234	5	9	9	NUM
aiua-2211	234	6	.	.	NOUN
aiua-2211	234	7	34	34	NUM
aiua-2211	234	8	.	.	PUNCT
aiua-2211	235	1	stathopoulou	stathopoulou	PROPN
aiua-2211	235	2	a	a	PRON
aiua-2211	235	3	,	,	PUNCT
aiua-2211	235	4	vlachonikolis	vlachonikolis	PROPN
aiua-2211	235	5	i	i	PROPN
aiua-2211	235	6	,	,	PUNCT
aiua-2211	235	7	mavroudis	mavroudis	PROPN
aiua-2211	235	8	d	d	PROPN
aiua-2211	235	9	,	,	PUNCT
aiua-2211	235	10	et	et	PROPN
aiua-2211	235	11	al	al	PROPN
aiua-2211	235	12	.	.	PUNCT
aiua-2211	236	1	molecular	molecular	ADJ
aiua-2211	236	2	detection	detection	NOUN
aiua-2211	236	3	of	of	ADP
aiua-2211	236	4	cytokeratin-19	cytokeratin-19	PROPN
aiua-2211	236	5	-	-	PUNCT
aiua-2211	236	6	positive	positive	ADJ
aiua-2211	236	7	cells	cell	NOUN
aiua-2211	236	8	in	in	ADP
aiua-2211	236	9	the	the	DET
aiua-2211	236	10	peripheral	peripheral	ADJ
aiua-2211	236	11	blood	blood	NOUN
aiua-2211	236	12	of	of	ADP
aiua-2211	236	13	patients	patient	NOUN
aiua-2211	236	14	with	with	ADP
aiua-2211	236	15	operable	operable	ADJ
aiua-2211	236	16	breast	breast	NOUN
aiua-2211	236	17	cancer	cancer	NOUN
aiua-2211	236	18	:	:	PUNCT
aiua-2211	236	19	evaluation	evaluation	NOUN
aiua-2211	236	20	of	of	ADP
aiua-2211	236	21	their	their	PRON
aiua-2211	236	22	prognostic	prognostic	ADJ
aiua-2211	236	23	significance	significance	NOUN
aiua-2211	236	24	.	.	PUNCT
aiua-2211	237	1	j	j	PROPN
aiua-2211	237	2	clin	clin	PROPN
aiua-2211	237	3	oncol	oncol	PROPN
aiua-2211	237	4	.	.	PUNCT
aiua-2211	238	1	2002	2002	NUM
aiua-2211	238	2	;	;	PUNCT
aiua-2211	238	3	20:3404	20:3404	X
aiua-2211	238	4	-	-	SYM
aiua-2211	238	5	12	12	NUM
aiua-2211	238	6	.	.	NOUN
aiua-2211	239	1	35	35	NUM
aiua-2211	239	2	.	.	PUNCT
aiua-2211	239	3	benoy	benoy	VERB
aiua-2211	239	4	ih	ih	NOUN
aiua-2211	239	5	,	,	PUNCT
aiua-2211	239	6	elst	elst	PROPN
aiua-2211	239	7	h	h	PROPN
aiua-2211	239	8	,	,	PUNCT
aiua-2211	239	9	van	van	PROPN
aiua-2211	239	10	der	der	PROPN
aiua-2211	239	11	auwera	auwera	PROPN
aiua-2211	239	12	i	i	PRON
aiua-2211	239	13	,	,	PUNCT
aiua-2211	239	14	et	et	PROPN
aiua-2211	239	15	al	al	PROPN
aiua-2211	239	16	.	.	PUNCT
aiua-2211	240	1	real	real	ADJ
aiua-2211	240	2	-	-	PUNCT
aiua-2211	240	3	time	time	NOUN
aiua-2211	240	4	rt	rt	PROPN
aiua-2211	240	5	–	–	PUNCT
aiua-2211	240	6	pcr	pcr	NOUN
aiua-2211	240	7	correlates	correlate	VERB
aiua-2211	240	8	with	with	ADP
aiua-2211	240	9	immunocytochemistry	immunocytochemistry	NOUN
aiua-2211	240	10	for	for	ADP
aiua-2211	240	11	the	the	DET
aiua-2211	240	12	detection	detection	NOUN
aiua-2211	240	13	of	of	ADP
aiua-2211	240	14	disseminated	disseminate	VERB
aiua-2211	240	15	epithelial	epithelial	ADJ
aiua-2211	240	16	cells	cell	NOUN
aiua-2211	240	17	in	in	ADP
aiua-2211	240	18	bone	bone	NOUN
aiua-2211	240	19	marrow	marrow	NOUN
aiua-2211	240	20	aspirates	aspirate	NOUN
aiua-2211	240	21	of	of	ADP
aiua-2211	240	22	patients	patient	NOUN
aiua-2211	240	23	with	with	ADP
aiua-2211	240	24	breast	breast	NOUN
aiua-2211	240	25	cancer	cancer	NOUN
aiua-2211	240	26	.	.	PUNCT
aiua-2211	241	1	br	br	PROPN
aiua-2211	241	2	j	j	PROPN
aiua-2211	241	3	cancer	cancer	NOUN
aiua-2211	241	4	.	.	PUNCT
aiua-2211	242	1	2004	2004	NUM
aiua-2211	242	2	;	;	PUNCT
aiua-2211	243	1	91:1813	91:1813	NUM
aiua-2211	243	2	-	-	SYM
aiua-2211	243	3	20	20	NUM
aiua-2211	243	4	.	.	PUNCT
aiua-2211	243	5	36	36	NUM
aiua-2211	243	6	.	.	PUNCT
aiua-2211	244	1	doyen	doyen	PROPN
aiua-2211	244	2	j	j	PROPN
aiua-2211	244	3	,	,	PUNCT
aiua-2211	244	4	alix	alix	PROPN
aiua-2211	244	5	-	-	PUNCT
aiua-2211	244	6	panabièresd	panabièresd	NOUN
aiua-2211	244	7	c	c	NOUN
aiua-2211	244	8	,	,	PUNCT
aiua-2211	244	9	hofmanb	hofmanb	NOUN
aiua-2211	244	10	p	p	X
aiua-2211	244	11	,	,	PUNCT
aiua-2211	244	12	et	et	PROPN
aiua-2211	244	13	al	al	PROPN
aiua-2211	244	14	.	.	PROPN
aiua-2211	245	1	circulating	circulate	VERB
aiua-2211	245	2	tumor	tumor	NOUN
aiua-2211	245	3	cells	cell	NOUN
aiua-2211	245	4	in	in	ADP
aiua-2211	245	5	prostate	prostate	NOUN
aiua-2211	245	6	cancer	cancer	NOUN
aiua-2211	245	7	:	:	PUNCT
aiua-2211	245	8	a	a	DET
aiua-2211	245	9	potential	potential	ADJ
aiua-2211	245	10	surrogate	surrogate	ADJ
aiua-2211	245	11	marker	marker	NOUN
aiua-2211	245	12	of	of	ADP
aiua-2211	245	13	survival	survival	NOUN
aiua-2211	245	14	.	.	PUNCT
aiua-2211	246	1	crit	crit	PROPN
aiua-2211	246	2	rev	rev	VERB
aiua-2211	246	3	oncol	oncol	ADJ
aiua-2211	246	4	hematol	hematol	NOUN
aiua-2211	246	5	.	.	PUNCT
aiua-2211	247	1	2012	2012	NUM
aiua-2211	247	2	;	;	PUNCT
aiua-2211	247	3	81:241	81:241	NUM
aiua-2211	247	4	-	-	SYM
aiua-2211	247	5	56	56	NUM
aiua-2211	247	6	.	.	PUNCT
aiua-2211	248	1	37	37	NUM
aiua-2211	248	2	.	.	PUNCT
aiua-2211	249	1	perner	perner	PROPN
aiua-2211	249	2	s	s	PROPN
aiua-2211	249	3	,	,	PUNCT
aiua-2211	249	4	hofer	hofer	PROPN
aiua-2211	249	5	kr	kr	PROPN
aiua-2211	249	6	,	,	PUNCT
aiua-2211	249	7	shah	shah	NOUN
aiua-2211	249	8	rb	rb	PROPN
aiua-2211	249	9	,	,	PUNCT
aiua-2211	249	10	et	et	PROPN
aiua-2211	249	11	al	al	PROPN
aiua-2211	249	12	.	.	PUNCT
aiua-2211	249	13	prostate	prostate	NOUN
aiua-2211	249	14	-	-	PUNCT
aiua-2211	249	15	specific	specific	ADJ
aiua-2211	249	16	membrane	membrane	NOUN
aiua-2211	249	17	antigen	antigen	NOUN
aiua-2211	249	18	expression	expression	NOUN
aiua-2211	249	19	as	as	ADP
aiua-2211	249	20	a	a	DET
aiua-2211	249	21	predictor	predictor	NOUN
aiua-2211	249	22	of	of	ADP
aiua-2211	249	23	prostate	prostate	NOUN
aiua-2211	249	24	cancer	cancer	NOUN
aiua-2211	249	25	progression	progression	NOUN
aiua-2211	249	26	.	.	PUNCT
aiua-2211	250	1	hum	hum	PROPN
aiua-2211	250	2	pathol	pathol	PROPN
aiua-2211	250	3	.	.	PUNCT
aiua-2211	251	1	2007	2007	NUM
aiua-2211	251	2	;	;	PUNCT
aiua-2211	251	3	38:696	38:696	NUM
aiua-2211	251	4	-	-	SYM
aiua-2211	251	5	701	701	NUM
aiua-2211	251	6	.	.	PUNCT
aiua-2211	252	1	38	38	NUM
aiua-2211	252	2	.	.	PUNCT
aiua-2211	253	1	israeli	israeli	ADJ
aiua-2211	253	2	rs	rs	PROPN
aiua-2211	253	3	,	,	PUNCT
aiua-2211	253	4	powell	powell	PROPN
aiua-2211	253	5	ct	ct	PROPN
aiua-2211	253	6	,	,	PUNCT
aiua-2211	253	7	corr	corr	PROPN
aiua-2211	253	8	jg	jg	PROPN
aiua-2211	253	9	,	,	PUNCT
aiua-2211	253	10	et	et	PROPN
aiua-2211	253	11	al	al	PROPN
aiua-2211	253	12	.	.	PUNCT
aiua-2211	253	13	expression	expression	NOUN
aiua-2211	253	14	of	of	ADP
aiua-2211	253	15	the	the	DET
aiua-2211	253	16	prostatespecific	prostatespecific	ADJ
aiua-2211	253	17	membrane	membrane	NOUN
aiua-2211	253	18	antigen	antigen	ADV
aiua-2211	253	19	.	.	PUNCT
aiua-2211	254	1	cancer	cancer	NOUN
aiua-2211	254	2	res	re	NOUN
aiua-2211	254	3	.	.	PUNCT
aiua-2211	254	4	1994	1994	NUM
aiua-2211	254	5	;	;	PUNCT
aiua-2211	254	6	54:1807	54:1807	NUM
aiua-2211	254	7	-	-	SYM
aiua-2211	254	8	11	11	NUM
aiua-2211	254	9	.	.	NOUN
aiua-2211	254	10	39	39	NUM
aiua-2211	254	11	.	.	PUNCT
aiua-2211	255	1	sobin	sobin	PROPN
aiua-2211	255	2	lh	lh	PROPN
aiua-2211	255	3	,	,	PUNCT
aiua-2211	255	4	gospodariwicz	gospodariwicz	VERB
aiua-2211	255	5	m	m	PROPN
aiua-2211	255	6	,	,	PUNCT
aiua-2211	255	7	wittekind	wittekind	ADP
aiua-2211	255	8	c.	c.	PROPN
aiua-2211	255	9	tnm	tnm	PROPN
aiua-2211	255	10	classification	classification	NOUN
aiua-2211	255	11	of	of	ADP
aiua-2211	255	12	malignant	malignant	ADJ
aiua-2211	255	13	tumors	tumor	NOUN
aiua-2211	255	14	.	.	PUNCT
aiua-2211	256	1	uicc	uicc	ADJ
aiua-2211	256	2	international	international	PROPN
aiua-2211	256	3	union	union	NOUN
aiua-2211	256	4	against	against	ADP
aiua-2211	256	5	cancer	cancer	NOUN
aiua-2211	256	6	.	.	PUNCT
aiua-2211	257	1	7th	7th	ADJ
aiua-2211	257	2	edn	edn	NOUN
aiua-2211	257	3	.	.	PUNCT
aiua-2211	258	1	wiley	wiley	PROPN
aiua-2211	258	2	-	-	PUNCT
aiua-2211	258	3	blackwell	blackwell	PROPN
aiua-2211	258	4	.	.	PUNCT
aiua-2211	259	1	2009	2009	NUM
aiua-2211	259	2	;	;	PUNCT
aiua-2211	259	3	pp	pp	X
aiua-2211	259	4	.	.	PUNCT
aiua-2211	260	1	243	243	NUM
aiua-2211	260	2	-	-	SYM
aiua-2211	260	3	248	248	NUM
aiua-2211	260	4	.	.	PUNCT
aiua-2211	261	1	40	40	NUM
aiua-2211	261	2	.	.	PUNCT
aiua-2211	262	1	andreopoulou	andreopoulou	PROPN
aiua-2211	262	2	e	e	PROPN
aiua-2211	262	3	,	,	PUNCT
aiua-2211	262	4	yang	yang	PROPN
aiua-2211	262	5	ly	ly	PROPN
aiua-2211	262	6	,	,	PUNCT
aiua-2211	262	7	rangel	rangel	PROPN
aiua-2211	262	8	km	km	PROPN
aiua-2211	262	9	,	,	PUNCT
aiua-2211	262	10	et	et	PROPN
aiua-2211	262	11	al	al	PROPN
aiua-2211	262	12	.	.	PROPN
aiua-2211	262	13	comparison	comparison	NOUN
aiua-2211	262	14	of	of	ADP
aiua-2211	262	15	assay	assay	ADJ
aiua-2211	262	16	methods	method	NOUN
aiua-2211	262	17	for	for	ADP
aiua-2211	262	18	detection	detection	NOUN
aiua-2211	262	19	of	of	ADP
aiua-2211	262	20	circulating	circulate	VERB
aiua-2211	262	21	tumor	tumor	NOUN
aiua-2211	262	22	cells	cell	NOUN
aiua-2211	262	23	in	in	ADP
aiua-2211	262	24	metastatic	metastatic	ADJ
aiua-2211	262	25	breast	breast	NOUN
aiua-2211	262	26	cancer	cancer	NOUN
aiua-2211	262	27	:	:	PUNCT
aiua-2211	262	28	adnagen	adnagen	PROPN
aiua-2211	262	29	adnatest	adnate	ADJ
aiua-2211	262	30	breastcancer	breastcancer	PROPN
aiua-2211	262	31	select	select	ADJ
aiua-2211	262	32	/	/	SYM
aiua-2211	262	33	detect	detect	NOUN
aiua-2211	262	34	™	™	NOUN
aiua-2211	262	35	versus	versus	ADP
aiua-2211	262	36	veridex	veridex	NOUN
aiua-2211	262	37	cellsearch	cellsearch	ADJ
aiua-2211	262	38	™	™	ADJ
aiua-2211	262	39	system	system	NOUN
aiua-2211	262	40	.	.	PUNCT
aiua-2211	263	1	int	int	NOUN
aiua-2211	263	2	j	j	PROPN
aiua-2211	263	3	cancer	cancer	NOUN
aiua-2211	263	4	.	.	PUNCT
aiua-2211	264	1	2012	2012	NUM
aiua-2211	264	2	;	;	PUNCT
aiua-2211	264	3	130:1590	130:1590	NUM
aiua-2211	264	4	-	-	SYM
aiua-2211	264	5	7	7	NUM
aiua-2211	264	6	.	.	PUNCT
aiua-2211	264	7	correspondence	correspondence	NOUN
aiua-2211	264	8	giuseppe	giuseppe	PROPN
aiua-2211	264	9	albino	albino	PROPN
aiua-2211	264	10	,	,	PUNCT
aiua-2211	264	11	md	md	PROPN
aiua-2211	264	12	(	(	PUNCT
aiua-2211	264	13	corresponding	corresponding	ADJ
aiua-2211	264	14	author	author	NOUN
aiua-2211	264	15	)	)	PUNCT
aiua-2211	264	16	urology	urology	NOUN
aiua-2211	264	17	unit	unit	NOUN
aiua-2211	264	18	ospedale	ospedale	PROPN
aiua-2211	264	19	di	di	PROPN
aiua-2211	264	20	andria	andria	PROPN
aiua-2211	264	21	asl	asl	PROPN
aiua-2211	264	22	bat	bat	NOUN
aiua-2211	264	23	ospedale	ospedale	NOUN
aiua-2211	264	24	“	"	PUNCT
aiua-2211	264	25	l.	l.	PROPN
aiua-2211	264	26	bonomo	bonomo	PROPN
aiua-2211	264	27	”	"	PUNCT
aiua-2211	264	28	,	,	PUNCT
aiua-2211	264	29	andria	andria	PROPN
aiua-2211	264	30	,	,	PUNCT
aiua-2211	264	31	italy	italy	PROPN
aiua-2211	264	32	peppealbino@hotmail.com	peppealbino@hotmail.com	PROPN
aiua-2211	265	1	francesca	francesca	PROPN
aiua-2211	265	2	vendittelli	vendittelli	PROPN
aiua-2211	265	3	,	,	PUNCT
aiua-2211	265	4	md	md	PROPN
aiua-2211	265	5	carmela	carmela	PROPN
aiua-2211	265	6	paolillo	paolillo	PROPN
aiua-2211	265	7	,	,	PUNCT
aiua-2211	265	8	md	md	PROPN
aiua-2211	265	9	cecilia	cecilia	PROPN
aiua-2211	265	10	zuppi	zuppi	PROPN
aiua-2211	265	11	,	,	PUNCT
aiua-2211	265	12	md	md	PROPN
aiua-2211	265	13	ettore	ettore	NOUN
aiua-2211	265	14	capoluongo	capoluongo	PROPN
aiua-2211	265	15	,	,	PUNCT
aiua-2211	265	16	md	md	PROPN
aiua-2211	265	17	laboratory	laboratory	NOUN
aiua-2211	265	18	of	of	ADP
aiua-2211	265	19	molecular	molecular	ADJ
aiua-2211	265	20	diagnostics	diagnostic	NOUN
aiua-2211	265	21	,	,	PUNCT
aiua-2211	265	22	institute	institute	NOUN
aiua-2211	265	23	of	of	ADP
aiua-2211	265	24	biochemistry	biochemistry	NOUN
aiua-2211	265	25	and	and	CCONJ
aiua-2211	265	26	clinical	clinical	ADJ
aiua-2211	265	27	biochemistry	biochemistry	NOUN
aiua-2211	265	28	,	,	PUNCT
aiua-2211	265	29	catholic	catholic	PROPN
aiua-2211	265	30	university	university	PROPN
aiua-2211	265	31	,	,	PUNCT
aiua-2211	265	32	largo	largo	PROPN
aiua-2211	265	33	a.	a.	PROPN
aiua-2211	265	34	gemelli	gemelli	PROPN
aiua-2211	265	35	8	8	NUM
aiua-2211	265	36	00168	00168	NUM
aiua-2211	265	37	rome	rome	PROPN
aiua-2211	265	38	,	,	PUNCT
aiua-2211	265	39	italy	italy	PROPN